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Summary 
Agrobacterium tumefaciens uses a mechanism similar to plasmid conjugation to 
transfer its oncogenic T-DNA to a plant cell. During Agrobacterium-mediated T-DNA 
transfer to plant cells, VirD2 plays an important role in guiding the transfer of T-complex 
composed of single-stranded T-DNA, VirD2 and VirE2. We used the VirD2 protein as an 
affinity ligand to isolate VirD2-binding protein(s). By using pull down assay and peptide-
mass-fingerprinting match, we identified an A. tumefaciens protein that can specifically 
bind VirD2. This VirD2-binding protein is designated VBP1.  
Genome-wide sequence analysis showed that A. tumefaciens has two additional 
genes highly homologous to vbp1; they are designated vbp2 and vbp3. Like VBP1 both 
VBP2 and VBP3 could bind VirD2 specifically. Mutational analysis of vbp genes 
demonstrated that the three vbp genes could functionally complement each other. 
Consequently, only inactivation of all three vbp genes highly attenuated the bacterial 
ability to cause tumors on plants. All the VBP proteins possessed a putative 
nucleotidyltransferase motif in their N-termini and a putative higher eukaryotes and 
prokaryotes nucleotide-binding (HEPN) domain in their C-termini. The predicted amino 
acid numbers of three VBP proteins are 313, 311 and 308, respectively. Although vbp1 is 
harbored on the cryptic plasmid AT, vbp2 and vbp3 reside on the linear chromosome. The 
loci of vbp2 and vbp3 on the linear chromosome are close to each other. 
The interaction between VBP1 and VirD2 was shown to be specific and strong. The 
presumable VirD2-T-strand-VirE2 complex could be pulled down by VBP1 from AS-
induced A. tumefaciens cell extract. By using co-immunoprecipitation, we confirmed that 
 xv
the presumable VirD2-T-strand-VirE2 complex exists in the A. tumefaciens cell extract. 
To gain an insight into VBP biochemical function, we analyzed the functions of genes 
adjacent to vbp2 and vbp3. It was found that the gene organization of the region between 
vbp2 and vbp3 is similar to a DNA transfer and replication (Dtr) system. VBP proteins 
are most likely auxiliary proteins of T-DNA processing nucleoprotein complex, which is 
also known as relaxosome. The redundancy of three homologs for the VirD2-binding 
protein indicates a conserved function that is important for the gene transfer.  
On the other hand, the T-complex is exported out of the bacterial cell by a type IV 
secretion system (T4SS) composed of VirB proteins. VBP proteins were used to pull 
down the T4SS components. Both the pull-down and co-immunoprecipitation 
experiments showed that VBP1 interacts with VirD4, VirB4 and VirB11. VBP proteins 
were demonstrated to be cytoplasmic proteins. VBP proteins can bind both T-complex 
and T4SS transporter specifically; and the vbp triple mutant has a highly attenuated 
ability to cause tumors on plants. This suggests that VBP recruits the T-complex to the 
transport site, thus coupling the two events in the conjugal transfer. It was shown that 
VBP protein is also involved in the conjugation of some plasmids. Therefore, our work 
defined VBP proteins as a new class of proteins that are responsible for recruiting 
proteins that can in turn recruit the cytoplasmic DNA transfer intermediate to the 
membrane transporter. 
 xvi
Chapter 1  Literature Review 
 
1.1. Introduction 
1.1.1. Chronicle and importance of Agrobacterium tumefaciens research 
Agrobacterium tumefaciens is a soil phytopathogen. It causes the crown gall disease 
of dicotyledonous plants, which is characterized by a tumorous phenotype. The first 
paper that identified A. tumefaciens as the causal agent of crown gall disease was 
published in 1907 (Smith and Townsend, 1907). This organism is capable of inducing 
tumors at wound sites on the stems, crowns and roots of hundreds of dicotyledonous 
plants. At the beginning of the last century, crown gall disease was considered a major 
problem in horticultural production. This disease caused significant reduction of crop 
yield in many perennial horticultural crops (Kennedy, 1980), such as grape (Schroth et al., 
1988), apple (Ricker et al., 1959), and cherry (Lopatin, 1939). All these horticultural 
crops are woody species and propagated by grafting scions onto rootstocks. The grafting 
causes wounds that are usually covered by soil and thus provides an excellent infection 
point for A. tumefaciens cells. In 1941, White and Braun demonstrated that crown gall 
tumor tissue could be permanently transformed by only transient exposure to the 
pathogen of A. tumefaciens (White and Braun, 1941). Thereafter, they proposed that a 
‘tumor-inducing capacity’ was transmitted from A. tumefaciens to plant tissue (Braun, 
1947; Braun and Mandle, 1948). However, the transformation principle remained elusive 
until the advent of molecular techniques that provided the first evidence that crown gall 
tumors, cultured axenically, contained DNA of A. tumefaciens origin (Schilperoort et al., 
1967). In 1974, the tumor-inducing (Ti) plasmid was identified to be essential for the 
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crown gall-inducing ability (Van Larebeke et al., 1974; Zaenen et al., 1974). Southern 
hybridization turned out to prove that the bacterial DNA, which encodes genes 
responsible for both the tumor formation and the opine production, originates from the Ti 
plasmid and ultimately resulted in the discovery of T-DNA (transferred DNA), specific 
segments transferred from A. tumefaciens to plant cells (Chilton et al., 1977; Chilton et 
al., 1978; Depicker et al., 1978). The T-DNA is referred to as the T-region when located 
on the Ti-plasmid. The T-region is delimited by 25-bp directly repeated sequences, which 
are called T-DNA border sequences. The T-DNAs, when transferred to plant cells, 
encode enzymes for the synthesis of the plant hormones auxin and cytokinin and strain-
specific low molecular weight amino acid and sugar phosphate derivatives called opines. 
The massive accumulation of auxin and cytokinin in transformed plant cells causes 
uncontrolled cell proliferation and the synthesis of nutritive opines that can be 
metabolized specifically by the infecting A. tumefaciens strain. Thus, the opine-producing 
tumor effectively creates an ecological niche specifically suited to the infecting A. 
tumefaciens strain (for reviews see Escobar and Dandekar, 2003; Hooykaas and 
Schilperoort, 1992). Besides the T-DNAs, Ti-plasmid also contains most of the genes that 
are required for the transfer of the T-DNAs from A. tumefaciens to the plant cell. 
Initial study of these plant tumors was intended to reveal the molecular mechanism 
that may be relevant to animal neoplasia. Although no relationship was found between 
animal and plant tumors, A. tumefaciens and plant tumor were proved to be of intrinsic 
interest because the tumorous growth was shown to result from the transfer of T-DNA 
from bacterial Ti-plasmid to the plant cell and the stable integration of the T-DNA to 
plant genome. The demonstration that wild-type T-DNA coding region can be replaced 
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by any DNA sequence without any effect on its transfer from A. tumefaciens to the plant 
inspired the promise that A. tumefaciens might be used as gene vector to deliver genetic 
material into plants. In the early of 1980’s, two events about A. tumefaciens mediated T-
DNA transfer signaled the beginning of the era of plant genetic engineering. First, the Ti-
plasmid in A. tumefaciens was used as a gene vector system to produce the first 
transgenic plant (Zambryski et al., 1983). The healthy transgenic plants had the ability to 
transmit the disarmed T-DNA, including the foreign genes, to their progeny. Second, 
non-plant antibiotic-resistance genes, for example, a bacterial kanamycin-resistance gene, 
could be driven by a plant-active promotor to function efficiently in plant cells. This 
enabled accurate selection of transformed plant cells (Beven, 1984). The eventual success 
of using A. tumefaciens as a gene vector to create transgenic plants was viewed as a 
prospect and a “wish”. The future of A. tumefaciens as a gene vector for crop 
improvement began to look bright. During the 1990’s, maize, a monocot plant species 
that was thought to be outside the A. tumefaciens “normal host range”, was successfully 
transformed by A. tumefaciens (Chilton, 1993). Today, many agronomically and 
horticulturally important plant species are routinely transformed using A. tumefaciens, 
and the list of plant species that can be genetically transformed by A. tumefaciens seems 
to grow daily (for review see Gelvin, 2003). At present, many economically important 
crops, such as corn, soybeans, cotton, canola, potatoes, and tomatoes, were improved by 
A. tumefaciens–mediated genetic transformation and their transgenic varieties are 
growing worldwide (Valentine, 2003). Recently, the species that is susceptible to A. 
tumefaciens–mediated transformation was broadened to yeast (Piers et al., 1996), fungi 
(Groot et al., 1998), and mammalian cells (Kunik et al., 2001). 
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In addition to the technical application as a gene vector to create transgenic plants, A. 
tumefaciens also provides a fascinating model system to study the wide variety of 
biological processes, including bacterial detection of host signaling chemicals (Winans, 
1992), intercellular transfer of macromolecules (Christie, 2001), importing of 
nucleoprotein into plant nuclei (Ziemienowicz et al., 2001), and interbacterial chemical 
signaling via autoinducer-type quorum sensing (Newton and Fray, 2004). 
  1.1.2. Basic process of A. tumefaciens–mediated T-DNA transfer 
The process of A. tumefaciens–mediated T-DNA transfer consists of several critical 
steps: (1) Sensing of plant chemical signals and inducing of virulence (vir) proteins. The 
chemical signals released by wounded plant are perceived by a VirA/VirG two-
component system of A. tumefaciens, which leads to the transcription of virulence (vir) 
gene promoters and thus the expression of vir proteins. (2) T-DNA processing. T-DNA is 
nicked by VirD2/VirD1 from the T-region of Ti plasmid and forms a single-stranded 
linear T-strand by strand displacement; the T-strand is coated by VirE2 molecules along 
the entire T-strand length and forms a T-complex. (3) Attaching of A. tumefaciens to 
plant and transferring of T-complex to plant cell. A. tumefaciens cell attaches to plant and 
transfers the T-complex from A. tumefaciens to plant cell by a VirD4/B T4SS transport 
system. (4) Targeting of T-complex to plant cell nucleus and integrating of T-DNA into 
plant genome. The T-complex is transported into the nucleoplasm under the assistance of 
some host proteins and then integrated into plant genomic DNA. (5) Expressing of T-
DNA in plant cell and inducing of plant tumor. The T-DNA genes encode phytohormone 
synthases that lead to the uncontrolled proliferation of plant cell and opine synthases that 
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provide nutritive compounds to infecting bacteria. The basic steps of A. tumefaciens-
mediated T-DNA transfer are summarized in Fig. 1.1. 
1.2. Sensing of Plant Signal Molecules and vir Gene Induction 
1.2.1. Chemotaxis of A. tumefaciens 
A. tumefaciens is a motile organism with peritrichous flagellae and possesses a 
highly sensitive chemotaxis system. It could respond to a range of sugars and amino acids 
and was attracted to these sugars and amino acids (Loake et al., 1988). A. tumefaciens 
mutants deficient in motility and in chemotaxis were fully virulent when inoculated 
directly, but when used to inoculate soil, which was air-dried and then to used to grow 
plants, these mutants were completely avirulent, indicating that the motility and 
chemotaxis is critical to A. tumefaciens infection under natural conditions (Hawes and 
Smith, 1989). Wild-type A. tumefaciens strains both containing and lacking Ti plasmid 
exhibited chemotaxis toward excised root tips from all plant species tested and toward 
root cap cells of pea and maize, suggesting that the majority of chemotactic responses in 
A. tumefaciens appear to be chromosomally encoded (Loake et al., 1988; Parke et al., 
1987). However, the chemotactic response to some phenolic compounds, for example 
acetosyringone, which were identified as strong vir gene inducers, is controversial. Some 
reports showed that chemotaxis toward acetosyringone requires the presence of a Ti 
plasmid, specifically the regulatory genes virA and virG, and occurs with a threshold 
sensitivity of < 10-8 M, 1000-fold below the maximal vir-inducing concentration (Ashby 
et al., 1988; Shaw et al., 1989). Whereas, reports from other groups indicated that 
acetosyringone did not elicit chemotaxis at any concentrations (Hawes and Smith, 1989) 
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Fig. 1.1. Basic steps of the Agrobacterium infection process. Critical
steps that occur to or within the bacterium (chemical signaling, vir gene
induction, and T-DNA processing) and within the plant cell (bacterial
attachment, T-DNA transfer, nuclear targeting, and T-DNA integration) are
highlighted, along with genes and/or proteins known to mediate these
events (Cited from Gelvin, 2000). 
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and chemotaxis toward related compounds did not require the Ti plasmid (Park et al., 
1987). So, it does seem difficult to rationalize a role for acetosyringone and the 
regulatory genes virA and virG in chemotaxis. 
1.2.2. vir gene induction 
Many genes are involved in A. tumefaciens-mediated T-DNA transfer, but most of 
the genes required for T-DNA transfer are found on the vir region of Ti plasmid. This vir 
region comprises at least six essential operons (virA, virB, virC, virD, virE, and virG,) 
and two non-essential operons (virF and virH) encoding approximate 25 proteins. These 
proteins are termed virulence (vir) proteins and required for the sensing of plant signal 
molecules as well as the processing, transfer, nuclear localization, and perhaps integration 
of T-DNA into the plant genome. The protein number encoded by each operon differs, 
virA, virG and virF encode only one protein; virE, virC, and virH encode two proteins; 
virD encodes four proteins and virB encodes eleven proteins. Only virA and virG are 
constitutively expressed. The transcription of all other vir operons is coordinately induced 
during infection by a family of host-released phenolic compounds in combination with 
some monosaccharides and extracellular acidity in the range of pH 5.0 to 5.8. Virtually 
all of the genes in the vir region are tightly regulated by two proteins VirA and VirG 
encoded by virA operon and virG operon. 
The inducible expression of vir operons was first found by using the cocultivation of 
A. tumerfaciens with mesophyll protoplasts, isolated plant cells or cultured tissues 
(Stachel et al., 1986). In vegetatively growing bacteria, only virA and virG are expressed 
at significant level. However, when Agrobacteria are cocultivated with the susceptible 
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plant cells, the expression of virB, virC, virD, virE and virG becomes induced to high 
levels (Engstrom et al., 1987). The partially purified extracts of conditioned media that 
are from root cultures can also induce the expression of vir operons, demonstrating that 
the vir-inducing factors are some diffusible plant cell metabolites. By screening 40 plant-
derived chemicals, Bolton et al (1986) identified seven simple plant phenolic compounds 
that possess the vir-inducing activity. Most of these vir-inducing phenolic compounds are 
needed to make lignin, a plant cell wall polymer. The best characterized and most 
effective vir gene inducers are acetosyringone (AS) and hydroxy-acetosyringone from 
tobacco cells or roots (Stachel et al., 1985). The specific composition of phenolic 
compounds secreted by wounded plants is thought to underlie the host specificity of some 
Agrobacterium strains (Sheng and Citovsky, 1996). 
When plant phenolic compounds are absent or present in low concentrations, 
specific monosaccharides, such as glucose, arabinose, galactose, xylose and fucose, may 
play a central role in vir gene induction. All these sugars significantly increase vir gene 
expression when acetosyringone (AS) is limited or absent. Some nonmetabolizable 
sugars, for example 2-deoxy-D-glucose and 6-deoxy-D-glucose, can also upregulate vir 
gene expression, demonstrating that the enhancement of vir gene expression does not 
result from nutritional benefits to Agrobacterium. Indeed, the regulatory pathway for vir 
gene induction by sugars is different from the pathway for induction by phenolics. This 
process is mediated by a chromosomal gene encoding the protein ChvE, a homolog of the 
Escherichia coli sugar-binding proteins (Cangelosi et al., 1990). The subsequent studies 
showed that most of the vir-inducing sugars are monomers of plant cell wall 
polysaccharides and were therefore postulated to be exuded from a wide variety of plant 
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wounds. The most potent sugar inducers are the acidic sugars D-glucuronic acid and D-
galacturonic acid. 
The induction of vir genes also depends on external factors such as pH and 
temperature. Acidic pH is thought to be a third environmental signal of central 
importance in vir gene induction. The induction requires extremely low pHs, a range of 
5.0 to 5.5, and does not occur at neutral pH. The underlying mechanism by which pH 
regulates the vir gene induction remains unclear. One hypothesis is that acidic pH may 
protonate phenolic compounds, which would increase their membrane permeability. The 
vir genes cannot be induced at temperatures higher than 32 ºC because high temperature 
may induce the conformational change of VirA and thus inactivates its regulating 
properties (Jin et al., 1993). 
1.2.3. Regulation of vir gene induction 
The regulatory pathway for vir gene induction by phenolic compounds is mediated 
by the VirA/VirG two-component system, which has structural and functional similarities 
to other already described for other cellular mechanisms (Bourret et al., 1991; Nixon et 
al., 1986). The presence of acidic environment and phenolic compounds at a plant wound 
site may directly or indirectly induce autophosphorylation of VirA. VirA is a 
transmembrane receptor kinase. The phosphorylated VirA can transfer its phosphate to 
the cytoplasmic VirG to activate VirG. The activated VirG binds to sequences called vir 
box enhancer elements that are found in the promoters of the virA, virB, virC, virD, virE 
and virG operons, and then upregulates the transcription of these operons (Winans 1992). 
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Octopine-type Ti plasmid encoded VirA protein has 829 amino acids. Based on 
protein sequence similarities, VirA is a member of the histidine protein kinase class. 
VirA has been proved to be a kinase and able to autophosphorylate. When VirA 
autophosphorylates in vitro, the phosphate was found to bind to histidine residue 474, a 
histidine residue that is absolutely conserved among homologous proteins (Jin et al., 
1990). VirA protein can be structurally divided into a number of domains. In an order 
from N-terminus to C-terminus, these domains are defined as transmembrane domain 1 
(TM1), periplasmic domain, transmembrane domain 2 (TM2), linker domain, kinase 
domain and receiver domain (Lee et al., 1996). Two transmenbrane domains TM1 and 
TM2 serve to anchor VirA protein into the cytoplasmic membrane. TM1 and TM2 are 
supposed to play a role in maintaining the conformation of the periplasmic domain. The 
periplasmic domain is required for the interaction with ChvE, the sugar-binding protein 
that responds to the vir-inducing sugars. The linker domain is located on the region of 
amino acid 280~414. This region was supposed to interact with the vir gene inducing 
phenolic compounds. The evidence that deleting the periplasmic domain still allowed vir 
gene induction by phenolic compounds whereas the deletion of the linker domain 
eliminated the induction by this class of chemical confirmed the central role of the linker 
domain in detecting phenolic inducers (Chang and Winans 1992). A highly amphipathic 
helix sequence of 11 amino acids was identified in the region of amino acid 278-288. 
This amphipathic sequence is highly conserved in a large number of chemoreceptor 
proteins and thus was supposed to be the receptor site for phenolic inducers (Turk et al., 
1994). However, it is unclear whether the phenolic inducers interact with VirA directly or 
indirectly. The kinase domain is a highly conserved domain that presents in the family of 
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the sensor proteins and contains the conserved histidine residue 474 that is the 
autophosphorylation site. Site-directing mutation of this His 474 results in avirulence and 
the lost of vir gene inducing expression in the presence of plant signal moleculaes (Jin et 
al., 1990). The receiver domain shows an unusual feature that is homologous to a region 
of VirG. Similar receiver domains are present in a small number of homologous histidine 
protein kinases, but the function of this domain is unclear. 
VirG is a cytoplasmic protein of 241 amino acid residues, which is homologous 
over its entire length to a family of regulatory proteins (Miller et al., 1989). It is now 
known that VirG is a transcriptional activator. VirG is composed of two main domains, 
N-terminal domain and C-terminal domain. The aspartic acid 52 in the N-terminal 
domain of VirG can be phosphorylated by the phosphorylated VirA. The phosphorylation 
of N-terminal domain is thought to induce the conformation change of C-terminal domain. 
The C-terminal domain of VirG possesses the DNA-binding function. VirG can 
specifically bind to the vir box sequence that is found within 80 nucleotides upstream 
from the transcription initiation sites of vir genes. Phosphorylation is required for the 
transcriptional activation function of VirG, but how phosphorylation modulates the 
properties of VirG is unknown. Some models suggested that phosphorylation might 
increase the affinity of VirG to its binding sites or promote the ability of VirG to contact 
RNA polymerase. 
1.3. T-DNA Processing 
1.3.1. T-region in Ti plasmid  
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The activation of vir genes initiates a cascade of events. Following the expression of 
vir genes, some Vir proteins produce the transfer intermediate, a linear single stranded (ss) 
DNA called T-DNA or T-strand. The T-strand is derived from the bottom (coding) strand 
of the T-region of the Ti plasmid and is found at approximately one copy per induced 
Agrobacterium cell (Stachel et al., 1986b). The T-strand production is believed to initiate 
at the right T-DNA border and elongate in a 5´ to 3´ direction (Sheng and Citovsky, 
1996). The right T-DNA border is required for efficient tumorigenesis and acts in a polar 
fashion, directing the transfer of sequences to its left (Shaw et al., 1984; Wang et al., 
1984), whereas, the left T-DNA border is dispensable for tumor formation (Joos et al., 
1983). An enhancer (or overdrive) sequence is found to present near many T-DNA right 
borders, but not left borders. Overdrive sequences enhance the transfer efficiency (Peralta 
et al., 1986; Peralta and Ream, 1985). The shift of overdrive sequences within 5 kb of the 
right border and the inversion of its orientation do not disrupt its function (Wang et al., 
1987). 
1.3.2. Roles of VirD2/VirD1 in T-DNA processing 
The T-strand is produced by the cleavage of VirD2/VirD1 on the bottom strand of 
T-region at identical positions between bp 3 and 4 from the left end of each border 
(Albrigt et al., 1987; Jayaswal et al., 1987; Wang et al., 1987b). Double-stranded breaks 
have also been observed at this position although these breaks may result from the 
shearing of nicked DNA during isolation (Steck et al., 1989; Veluthambi et al., 1987). In 
vitro, purified VirD2 alone can cleave a single-stranded T-DNA border sequence (Jasper 
et al., 1994; Pansegrau et al., 1993), indicating that VirD2 possesses nickase activity. For 
the cleavage of double-stranded border sequences, research data obtained both in vivo 
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(Filichkin and Gelvin 1993; Yanofsky et al., 1986) and in vitro (Scheiffele et al., 1995) 
revealed that both VirD1 and VirD2 are required. After cleavage of T-DNA border 
sequence, VirD2 remains associated with the 5´-end of the ssT-strand covalently. The 
excised ssT-strand is removed, and the resulting single-stranded gap in the T-region is 
repaired, which is most likely replaced by a newly synthesizing DNA strand. The 
association of VirD2 with the 5´-end of the ssT-strand is believed to prevent the 
exonucleolytic attack to the 5´-end of the ssT-strand (Durrenberger et al., 1989) and to 
distinguish the 5´-end as the leading end of the T-DNA complex during transfer. The 
VirD2-catalyzed cleavage of T-DNA border sequence is dependent on the presence of 
Mg2+. The oligonucleotide cleavage catalyzed by VirD2 is an equilibrium reaction that 
allows specific linkage of cleavage products. VirD2 site-direct mutations indicated that 
the tyrosine 29 is required for the association of VirD2 with the 5´-end of T-strand 
(Vogel and Das, 1992).  
One report indicated that VirD1 possesses a topoisomerase-like activity (Ghai and 
Das, 1989). VirD1 appears to be a type I DNA topoisomerase that do not require ATP for 
activity. However, another study (Scheiffele et al., 1995) contradicted this conclusion. 
The VirD1 protein purified by Scheiffele et al (1995) never showed any topoisomerase 
activity. It was speculated that the topoisomerase activity observed by Ghai and Das 
(1989) might originate from VirD2. Mutational study of VirD1 showed that a region from 
amino acids 45~60 is important for VirD1 activity (Vogel and Das, 1994). Sequence 
comparison of this fragment with the functionally analogous proteins of conjugatable 
bacterial plasmids showed that this region is a potential DNA-binding domain (Vogel and 
Das, 1994). 
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The nopaline Ti plasmid encoded VirD2 consists of 447 amino acids with a 
molecular weight of 49.7 kDa. Deletion analysis of VirD2 demonstrated that the C-
terminal 50% of VirD2 could be deleted or replaced without affecting its endonuclease 
activity. Sequence comparison of VirD2 from different Agrobacterium species shows that 
the N-terminus is highly conserved with 90% homology, whereas only 26% homology is 
found in the C-terminus (Wang et al., 1990). A sequence comparison of VirD2 protein 
with its functionally homologous proteins in bacterial conjugation and in rolling circle 
replication revealed that a conserved 14-residue motif lies in the residues 126~139 of 
VirD2. This motif contains the consensus sequence HxDxD(H/N)uHuHuuuN (invariant 
residues in capital letters; x, any amino acid; u, hydrophobic residue) (Ilyina and Koonin, 
1992). Mutational analysis indicated that all the invariant residues except for the last 
asparagine (N) in this motif are important for the endonuclease activity of VirD2. The 
second aspartic acid (D) and three nonconserved residues in this motif are also essential 
for the endonuclease activity of VirD2 (Vogel et al., 1995). This motif is believed to 
coordinate the essential cofactor Mg2+ by the two histidines in the hydrophobic region of 
the motif (Ilyina and Koonin, 1992). The poorly conserved C-terminal halves of VirD2 
from different Agrobacterium species displayed a very similar hydropathy profile (Wang 
et al., 1990). The C-terminal domain of VirD2 is thought to guide the T-complex to the 
plant nucleus. The sequence characterization and function of this region of VirD2 will be 
discussed in a late section of this chapter. 
1.3.3. Roles of VirC1 and VirC2 in T-DNA processing 
Besides VirD2 and VirD1, two additional virulence (Vir) proteins VirC1 and VirC2 
were also suggested to be involved in the T-DNA processing. VirC1 and VirC2 have 
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been shown to bind to the overdrive site of octopine-type Ti plasmid and were supposed 
to enhance T-DNA border cleavage by the VirD1/VirD2 endonuclease (Toro et al., 1989). 
Deletion of both VirC proteins does not abolish virulence, but attenuates virulence about 
100-fold, which is about the same level attenuated by the deletion of overdrive sequence. 
It should be noted that a strain containing both a virC deletion and an overdrive deletion 
is no more deficient in tumor formation than a strain containing only one of these two 
deletions (Ji et al., 1988). However, some reports showed that mutation of both virC1 and 
virC2 genes resulted in the loss of virulence on many plant species, indicating that VirC 
proteins are important for virulence (Stachel and Nester, 1986). Several reports indicated 
that T-strand production of Agrobacterium virC mutant strains occurs at wild-type levels 
(Stachel et al., 1986b; Veluthambi et al., 1987), suggesting that the VirC proteins may 
play a role after T-DNA processing, possibly in T-DNA export (Zhu et al., 2000). No 
more virulence proteins are identified to be involved in the T-DNA production. Because 
so few plant-induced Agrobacterium proteins are necessary for T-DNA production, many 
reports speculated that some bacterial housekeeping proteins or enzymes of DNA repair 
and replication, such as helicase, may also be involved in this process (Jasper et al., 1994; 
Pansegrau et al., 1993; Scheiffele et al., 1995; Sheng and Citovsky, 1996). 
1.3.4. VirE2 and its roles in protecting ssT-strand from nucleolytic degradation 
Single-stranded T-DNA is believed to be susceptible to nucleases. The action of 
cellular nucleases will result in the nucleolytic degradation of T-strand and thus the loss 
of genetic information on the T-DNA. An effective way to protect the T-strand from 
nucleolytic degradation is to make it inaccessible to these nucleases. VirE2 is a single-
stranded DNA-binding protein (Christie et al., 1988; Citovsky et al., 1988) that can bind 
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single-stranded DNA without sequence specificity; the binding is strong and co-operative, 
suggesting that VirE2 coats the T-strand along its length (Citovsky et al., 1989). Another 
possible function of VirE2 is to guide the nuclear import of T-DNA (Ziemienowicz et al., 
1999; 2001). This will be discussed in the following section of this chapter. Induced 
Agrobacterium cell can produce sufficient VirE2 to bind all intracellular single-stranded 
T-DNA. When bound to single-stranded DNA, VirE2 can alter the ssDNA from a 
random-coil conformation to a telephone cord-like coiled structure and increases the 
relative rigidity (Citovsky et al., 1997). Initial hypothesis is that the protective role of 
VirE2 is required to function in both bacteria and plant cells. So, the prevailing view on 
the T-DNA transfer is that a packaged nucleoprotein complex, the T-complex, composed 
of the T-strand DNA containing the 5´-associated VirD2 and coated with VirE2 along its 
length, is the transfer intermediate (Howard and Citovsky, 1990; Zupan and Zambryski, 
1995). This T-complex structure model implies that both VirD2 and VirE2 together with 
the T-strand are transported into plant cell at the same time. This idea makes biological 
sense because it is likely that VirE2 with a high affinity to ssDNA (Citovsky et al., 1989) 
may form a complex with the T-strand present inside Agrobacterium cell, especially if 
both VirE2 and the T-strand are transported through the same channel (Binns et al., 1995). 
Indeed, the T-complex, which contains T-strand, VirD2 and VirE2, was observed in the 
crude extracts from vir-induced Agrobacterium by using anti-VirE2 antibodies to co-
immunoprecipitate both T-strand and VirE2 (Christie et al., 1988). A model for the 
formation of T-complex is shown in Fig. 1.2. 
However, two kinds of evidence argued against that the protective role of VirE2 is 























Fig. 1.2. Proposed mechanism of ssT-DNA processing and packaging.
LB, RB, and ODE stand for the left border, right border, and overdrive
sequences, respectively. Thick arrows indicate newly synthesized DNA
that could displace the bottom strand of T-DNA. C1, C2, D1, D2, and E2
represent VirC1, VirC2, VirD1, VirD2, and VirE2 proteins, respectively. 
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expressing virE2 but lacking T-DNA can complement a virE2 mutant in a tumor 
formation assay (Otten et al., 1984) and the T-strand accumulates to wild-type levels in 
virE2 mutants (Stachel et al., 1987; Veluthambi et al., 1988). The second kind of 
evidence is that virE2 expression in transgenic tobacco plants restores the infectivity of a 
VirE2-deficient Agrobacterium strain (Citovsky et al., 1992). In addition, the observation 
that virE2 mutants can transfer T-DNA into plant cells (Yusibov et al., 1994) also proved 
that VirE2 is not essential for the export of T-DNA. All these data appear to support that 
T-DNA may not be packaged by VirE2 in the bacterial cells, at least, the packaging of T-
DNA inside bacterial cells by VirE2 is not necessary for the tumor formation. This 
question will be further discussed in the section of T-DNA transfer. 
1.3.5. VirE1 may regulate the binding of VirE2 to T-strand 
Another protein encoded by virE oporen is VirE1 with a molecular weight of 7 kDa. 
Protein sequence analysis of the VirE1 revealed that VirE1 shares a number of properties 
with molecular chaperones that are involved in the protein transport (Deng et al., 1999). 
VirE1 also possesses the structural characteristics of a molecular chaperone (Wattiau et 
al., 1996), being a small (7 kDa), acidic (pI = 5.0) protein with a dimerization domain 
(Deng et al., 1999; Vergunst et al., 2003). Mutational analysis of virE1 showed that virE1 
is essential for the export of VirE2 to plant (Binns et al., 1995). A VirE1-deficient mutant 
having normal amounts of VirE2 and T-strand is not infectious, however, the VirE1-
deficient mutant can be complemented by the coinfection with a strain producing both 
VirE1 and VirE2 but lacking T-DNA, indicating that the VirE1 assists the export of 
VirE2 but not of T-strands or VirE1 can be exported independently (Sundberg et al., 
1996). In vitro, VirE1 can bind VirE2 strongly and prevent VirE2 from self-aggregation. 
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Analysis of various virE2 deletions showed that the VirE1 binding domain of VirE2 
overlaps the VirE2 self-interaction domain (Deng et al., 1999). The VirE1 binding 
domain of VirE2 is further proved to be the same domains that required for single-
stranded DNA binding and cooperative interaction (Sundberg and Ream, 1999) implying 
that VirE1 can prevent VirE2 from binding to T-strand. The VirE1 binding domain of 
VirE2 lies in the N-terminal domain (Zhao et al., 2001). VirE1 interacts with VirE2 to 
form a VirE1-VirE2 complex with a predicted 2:1 stoichiometry (Zhao et al., 2001). 
Deletion of virE1 did not affect transcription but decreased translation of virE2, 
indicating that virE1 regulates efficient virE2 translation in the context of expression 
from the native PvirE promoter (Zhao et al., 2001). Recent results show that VirE1 is not 
essential for the recognition of the translocation signal of ViE2 by the transport 
machinery and the subsequent translocation of VirE2 into plant cells, indicating that the 
role of VirE1 playing in the export process of VirE2 seems restricted to the stabilization 
of VirE2 by preventing VirE2 from the premature interactions in the bacterial cell before 
translocation into plant cells (Vergunst et al., 2003). 
1.4. Attachment of A. tumefaciens to Plant 
1.4.1. Bacterial genes involved in the attachment of A. tumefaciens to plant 
For the transfer of T-complex into plant cells, A. tumefaciens must contact the plant 
and attach to the plant cells. The binding of A. tumefaciens to host plant cells seems to 
require the participation of specific receptors that may exist on the bacterial and plant cell 
surface because the binding of A. tumefaciens to host plant cells is saturable and 
unrelated bacteria fail to inhibit the binding of A. tumefaciens to host plant cells 
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(Lippincot and Lippincot, 1969). A number of A. tumefaciens mutants affecting the 
attachment of bacteria to plant cells have been isolated. Some related genes are identified 
and sequenced (Matthysse et al., 2000; Reuhs et al., 1997). However, it is surprising that 
a large number of genes are involved in the bacterial attachment to host cells and the 
actual functions of most genes are unclear (Matthysse et al., 2000). All the genes reported 
to affect the bacterial attachment to host cells are chromosomal genes. 
The genes involved in the binding of bacteria to host plant cells are mainly located 
at two regions of the bacterial chromosome. The binding of bacteria to host cells is 
thought to be a two-step process (Matthysse and McMahan, 1998). The binding in the 
first step is loose and reversible because it is easy to wash the bound bacteria from the 
binding sites by shear forces, such as water washing or vortexing of tissue culture cells. 
Genes involved in this step are identified to locate on the att gene region (more than 20 
kb in size) of the bacterial chromosome. Gene mutations in this region abolish virulence. 
The mutants in the att gene region can be divided into two groups. The first group can be 
restored to attachment and virulence by the addition of conditioned medium. This group 
appears to be altered in signal exchange between the bacterium and the host. Mutations in 
this group of mutants occur in the genes homologous to ABC transporters and 
transcriptional regulator as well as some closely linked downstream genes (Matthysse et 
al., 2000; Matthysse and McMahan, 1998; Reuhs et al., 1997).  
The second group of mutants in the att gene region is not affected by the presence 
of conditioned medium. This mutant group appears to affect the synthesis of surface 
molecules, which may play a role in the bacterial attachment to the host. This group 
includes mutants in the genes homologous to transcriptional regulator and ATPase as 
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well as a number of biosynthetic genes, which include the transacetylase required for the 
formation of an acetylated capsular polysaccharide. The acetylated capsular 
polysaccharide is required for the bacterial attachment to some plants because the 
production of the acetylated capsular polysaccharide is correlated to the attachment of 
wild-type strain C58 to the host cells and the purified acetylated capsular polysaccharide 
from wild-type strains blocks the binding of the bacteria to some host cells (Matthysse et 
al., 2000; Matthysse and McMahan, 1998; 2001; Reuhs et al., 1997). 
The second step in the bacterial attachment to the host results in tight binding of the 
bacteria to the plant cell surface because the bound bacteria can no longer be removed 
from the plant cell surface by shear forces. This step requires the synthesis of cellulose 
fibrils by the bacteria, which recruits larger numbers of bacteria to the wound sites. 
Cellulose-minus bacterial mutants show reduced virulence (Minnemeyer et al., 1991). 
The genes required for the synthesis of bacterial cellulose fibrils (cel genes) are identified 
to locate on the bacterial chromosome near, but not contiguous with the att gene region 
(Robertson et al., 1988). 
Some other chromosomal virulence genes chvA, chvB, and pscA (exoC) are believed 
to be involved indirectly in bacterial attachment to host (Cangelosi et al., 1987; Douglas 
et al., 1982; O’Connell and Handelsman, 1989). These genes are involved in the 
synthesis, processing, and export of a cyclic β-1,2-glucan, which has been implicated in 
the bacterial binding to plant cells. Mutations in chvA, chvB, and pscA (exoC) cause a 10-
fold decrease in binding of bacteria to zinnea mesophyll cells (Douglas et al., 1985) and 
strongly attenuate virulence (Douglas et al., 1985; Kamoun et al., 1989; Thomashow et 
al., 1987). ChvB is believed to be involved in the synthesis of the cyclic β-1,2-glucan 
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(Zorreguieta and Ugalde, 1986). ChvA is homologous to a family of membrane-bound 
ATPases and appears to be involved in the export of the cyclic β-1,2-glucan from the 
cytoplasm to the periplasm and extracellular fluid (Cangelosi et al., 1989; De Iannino and 
Ugalde, 1989). However, the virulence of chvB mutants is temperature sensitive (Banta et 
al., 1998). At lower temperature (16 ºC), chvB mutants became virulent and were able to 
attach to plant roots (Bash and Matthysse, 2002). 
1.4.2. Plant factors involved in the attachment of A. tumefaciens to plant 
In addition to bacterial factors, some plant factors are essential for the attachment of 
A. tumefaciens to plant cells. Two plant cell wall proteins: a vitronectin-like protein 
(Wagner and Matthysse, 1992) and a rhicadhesin-binding protein (Swart et al., 1994) 
have been proposed to mediate the bacterial attachment to plant cells. Vitronectin is an 
animal receptor that is specifically utilized by different pathogenic bacteria (Burridge et 
al., 1988). A plant vitronectin-like protein is reported to occur in several A. tumefaciens 
host plant (Sanders et al., 1991). Human vitronectin and antivitronectin antibodies were 
shown to inhibit the binding of A. tumefaciens to plant tissues. Nonattaching A. 
tumefaciens mutants, such as chvB, pscA and att mutants, showed a reduction in the 
ability to bind vitronectin. Therefore, the plant vitronectin-like protein was proposed to 
play a role in A. tumefaciens attachment to its host cells (Wagner and Matthysse, 1992). 
Recently, some genetic studies showed that additional plant cell-surface proteins 
might play a role in A. tumefaciens attachment. Two Arabidopsis ecotypes, B1-1 and 
Petergof, which are highly recalcitrant to Agrobacterium-mediated transformation, were 
proposed to be blocked at an early step of the binding (Nam et al., 1997). Two 
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Arabidopsis T-DNA insertion mutants of the ecotype Ws, rat1 and rat3, which are 
resistant to Agrobacterium transformation (rat mutants), are deficient in A. tumefaciens 
binding to cut root surfaces (Nam et al., 1999). DNA sequence analysis indicated that 
rat1 and rat3 mutations affect an arabinogalactan protein (AGP) and a potential cell-wall 
protein, respectively. AGPs were confirmed to be involved in A. tumefaciens 
transformation (Nam et al., 1999). Other two rat mutans, ratT8 and ratT9, were 
identified to be mutated in the genes coding for receptor-like protein kinases (Zhu et al., 
2003). 
1.5. T-DNA Transfer 
1.5.1. T-DNA transfer models 
T-DNA is transferred in the form of ssT-strand-protein complex. However, the 
controversy is where and when VirE2 binds to T-strand. In other word, whether T-DNA 
is transferred from A. tumefaciens to plant cell in the form of VirD2-ssT-strand complex 
or in the form of VirD2-ssT-strand-VirE2 complex is in the controversy (Zupan and 
Zambryski, 1997). Therefore, three models were proposed to envision the T-DNA 
transfer from A. tumefaciens to plant cell.  
The most accepted model is that T-DNA is transferred in the form of VirD2-ssT-
strand-VirE2 complex. In this model, VirE2 is believed to bind to the ssT-strand inside A. 
tumefaciens cell. The evidence supporting this model includes: (1) VirE2 accumulates in 
A. tumefaciens cell at the same time as T-strand and in stoichiometric amounts sufficient 
to bind the T-strand completely (Citovsky et al., 1988; 1989; Zambryski, 1992). (2) 
VirE2 can bind ssT-strand strongly and cooperatively and the cooperative association 
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extends the ssT-strand, which reduces the complex diameter to approximately 2 nm and 
makes the translocation through membrane channels easier (Citovsky et al., 1989; 1997). 
(3) The ssT-strand can be co-immunoprecipitated from an extract of induced A. 
tumefaciens cells by using anti-VirE2 antibodies (Christie et al., 1988). 
However, more and more experimental evidences demonstrated that VirE2 could be 
exported independently (Atmakuri et al., 2003; Cascales and Christie, 2004; Chen et al., 
2000; Deng et al., 1999; Schrammeijer et al., 2003; Simone et al., 2001; Vergunst et al., 
2000) and that the transfer of VirE2 as part of the ssT-strand complex is not necessary for 
the tumorigenesis (Sundberg et al., 1996). In addition, A. tumefaciens was shown to be 
able to transfer naked T-srand to the plant cells although the transfer efficiency may be 
very low (Binns et al., 1995; Sundberg et al., 1996). Therefore, a second model was 
proposed to light for the ssT-strand complex transfer. In this model, the transferred ssT-
strand complex is a naked ssT-strand with a VirD2 molecular covalently bound at its 5´-
end, no VirE2 coated the ssT-strand. VirE2 is exported to the periplasm (and possibly 
secreted into the extracellular environment) independently of ssT-strand transfer and then 
transported to plant cells via VirB channel (Chen et al., 2000; Simone et al., 2001). Once 
the naked ssT-strand-VirD2 complex is transported into the plant cell, it will be coated by 
VirE2 (Binns et al., 1995; Lessl and Lanka, 1994). To explain why VirE2 can not access 
to the ssT-strand and not coat it inside the bacterial cytoplasm, it was suggested that A. 
tumefaciens may adopt a mechanism analogous to conjugal DNA transfer, in which the 
Ti plasmid is tightly associated with the export apparatus VirB channel so that the naked 
ssT-strand is exported as it is produced before VirE2 has the opportunity to bind 
(Sundberg et al., 1996). Recent results suggested that VirE1, as a specific molecular 
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chaperone, might play a role in preventing VirE2 from accessing to ssT-strand inside 
agrobacterial cytoplasm (Deng et al., 1999; Vergunst et al., 2003). 
Although most of the recent data appear to support the second model, additional 
questions are still confounded by this model. (1) If T-DNA transfer evolved from plasmid 
conjugation (Lessl and Lanka, 1994), then Agrobacterium : plant contact would likely be 
maintained because the donor : recipient contact is required for ensuring that conjugal 
DNA transfer occurs with high efficiency. Thus, it is unlikely that VirE2 is exported into 
the environment. In addition, export of VirE2 outside of the bacterium would require a 
plant apparatus to import VirE2 across the plant plasma membrane, but no experimental 
evidence supports such a mechanism. (2) If the naked ssT-strand and VirE2 are exported 
by the same apparatus VirB channel independently (Atmakuri et al., 2003; Simone et al., 
2001), the export apparatus must distinguish between VirE2 and the naked ssT-strand to 
regulate their independent export. (3) In order to maintain the VirE2 concentration in 
plant cytoplasm being high enough to favor the binding of VirE2 to ssT-strand, A. 
tumefaciens has to export an extremely large excess of VirE2 to plant cell cytoplasm 
because the volume of plant cell cytoplasm is so much greater than that of A. tumefaciens. 
For these reasons, an explanation may be acceptable that, in principle, the independent 
export of naked ssT-strand and VirE2 can occur, but this may not be the natural export 
mechanism in A. tumefaciens tumorigenesis (Zupan and Zambryski, 1997). 
To incorporate the features of the first two models, an intermediate model for the T-
DNA transfer was proposed. In this intermediate model, both naked ssT-strand and VirE2 
are possibly localized near the export apparatus. The ssT-strand might be exported in a 
range of partially to completely VirE2-coated states. In the same time, free VirE2 could 
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also be exported in the same export apparatus and would be expected to bind the ssT-
strand during the transit and entry into the plant cell so that the ssT-strand could be 
coated by VirE2 completely before the ssT-strand arrives in the plant cell cytoplasm. Any 
free VirE2 might also enter the plant cell cytoplasm. To compare these three models of T-
complex transfer, a schematic diagram is shown in Fig.1.3. 
1.5.2. T-DNA transfer apparatus is a type IV secretion system (T4SS) 
A. tumefaciens uses type IV secretion system (T4SS) to transfer T-DNA and 
effector proteins, VirE2, VirF, and possibly VirE3 to its host cells (Cascales and Christie, 
2003; 2004). The T4SS were initially defined to be a class of DNA transporters whose 
components are highly homologous to the conjugal transfer (tra) system of the 
conjugative IncN plasmid pKM101 and the A. tumefaciens T-DNA transfer system 
(Burns, 2003; Christie and Vogel, 2000).  T4SS, also known as the mating pair formation 
(Mpf) apparatus, are cell envelope-spanning complexes (composed of 11-13 core proteins) 
that are believed to form a pore or channel through which DNA and/or protein is 
delivered from the donor cell to the recipient cell.  Recently the members of T4SS have 
steady increased, with the identification of additional systems involved in DNA and 
protein translocation (Cascales and Christie, 2003; Christie and Vogel, 2000). However, 
the best-studied T4SS member is the VirB transporter of A. tumefaciens. In the past 
decade, much of the research on Agrobacterium-mediated T-DNA transfer has focused 
on the vir-specific T4SS, the T-complex transporter. Thus, the A. tumefaciens T-complex 
transporter has become a paradigm of T4SS (Cascales and Christie, 2003; Christie, 1997). 
The T-complex transporter is assembled from 11 proteins (VirB1 to VirB11) 
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Fig. 1.3. Three models of T-complex formation and transfer. In each
model, formation of the T-complex initiates with the nicking reaction at the
border sequences and the subsequent covalent bonding of VirD2 to the 5´ end
of the T-strand. (a) The T-strand is displaced from the Ti plasmid and coated
with VirE2 inside the bacterial cell, followed by export of the entire complex.
(b) T-strand and VirE2 are exported independently from the bacterial cell, and
binding of VirE2 to the T-strand occurs in the plant cell cytoplasm. As shown
here, VirE2 is exported first, followed by the T-strand. Sundberg et al. (1996)
have suggested that the T-strand might be exported, as it is displaced and
VirE2 is exported subsequently. (c) VirE2 primarily binds to the T-strand
shortly after it is displaced inside the bacterial cell. Independent export of
VirE2 ensures that the T-strand becomes completely coated during transit
through the export apparatus (Cited from Zupan and Zambrysky, 1997). 
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encoded by the virB operon, and VirD4. At least 10 of the 11 VirB proteins are believed 
to be the structural subunits of the T-pilin and associated transport apparatus that spans 
from the cytoplasm of the cell, through the inner membrane, periplasmic space and outer 
membrane, to the outside of the cell. In the past few years, work in identifying the 
interactions among the VirB protein subunits and defining the steps in the transporter 
assembly pathway has extended our knowledge of the structure of the VirB transport 
apparatus. The subcellular localizations, protein-protein interactions and proposed 
functions of the VirB proteins are summarized in Table 1.1. 
1.5.3. Characteristics of T4SS components 
        VirB1 has a motif found among lytic transglycosylases in its N-terminus and is 
postulated to have glycosidase activity (Mushegian et al., 1996). Such a lysozyme-like 
activity is believed to be important for the hydrolysis of peptidoglycan layer of bacterial 
membrane and the formation of a channel in the bacterial membrane so that the other 
VirB proteins can penetrate the peptidoglycan layer to assemble a multiprotein apparatus 
large enough to traffic nucleoprotein complexes. VirB1 is processed to release its C-
terminal 73-residue peptide. This 73-residue peptide is designated as VirB1*. VirB1* is 
secreted to the exterior of A. tumefaciens cells and remains loosely associated with the 
exterior of the cell (Baron et al., 1997). VirB1* is not detected in purified T-pilus 
preparations, but chemically crosslinks with VirB9, and thus might mediate close 
contacts between donor and recipient cells (Llosa et al., 2000). 
        VirB2, as the pro-pilin, is translated as a 12.3 kDa protein with 121 amino acid 
residues. This 12.3 kDa protein is quickly processed into a 7.2 kDa protein, the T-pilin of 
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 Table 1.1. a Molecular weights, subcellular localizations, protein-protein interactions 
and postulated functions of the VirB proteins b 
Proteins Size (kDa) c Localization Protein-protein contacts d Proposed function 





Channel subunits     
VirB6 31.8 IM  B7, B9 Assembly factor; channel 
subunit 
VirB8 26.4 IM B1, B8, B9, 
B10 
B8, B9, B10 Assembly factor; bridge 
between subcomplexes; 
IM & OM VirB channel 
subunit 
VirB10 40.6 IM B8, B9, B10 B8, B9, B10 Bridge between IM & 
OM subcomplexes; 
channel subunit 
VirB3 11.6 OM   Unknown 
VirB7 5.9, 4.5* OM 
lipoprotein 
B7, B9 B2, B6, B7, 
B9, B10 
Stabilizes B9 by 
disulphide crosslink; B7-
B9 dimer stabilizes other 
VirB proteins 
VirB9 32.1 OM B1, B7, B8, 
B9, B10, 
B11 
B6, B7, B9, 
B10 
OM pore? 
Energetics     
VirB4 87.4 IM B4, B8, 
B10, B11 
B4 ATPase; energy for 
substrate export & pilus 
biogenesis; 
homomultimer  
VirB11 38.1 IM B4, B9 B11 ATPase; energy for 
substrate export & pilus 
biogenesis; 
homomultimer  
Periplasmic factor     
VirB1 28.0, 12.0* PP B1, B4, B8, 
B9, B10 
B1 Peptidoglycan hydrolase; 
channel assembly 
T pilus      
VirB2 12.3, 7.2* IM, EX B2, B5, B7  Cyclized pilin subunit 
VirB5 23.3 PP, EX B2  Pilus subunit;chaperone? 
VirB7 5.9, 4.5* OM, EX  B2 Pilus assembly? 
 
a Cited from Cascales and Christie, 2003; Lai and Kado, 2000. 
b Abbreviations: IM, inner membrane; OM, outer membrane; PP, periplasm; EX, Exocellular. 
c Processed proteins are indicated with an asterisk. 
d Evidence for subunit-subunit contacts on the basis of results of yeast or bacterial dihybrid screen 
or biochemical assays. References are presented in the text. 
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74 amino acid residues (Jones et al., 1996). The N-terminus of the full-length VirB2 is 
removed by cleaving the peptide bound between Ala 47 and Gln 48. The resulting 74-
residue T-pilin is ligated between its N-terminus (Gln 48) and C-terminus (Gly 121) by a 
head-to-tail peptide bond, forming a cyclic peptide, the cyclized T-pilin subunit 
(Eisenbrandt et al., 1999; Jones et al., 1996). 
VirB3 and VirB4 show highly homologous to the IncF proteins TraC and TraL. 
These two IncF proteins were proved to be essential for pilus formation but not be pilus 
structural components. So, VirB3 and VirB4 were suggested to play a role in pilus 
assembly (Jones et al., 1994). VirB4 possesses a conserved Walker A nucleotide-binding 
motif and the purified VirB4 shows week ATPase activity (Christie, 1997). Cellular 
levels of VirB3 are reduced in virB4 deletion mutant. The localization of VirB3 is also 
affected by the virB4 deletion. In the virB4 deletion mutant, VirB3 is localized to the 
inner membrane rather than both inner and outer membranes as in wild-type strains 
(Jones et al., 1994). Research data showed that the VirB-specific transporter is not only 
used for transferring the T-complex, but also for exporting the cyclic T-pilin subunit to 
the bacterial cell surface, perhaps as a scaffold to facilitate efficient assembly of the T-
pilus (Lai et al., 2000). Therefore, it was suggested that VirB3 specific localization, 
mediated by VirB4, might assist the mobilization of the cyclic T-pilin subunit VirB2 to 
the cell exterior (Zupan et al., 2000). 
VirB5 is a minor component of T-pilus and is believed to function as auxiliary 
structural proteins in pili of T4SS (Schmidt-Eisenlohr et al., 1999). In contrast to VirB2, 
cellular levels of VirB5 were affected by other Vir proteins. When other Vir proteins are 
 30
absent, the cellular levels of VirB5 were strongly reduced. It was speculated that VirB5 
decreased due to the degradation in the periplasm. So, other Vir proteins may protect 
VirB5 from degradation by protein-protein interaction (Schmidt-Eisenlohr et al., 1999). 
VirB6~VirB10 proteins as well as one or more of the three ATPases (VirB4, 
VirB11 and VirD4) are thought to be the main channel components (Christie, 1997; 
Christie and Vogel, 2000). The protein-protein interactions of these VirB proteins were 
extensively studied by using dihybrid screens and complementary biochemical assays 
(Beaupre et al., 1997; Das et al., 1997; Das and Xie, 2000; Jakubowski et al., 2003; Krall 
et al., 2002; Shamaei-Tousi et al., 2004; Ward et al., 2002) (table 1.1). VirB6, a highly 
hydrophobic protein, contains multiple membrane-spanning domains and thus is believed 
to span the inner membrane several times (Beijersbergen et al., 1994; Christie, 1997). 
VirB6 is thought to be the best candidate for a channel-forming protein. It was suggested 
that VirB6 and two other VirB proteins, VirB8 and VirB10, which anchor to the inner 
membrane, constitute the inner membrane sub-complex. The oligomerization of VirB6 
complex is believed to be essential for the formation of the functional pore (Das, 1998). 
VirB7 is translated to a 55-residue preprotein and then processed to a 41-residue mature 
lipoprotein. VirB7 is localized in the outer membrane and covalently attached to a lipid 
moiety by the N-terminal cysteine (Cys 15) (Fernandez et al., 1996a). VirB7 interacts 
with VirB9 via a disulfide bond between the Cys 24 of VirB7 and the Cys 262 of VirB9. 
Both VirB7 and VirB9 can form homodimers in the absence of each other. The VirB7-
VirB9 heterodimer can further form heterotetramers (Anderson et al., 1996) and is 
essential for the stability of other VirB proteins during assembly of the T4SS (Christie 
and Vogel, 2000; Fernandez et al., 1996b). Yeast two-hybrid studies showed that VirB8, 
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VirB9 and VirB10 interact with one another (Das and Xie, 2000). Possibly, VirB8-VirB9 
interaction is required for the formation of chemically crosslinked VirB10 oligomers 
(Christie and Vogel, 2000; Zupan et al., 2000). VirB10 contains a large C-terminal 
periplasmic domain and a short N-terminal cytoplasmic domain and thus is thought to 
link inner membrane and outer membrane VirB subcomplexes (Beaupre et al., 1997). 
Like VirB4, VirB11 contains a conserved Walker A nucleotide-binding motif 
required for its function. Purified VirB11 also has weak ATPase activity (Christie, 1997). 
Both VirB4 and VirB11 ATPases are proposed to mediate T4SS apparatus assembly or 
function through dynamic, ATP-dependent conformation changes. VirB4 tightly 
associates within the inner membrane. It contains two periplasmic domains that confer 
this protein a transmembrane topology. This transmembrane topology was presumed to 
allow the ATP-dependent conformational change in the conjugation channel (Dang and 
Christie, 1997). VirB4 appears to function as a homomultimer in vivo. Homologues of 
both ATPases are widely found among the T4SS family members, but VirB11-like 
ATPase constitute a protein superfamily and members of VirB11-like ATPase family are 
present among all type II and IV secretion system (Planet et al., 2001). VirB11 proteins 
self-associate into homohexamers via two domains located in its N- and C-termini. The 
VirB11 homohexamer functions as a hexameric pore. The closure and opening of this 
hexameric pore is regulated by ATP binding/hydrolysis. Nucleotide binding ‘locks’ the 
hexamer into a symmetric and compact structure. It was proposed that VirB11 uses the 
mechanical leverage generated by such nucleotide-dependent conformational changes to 
facilitate the export of substrates or the assembly of the T4SS apparatus. So, VirB11 is 
thought to function as a gating molecule at the inner membrane (Savvides et al., 2003). 
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1.5.4. Coupling protein VirD4 and its roles in T-DNA transfer 
Agrobacterium-mediated T-DNA transfer to plant shows striking similarities to the 
plasmid interbacterial conjugation (Stachel and Zambryski, 1986; Ream, 1989). Bacterial 
conjugation can be visualized as the merging of two ancient bacterial systems: the DNA 
rolling-circle replication system and type IV secretion system (T4SS) (Llosa et al., 2002). 
The DNA rolling-circle replication system in plasmid conjugation was also known as the 
DNA transfer and replication (Dtr) system. The Dtr system corresponds to the T-DNA 
relaxase nucleoprotein complex. The T4SS responding for the plasmid conjugation was 
initially called mating pair formation (Mpf) system. In order to recognize these two 
systems and link them, a protein is normally required for many conjugal plasmids to 
couple the Dtr to the Mpf. This protein was called coupling protein as its function 
(Gomis-Ruth et al., 2002).  
VirD4 is a homologue of coupling protein family and is believed to be the coupling 
protein that links the T-complex and T4SS transporter. VirD4 is an inner membrane 
protein with potential DNA binding ability and ATPase activity. Membrane topology 
analysis of VirD4 revealed that VirD4 contains a N-terminal-proximal region, which 
includes two transmembrane helices and a small periplasmic domain, and a large C-
terminal cytoplasmic domain (Cascales and Christie, 2003; Das and Xie, 1998). VirD4 
localizes to the cell pole. The polar location of VirD4 was not dependent on T-DNA 
processing, the assembly of T4SS transporter and the expression of other Vir proteins 
(Kumar and Das, 2002). Both the small periplasmic domain and the cytoplasmic 
nucleotide-binding domain are required for the polar localization of VirD4 and essential 
for T-DNA transfer. VirD4 forms a large oligomeric complex (Kumar and Das, 2002). 
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VirD4 can recruit VirE2 to the cell poles (Atmakuri et al., 2003) and weakly interact with 
VirD2-T-strand complex (Cascales and Christie, 2004). Although VirD4 is essential for 
coordinating the T4SS to drive T-DNA transfer, it has been unclear whether VirD4 
physically/directly interacts with the T4SS transporter. Recently, two reports showed that 
two VirD4 homologues TrwB and TraG interact with VirB10 homologues respectively 
(Gilmour et al., 2003; Llosa et al., 2003). However, the interaction between VirD4 
homologues and the protein components of Dtr system exhibits specificity (Llosa et al., 
2003).  It was supposed that VirD4 protein might recruit T-complex to the T4SS 
transporter through contacts with the T-complex protein and then through the contacts 
with VirB10 coordinate the passage of T-complex through the T4SS channel (Cascales 
and Christie, 2003; Llosa et al., 2003). However, it should be pointed out that the 
recruitment of T-complex might be much more difficult than the recruitment of single 
VirE2 molecule due to the difference of molecular size between T-complex and VirE2. 
To demonstrate the architecture of the VirB/D4 transporter, a recent model that depicts 
the subcellular locations and interactions of the VirB and VirD4 subunits of the A. 
tumefaciens VirB/D4 T4SS is shown in Fig. 1.4 (Cascales and Christie, 2004). 
1.5.5. Possible roles of VirE2 in T-DNA transfer 
One recent report showed that VirE2 could form channels in artificial membranes. 
These channels are voltage gated and anion selective and can specifically facilitate the 
efficient transport of ssDNA through membranes (Dumas et al., 2001). Based on this 
evidence, it was supposed that VirE2 might assemble as a receptor or transport channel at 
the plant plasma membrane to dock the T-DNA transfer system and translocate the 
incoming VirD2-T-strand complex, VirE2 and VirF substrates (Dumas et al., 2001). 
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Fig. 1.4. A model of the VirB/D4 transporter of A. tumefaciens. The VirD4
coupling protein assembles as a homohexameric, F1-ATPase-like structure
juxtaposed to the VirB channel complex. VirB11, a hexameric ATPase structurally
similar to members of the AAA ATPase superfamily, is positioned at the
cytoplasmic face of the channel entrance, possibly directing substrate transfer
through a VirB6/VirB8 inner membrane (IM) channel. The VirB2 pilin and VirB9
comprise channel subunits to mediate substrate transfer to and across the outer
membrane (OM). VirB10 regulates substrate transfer by linking IM and OM VirB
subcomplexes (Cited from Cascales and Christie, 2004). 
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Interestingly, another report showed that A. tumefaciens could export low level of VirE2, 
VirD2 and VirF proteins to the extracellular milieu via a virB-independent export 
pathway (Chen et al., 2000). VirE2 exported by the virB-independent pathway might be 
used to assemble the VirE2 receptor or transport channel at the plant plasma membrane. 
This model can account for the extreme broad host range of the A. tumefaciens-mediated 
T-DNA transfer because A. tumefaciens can deliver its own receptor to target cells 
(Christie 2001; Dumas et al., 2001).  
1.6. Nuclear Targeting of T-complex 
1.6.1. Nuclear localization signal 
Whether VirE2 coats to the ssT-strand within bacterium to assemble a VirD2-T-
strand-VirE2 complex remains controversial. However, it is clear that VirE2 is necessary 
for T-DNA transfer inside plant cells (Citovsky et al., 1992), indicating that the ssT-
strand must be coated by VirE2 inside plant cells and VirD2-T-strand-VirE2 complex 
exists inside plant cells. To deliver the T-DNA to target cell, the T-complex must target 
to the host cell nucleus and penetrate the nuclear membrane. The estimated size of the T-
complex is 50,000 kDa, which far exceeds the 60 kDa size-exclusion limit of the nuclear 
pore, indicating that active transport processes are required for the nuclear import of T-
complex. As a rule, active nuclear import of proteins requires a specific nuclear 
localization signal (NLS). Typical nuclear localization signals are short regions rich in 
basic amino acids (Silver, 1991). The most common type of NLS is the bipartite NLS that 
is originally found in nucleoplasmin from the amphibian Xenopus laevis (Robbins et al., 
1991). Bipartite NLS contains two interdependent basic domains, both needed for full 
 36
activity. The first active basic domain consists of two adjacent basic residues and the 
second active domain contains at least three out of five basic amino acids. Between this 
two active domains is a variable-length linker (Dingwall and Laskey, 1991). NLS-
binding proteins can recognize NLSs and guide the NLS-containing proteins to nuclear 
pores where active nuclear import occurs (Silver, 1991).  
1.6.2. Nuclear localization signals in VirD2 
Because T-strand is presumed to be completely coated with proteins inside plant 
cells it is impossible for T-strand itself to carry NLSs. Thus, the NLSs that guide T-
complex nuclear import most likely reside in its associated proteins, VirD2 and VirE2. 
Sequence analysis reveals that both VirD2 and VirE2 contain NLSs. Two NLSs are found 
in VirD2. One is the typical bipartite NLS that resides in residues 396~413. The nuclear 
localizing function of this bipartite NLS was confirmed by the observation that VirD2-
GUS fusion protein, when expressed in tobacco protoplasts, can target to plant cell nuclei 
(Howard et al., 1992; Tinland et al., 1992). However, mutations that destroy this bipartite 
NLS attenuate, and do not abolish tumorigenesis, indicating that although this NLS plays 
a role in T-DNA transfer, it is not essential (Rossi et al., 1993; Shurvinton et al., 1992). 
Another NLS in VirD2 is found in residues 32~35, adjacent to the active site in the 
endonuclease domain (Tinland et al., 1992). This NLS is a monopartite NLS. GUS 
proteins fused with this NLS accumulate in plant nuclei, but this NLS does not play a role 
in T-DNA nuclear localization (Shurvinton et al., 1992). The sequences of residues 419-
423 at the C-terminus of VirD2, known as the ω domain, are important for tumorigenesis, 
but do not contribute to nuclear localization activity despite its proximity to the bipartite 
NLS. The ω domain was supposed to be involved in T-DNA integration (Mysore et al., 
 37
1998). 
1.6.3. Nuclear localization signals in VirE2 
VirE2, the most abundant protein component of the T-complex, contains two 
bipartite NLSs in its central region (residues 205~221, and residues 273~287). When 
fused to GUS, each VirE2 NLS is capable of directing the fusion protein to the nucleus of 
a plant cell, but the maximum accumulation in the nucleus requires both VirE2 NLSs 
(Citovsky et al., 1992). Because these two NLSs overlap with the DNA binding domains, 
mutations of virE2 that abolish the activity of one of these NLSs will also eliminate the 
DNA binding activity. So, no genetic evidence can be provided to verify the function of 
these two VirE2 NLSs in T-complex nuclear localization. When VirE2 binds to T-strand, 
the NLSs of VirE2 may be occluded and inactive. It has been observed that for the 
nuclear import of short ssDNA, VirD2 was sufficient, whereas import of long ssDNA 
additionally required VirE2 (Ziemienowicz et al., 2001). All the evidence argued against 
the function of VirE2 in T-complex nuclear localization. The experimental evidence that 
RecA, a NLS-lacking ssDNA binding protein, could substitute for VirE2 in the nuclear 
import of T-strand, further demonstrated that VirE2 functions not in the nuclear 
localization, possibly in mediating the passage of T-strand through the pore 
(Ziemienowicz et al., 2001). VirE2 was assumed to shape the T-complex such that it is 
accepted for translocation into the nucleus. 
1.6.4. Plant proteins involved in T-complex nuclear targeting 
Besides the agrobacterial proteins VirD2 and VirE2, some plant proteins were 
supposed to be involved in the T-complex nuclear translocation. Early yeast two-hybrid 
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screen identified an A. thaliana importin-α (AtKAP, now known as importin-α1) that 
interacts with VirD2 (Ballas and Citovsky, 1997). Importin-α proteins interact with NLS-
containing proteins and guide the nuclear translocation of these proteins. Importin-α 
proteins constitute a protein family and Arabidopsis encodes at least nine of these 
proteins (Gelvin, 2003). Interaction between VirD2 and importin-α1 was verified to be 
VirD2 NLS dependent (Ballas and Citovsky, 1997). The importance of importin-α 
proteins in the T-complex transfer process was confirmed by the genetic evidence that a 
T-DNA insertion into the importin-α7 gene, or antisense inhibition of expression of the 
importin-α1 gene, highly reduces the transformation efficiency (Gelvin, 2003). 
Two other plant proteins were identified to interact with VirD2. Deng et al. (1998) 
showed that an Arabdopsis cyclophilin interacted strongly with VirD2. They further 
characterized the interaction domain of VirD2 and found that a central domain of VirD2 
(residues 274~337) was involved in the interaction with cyclophilin. No previous 
function of VirD2 had been ascribed this central region. Cyclosporin A, an inhibitor of 
VirD2-cyclophilin interaction, inhibits Agrobacterium-mediated transformation of 
Arabidopsis and tobacco (Deng et al., 1998). Cyclophilin were presumed to serve as a 
molecular chaperone to help in T-complex trafficking within the plant cell. In addition, a 
tomato type 2C protein phosphatase was identified to interact with VirD2 (Gelvin, 2003). 
This phosphatase was assumed to be involved in the phosphorylation and 
dephosphorylation of a serine residue near the C-terminal NLS in the VirD2. 
Overexpression of this phosphatase decreased the nuclear targeting of a GUS-VirD2-NLS 
fusion protein, suggesting that phosphorylation of the C-terminal NLS region may affect 
the nuclear targeting function of VirD2 (Gelvin, 2003). 
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Two VirE2-interacting proteins were designated VIP1 and VIP2. VIP1 was showed 
to facilitate the VirE2 nuclear import in yeast and mammalian cells. Tobacco VIP1 
antisense plants were highly resistant to A. tumefaciens infection (Tzfira et al., 2001), 
whereas, transgenic plants that overexpress VIP1 are hypersusceptible to A. tumefaciens 
transformation (Tzfira et al., 2002). VIP1 is a basic leucine zipper (bZIP) motif protein 
and shows no significant homology to known animal or yeast proteins (Tzfira et al., 
2001). So, how VIP1 facilitates the nuclear import of VirE2 remains unclear. Unlike 
VIP1, VIP2 was unable to mediate VirE2 into the yeast cell nucleus. However, VIP1 and 
VIP2 interacted with each other. Thus, VIP1, VIP2 and VirE2 were assumed to function 
in a multiprotein complex (Tzfira and Citovsky, 2000; 2002). 
1.6.5. Possible roles of VirF in T-DNA transfer 
Like VirD2 and VirE2, agrobacterial protein VirF can also be exported to plant cell 
(Vergunst et al., 2000). VirF gene is found only in the octopine-specific Ti plasmid. It is 
not essential for T-DNA transfer. Initially, VirF is thought to be a host-range factor of 
Agrobacterium (Regensburg-Tuink and Hooykaas, 1993). A recent report identified an 
Arabidopsis Skp1 protein as an interacting partner of VirF protein (Schrammeijer et al., 
2002). Yeast Skp1 protein and its animal and plant homologs are subunits of the 
complexes involved in targeted proteolysis. This targeted proteolysis can regulate the 
plant cell cycle. So, it was suggested that VirF may function in setting the plant cell cycle 
to effect better transformation (Gelvin, 2003; Schrammeijer et al., 2002; Tzfira and 
Citovsky, 2002). 
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1.7. Integration of T-DNA into Plant Genome 
1.7.1. Integration site 
The integration of the incoming ssT-strand of the T-complex into plant genome is 
the final step of the T-DNA transfer. The DNA sequence analysis of several T-DNA-host 
DNA junctions revealed that these junctions, in general, appear more variable than the 
junctions created by insertions of transposons, retroviruses, or retrotransposons (Gheysen 
et al., 1987). Most recently, a statistical analysis of 88,000 T-DNA genome-wild 
insertions of Arabidopsis revealed the existence of a large integration site bias at both the 
chromosome and gene levels (Alonso et al., 2003). At the chromosomal level, fewer T-
DNA insertions were found at the centromeric region. At the gene level, Insertions within 
promotor and coding exons make up nearly 50% of all insertion sites. However, these 
statistical results may be skewed by the antibiotic resistance selection of transformed 
plants (T1 plants) because only the T1 plants with transcriptionally active T-DNA 
insertions can be selected (Alonso et al., 2003; Valentine, 2003). Another statistical 
analysis of 9000 flanking sequence tags characterizing transferred DNA (T-DNA) 
transformants in Arabidopsis showed that there are microsimilarities involved in the 
integration of both the right and left borders of the T-DNA insertions (Brunaud et al., 
2002). These microsimilarities occur only a stretch of 3 to 5 bp and can be between any 
T-DNA and genomic sequence. This mini-match of 3 to 5 bp basically allows T-DNA to 
integrate at any locus in the genome. It was also showed that T-DNA integration is 
favored in plant DNA regions with an A-T-rich content (Brunaud et al., 2002).  
1.7.2. Integration mechanism 
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The observation of the random, as opposed to targeted, nature of T-DNA integration 
indicated that the integration occurs in illegitimate recombination, a mechanism that joins 
two double-stranded (ds) DNA elements that do not share extensive homology 
(Ziemienowicz, 2001). To date, it has not been possible to target T-DNA to any particular 
locus in the genome with any great efficiency. However, one of the major contributions 
of A. tumefaciens research has been the use of T-DNA as a mutagen to generate the 
desirable mutant (Valentine, 2003). So, the T-DNA integration has been one of the 
motives of intensive investigation of A. tumefaciens. But, the molecular mechanisms of 
the T-DNA integration remain largely unknown.  
It is likely that after nuclear import, the ssT-strand is turned into double-stranded 
DNA (dsDNA) with the concomitant displacement of VirE2. Conversion of ssT-strand to 
a dsDNA form is supported by the observation that the level of transient expression of T-
DNA genes is much greater than the expression from stably integrated T-DNA, because 
the conversion of the ssT-strand to a transcriptionally competent form requires the 
conversion of ssT-strand to a dsDNA form (Narasimhuhu, et al., 1996). In addition, the 
extrachromosomal homologous recombination of T-DNA prior to integration and the 
complex pattern of multiple T-DNA insertions at a single insertion site also supported 
that ssT-strand likely becomes double-stranded (De Buck et al., 1999). Although it is not 
sure whether these extrachromosomal dsT-DNAs are the substrates for integration, 
double-strand break repair via non-homologous end joining of the dsT-DNA is consistent 
with many of the products observed as a result of T-DNA integration (Britt, 1999; De 
Buck et al., 1999). 
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Unlike such mobile DNA elements as transposons and retroviruses, T-DNA itself 
does not encode enzymes that catalyze the integration. Thus, the integration of T-DNA 
into the plant genome must be mediated by proteins imported from A. tumefaciens or by 
host cell factors. Illegitimate recombination is an unfaithful DNA repair mechanism that 
often incorporates filler DNA, such as T-DNA, into the repair site. The sequence analysis 
of several T-DNA insertions and their respective pre-integration sites showed that the 
right junction is somewhat less variable than the left. In most cases the right junction of 
the T-DNA insertion includes all or almost all bases of the T-DNA. In contrast, the left 
junction of the T-DNA insertion lacks some of the sequences of the left end of the T-
DNA. The number of missing bases ranges from a few up to 100 bp (Mayerhofer et al., 
1991; Tinland et al., 1995). However, an A. tumefaciens mutant carrying an Arg to Gly 
substitution at position 129 in VirD2 resulted in the normally conserved 5΄ end of the 
integrated DNA to be truncated or significantly rearranged, but did not affect the 
integration efficiency (Tinland et al., 1995). This VirD2 mutation affected the precision 
of the integration of 5΄ end of T-DNA (the right junction of the T-DNA insertion) but not 
the efficiency, suggested that VirD2 is very important for the T-DNA integration process. 
Analysis of the T-DNA integration junctions also showed that VirE2 is required for 
integration fidelity at the 3΄ but not the 5΄ end of the T-DNA (Rossi et al., 1996). 
1.7.3. Plant proteins involved in the T-DNA integration 
The plant proteins that may be involved in the T-DNA integration process are only 
now beginning to be defined. A recent research showed that VirD2 interacts with 
CAK2Ms, a conserved plant ortholog of cyclindependent kinase-activating kinases, and 
the TATA box-binding protein (Bako et al., 2003). In vivo, VirD2 can be phosphorylated 
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by CAK2Ms. CAK2Ms also binds to and phosphorylates the C-terminal regulatory 
domain of RNA polymerase II largest subunit, which can recruit the TATA box-binding 
protein. TATA box-binding protein not only plays a defined role in the regulation of 
transcription, but also controls transcription-coupled repair, which ensures preferential 
and effective removal of DNA lesions from transcribed genes. These nuclear VirD2-
binding factors provide a link between T-DNA integration and transcription-coupled 
repair, suggesting that transcription and transcription-coupled repair may play a role in T-
DNA integration (Bako et al., 2003). 
1.8. Aims and Significance of This Study 
1.8.1. Significanc of this study 
A. tumefaciens-mediated T-DNA transfer to plant has become the most popular 
method for the introduction of foreign genes into plant cells and the subsequent 
regeneration of transgenic plants because A. tumefaciens-mediated transformation has 
remarkable advantages over other direct transformation methods such as microinjection, 
electroporation and particle bombardment (De la Riva et al., 1998). The advantages of A. 
tumefaciens-mediated transformation include: (1) significantly high transformation 
efficiency; (2) easy to manipulate; (3) low copy number of the transgene, usually single 
copy insertion into the plant genome, potentially resulting in fewer problems with 
transgene cosuppresion and instability (Hansen et al., 1997); and (4) less frequent to form 
mosaic plants (Enriquez-Obregon et al., 1998). Now, many agronomically and 
horticulturally important species are routinely transformed using A. tumefaciens. Besides 
its natural host, dicotyledonous plants, the list of species that is susceptible to A. 
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tumefaciens-mediated transformation was enlarged to monocotyledonous plants (Chilton, 
1993), yeast (Piers et al., 1996), fungi (Groot et al., 1998), and human cells (Kunik et al., 
2001). Because A. tumefaciens represents a major tool for plant molecular breeding and 
for the delivery of DNA to other eukaryotic cells, the molecular mechanism by which it 
genetically transform the host cells has been the focus of research for a wide spectrum of 
biologists, from bacteriologists to molecular biologists to botanists, for a number of years. 
In addition, A. tumefaciens-mediated T-DNA transfer to plant is the only known 
natural example of DNA transport between kingdoms. The T-DNA is transferred into 
eukaryotic cells in the form of nucleoprotein complex. Thus, the A. tumefaciens-mediated 
T-DNA transfer system can be used as a model system to study the molecular mechanism 
of a wide variety of biological processes such as nucleoprotein trafficking, nuclear 
targeting of nucleoprotein, and the export of virulence effector (Christie, 2001; 
Ziemienowicz et al., 2001). Many of these biological processes are relevant to human 
pathogen, human gene therapy, as well as HIV viral infection. Apparently, it is extremely 
important to understand how this nucleoprotein trafficking process occurs. 
1.8.2. Aims of this study 
Although the molecular mechanism of A. tumefaciens-mediated T-DNA transfer has 
been intensively studied in the past decades and our understanding of the molecular 
mechanisms of T-DNA transfer has grown immeasurably in recent years, many details of 
the T-DNA transfer still remain unclear. As discussed in the above, so few virulence 
proteins (only VirD1 and VirD2) are identified to be necessary for T-DNA production. Is 
there any bacterial housekeeping protein or enzyme of DNA repair and replication to be 
 45
implicated in this process? We do not know whether the VirD2-guiding T-complex 
movement to the bacterial export apparatus is an active movement or passive movement. 
We also do not know if the coupling protein VirD4 can recruit the T-complex to the 
bacterial export apparatus. Whether VirE2 can coat to the ssT-strand inside bacteria is 
still in controversy. 
It is well known that during the T-DNA transfer process, VirD2 plays a crucial role. 
VirD2 participates the whole process of T-DNA transfer, including the T-DNA 
processing, the T-complex export, the nuclear localization of T-complex, and the 
integration of T-DNA into the plant genome. In order to identify any additional protein(s) 
that may be involved in the T-DNA transfer, VirD2 was used as a bait protein in a “pull-
down” assay experiment to fish agrobacterial proteins that can bind with VirD2 protein. 
In this study, an agrobacterial protein, designated VBP1, was identified to bind VirD2 
specifically. Two genes highly homologous to the vbp1 gene are also found in A. 
tumefaciens genome and designated vbp2 and vbp3. To understand the role of these vbp 
genes in A. tumefaciens, three vbp genes in the genome were mutated; a triple mutation of 
the three vbp genes exhibited attenuated bacterial ability to cause tumors on plants. These 
suggest that an additional virulence factor is important for the T-DNA transfer process. 
The redundancy of three homologs for the VirD2-binding ability indicates a conserved 
function that is important for the gene transfer. VBP proteins can also bind some 
components of VirD4/VirB T4SS and influnce the mobilization of a derivative of 
RSF1010, pML122, from A. tumefaciens to E. coli. VBP proteins were defined as a new 
class of proteins: recruiting proteins that can recruit cytoplasmic nucleoprotein complex 
to the membrane transport apparatus. 
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Chapter 2  Materials and Methods 
2.1. Bacterial Strains, Plasmids, Primers and Bacterial Culture  
Bacterial strains and plasmids used in this study are described in Table 2.1 and 2.2 
respectively. Media used in this study for culturing bacteria were prepared as described in 
Table 2.3. For long-term storage, all bacterial strains were saved in LB with 50% glycerol 
at – 80 °C freezer. The sequences and purposes of primers used in this study are 
described in Table 2.4. Escherichia coli strains were grown at 37°C in Luria-Bertani (LB) 
liquid or agar medium (Sambrook and Russell, 2001). Agrobacterium tumefaciens strains 
were grown at 28°C in MG/L or IB medium (Cangelosi et al., 1991). LB and MG/L 
media were supplemented with appropriate antibiotics when necessary. The preparation 
and concentration of antibiotics and related stock solutions are described in Table 2.5. 
2.2. DNA Manipulations 
DNA manipulations followed standard molecular protocols with some modifications. 
Most of the DNA manipulation protocols are mainly cited from Molecular Cloning 
(Sambrook and Russell, 2001). E. coli DH5α strain was routinely used as the host for 
cloning experiments.  
2.2.1. Preparation of plasmid DNA 
Plasmid DNA was prepared according to the protocol described in Molecular 
Cloning (Sambrook and Russell, 2001) with minimum modifications. E. coli cells from 2 
ml of overnight (12~14 hours) culture were collected by centrifugation at 6, 000 rpm 
(Eppendorf 5417C) for 1 min and subsequently washed once with sterile water.  The cell 
pellet was resuspended in 100 µl of ice-cold alkaline lysis solution I (50mM glucose, 25  
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Table 2.1. Bacterial strains used in this study 
Bacterial strain Relevant characteristic(s)a Source or reference 
 Escherichia coli    
DH5α EndA1 hsdR17 supE44 thi-1 recA1 
gyrA96 relA1 (argF-lacZYA) U169 
φ80dlacZ.  For DNA cloning. 
Bethesda Research 
Laboratories 
BL21(DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3).  
For protein expression. 
Invitrogen 
MT607 Pro-82 thi-1 hsdR17 supE44 end44 
endA1 recA56 
Finan et al. 1986 
MT616 MT607 (pRK600), mobilizer Finan et al. 1986 
Agrobacterium  tumefaciens  
C58 Wild type, nopaline-type pTiC58 plasmid Laboratory collection 
A348 Wild type, A136 (pTiA6NC) (octopine-
type) 
Laboratory collection 
LBA4404 A vir helper; harbors disarmed Ti plasmid 
pAL4404, a T-DNA deletion derivation 
of pTiAch5 (octopine type) RfR, SmR. 
Ooms et al., 1982 
WR1715 Harbors a Ti plasmid with 70% of virD2 
deleted (aa 94-388). 
Shurvinton et al., 
1992 
A348∆B4 Derivative of A348, VirB4:Tn5::VirB Stachel and Nester, 
1986 
A348∆B8 Derivative of A348 in which virB8 was 
deleted. 
Laboratory collection 
A348∆B11 Derivative of A348 in which virB11 was 
deleted, KmR. 
Laboratory collection 
GMI9017 C58 cured of pAtC58, SmR, SpR RfR Rosenberg and 
Huguet, 1984 




GMI9017∆vbp2∆vbp3 Derivative of GMI9017∆vbp2 in which 
vbp3 was disrupted by plasmid pUC19, 
CbR. 
This study 
A348∆vbp2 Derivative of A348 in which vbp2 was 
deleted. 
This study 
A348∆vbp2∆vbp3 Derivative of A348∆vbp2 in which vbp3 
was disrupted by plasmid pUC19, CbR. 
This study 
aAmp, ampicillin; Cb, carbenicillin;  Gm, gentamycin; Km, kanamycin; Nal, nalidixic 
acid; Rf, rifampicin; Sm, streptomycin; Tc, tetracycline. 
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Table 2.2. Plasmids used in this study 
Plasmids Relevant characteristic(s)a Source or reference 
pUC19 Cloning vector, ColE1 oriV bla, AmpR US Biochemical 
pEX18Tc Counterselectable plasmid carrying sacB marker, 
oriT, TcR
Hoang et al., 1998 
pIG121Hm Binary vector plasmid, carrying β-glucuronidase 
gene (gusA) between T-border, KmR. 
Ohata et al., 1990 
pQM118 Derivative of pEX18Tc in which TcR was 
replaced by npt III from pCB301, KmR. 
This study 
pMAL-cRI Expression vector carrying full-length maltose 
binding protein (MBP); AmpR
New England 
Biolabs 
pSQ166 pMAL-cRI containing a malE::VirD2 fusion 
encoding MBP-VirD2 with MBP fused onto 
VirD2 at the PstI site of virD2; AmpR
This study 
pSQ190 pMAL-cRI containing  a malE::VirJ fusion 
encoding MBP-VirJ with MBP fused onto VirJ at 
the PstI site of virJ; AmpR
This study 
pSQ203 pMAL-cRI containing a malE::VirD2 fusion 
encoding MBP-C-VirD2 with MBP fused onto 
VirD2 C-terminal domain at the BamHI site of the 
virD2 gene; AmpR
This study 
pXQ15 pRSET-A carrying a 2.17 kb XhoI – KpnI 
fragment containing the full length katA ORF 
fused in-frame with (His)6, AmpR. 
Xu et al., 2001 
pEXKmVD pQM118 carrying a 2.183 kb HindIII fragment 
from vbp2 downstream, KmR. 
This study 
pEXKmVUD pEXKmVD carrying a 1.395 kb BamHI fragment 
from vbp2 upstream, KmR. 
This study 
pUCvbp3 PUC19 carrying a 596 bp BamHI fragment from 
vbp3 N-terminus without start code, AmpR. 
This study 
pRvbp1 pRSET-A carrying a 947 bp XhoI fragment 
containing the full length vbp1 ORF fused in-
frame with (His)6, AmpR. 
This study 
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pRvbp2 pRSET-B carrying a 952 bp BamHI fragment 
containing the full length vbp2 ORF fused in-
frame with (His)6, AmpR. 
This study 
pRvbp3 pRSET-B carrying a 936 bp BamHI fragment 
containing the full length vbp3 ORF fused in-
frame with (His)6, AmpR. 
This study 
pCBvbp1C pCB301 carrying a 2054 bp HindIII fragment 
containing the 941 bp full length vbp1 ORF as 
well as its 597 bp upstream and 516 bp 
downstream sequence, KmR. 
This study 
pCBvbp2C pCB301 carrying a 2031 bp HindIII fragment 
containing the 935 bp full length vbp2 ORF as 
well as its 602 bp upstream and 494 bp 
downstream sequence, KmR. 
This study 
pCBvbp3C pCB301 carrying a 2027 bp HindIII fragment 
containing the 926 bp full length vbp3 ORF as 
well as its 597 bp upstream and 504 bp 
downstream sequence, KmR. 
This study 
pML122 A  derivative of  IncQ plasmid pRSF1010, GmR. Labes et al., 1990 
aAmp, ampicillin; Cb, carbenicillin;  Gm, gentamycin; Km, kanamycin; Nal, nalidixic 
acid; Rf, rifampicin; Sm, streptomycin; Tc, tetracycline. 
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Table 2.3. Media used in this study and their preparation 
Media or solutions Preparationa, b Reference 
For routinely culturing E. coli  




    LB rich medium Tryptone, 10 g; yeast extract, 5 g; NaCl, 5 g; 
glucose, 2 g 
New England 
Biolabs 
For preparing E. coli competent cells  
    SOB Tryptone, 20 g; yeast extract, 5 g; NaCl, 0.5 g; 
10 ml of 250 mM KCl; pH 7.0, sterilize by 




    TB 10 mM PIPS, 55 mM MnCl2, 15 mM CaCl2, 
250mM KCl;  
Sambrook et 
al., 1989 
For culturing A. tumefaciens  
    MG/L  LB, 500 ml; mannitol, 10 g; sodium glutamate, 
2.32 g; KH2PO4, 0.5 g; NaCl, 0.2 g; MgSO4. 
7H2O, 0.2 g; biotin, 2 µg; pH 7.0. 
Cangelosi et 
al., 1991 
    20 × AB salts NH4Cl, 20 g; MgSO4. 7H2O, 6 g; KCl, 3 g; 
CaCl2, 0.2 g; Fe SO4. 7H2O, 50 mg. 
Cangelosi et 
al., 1991 
    20 × AB buffer K2HPO4, 60 g; NaH2PO4, 23 g; pH 7.0. Cangelosi et 
al., 1991 
    0.5 M MES MES, 97.6 g; pH 5.5. Cangelosi et 
al., 1991 
IB (Induction    
Medium) 
20 × AB salts, 50 ml; 20 × AB buffer, 1 ml; 0.5 
M MES (pH 5.5), 8 ml; 30% glucose, 60 ml 





20 × AB salts, 50 ml; 20 × AB buffer, 50 ml; 




a Preparation for 1 liter, and sterilized by autoclaving;  b For solid media, 1.5% agar was 
added. 
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Table 2.4. Primers used in this study 
Primers Sequence and purpose  Origin 
Pvbp1-1 5'---ccgctcgagcatgaaacatcgctcg---3' (Amplify 
vbp1 gene) 
plasmid AT – 124902 
Pvbp1-2 5'---ccgctcgagcccgctattcttcag---3' (Amplify 
vbp1 gene) 
plasmid AT – 123961 
Pvbp1-3 5'---cgctgacgaactacacgccggcg---3' (Sequence 
vbp1 gene in the expression vector) 
plasmid AT – 124266 
Pt7 5'---aatacgactcactatagg---3'  (Sequence the 
genes in pRSET vector) 
pRSET – T7 promoter 
Pt7r 5'---ctagttattgctcagcg---3' (Sequence the genes 
in pRSET vector) 
pRSET – T7 reverse primer 
Pdow3 5'---tccaagcttgatcatatcccgcacag---3' (Amplify 
downstream of vbp2 gene) 
linear chromosome – 2045222 
Pdow4 5'---cccaagcttccagcgcgagtaccag---3' (Amplify 
downstream of vbp2 gene) 
linear chromosome – 2047409 
Pup10 5'---acaggatcccttcctgccacgcc---3' (Amplify 
upstream of vbp2 gene) 
linear chromosome – 2043756 
Pup11 5'---gtgggatccatgaactttatacgcttc---3' (Amplify 
upstream of vbp2 gene) 
linear chromosome – 2045151 
Pscreen1 5'---ctcgagagaggagacgcatcg---3' (Screen the 
vbp2-deleting mutant) 
linear chromosome – 2044997 
Pscreen2 5'---cagcgcatcctcgaactcctc---3'  (Screen the 
vbp2-deleting mutant) 
linear chromosome – 2045303 
Pvbp3-1 5'---atgggatccagccttgaacatttgcc---3' (Amplify 
a fragment of vbp3 gene) 
linear chromosome – 2040241 
Pvbp3-3 5'---gcgggatccactgcctgatgg---3' (Amplify a 
fragment of vbp3 gene) 
linear chromosome – 2040840 
Ppuc1 5'---cggagcctatggaaaaacgcc---3' (Screen vbp3-
disrupting mutant) 
plasmid pUC19 – 881 
Pvbps1 5'---cctctggaatggcccgtacag---3'  (Screen vbp3-
disrupting mutant) 
linear chromosome – 2040192 
 53
Pvbps3 5'---gaggttgtgcgacgcaggc---3' (Screen vbp3-
disrupting mutant) 
linear chromosome – 2040895 
Pvbp2p1 5'---gatggatccctcccttgatcatatc---3' (Amplify 
vbp2 gene) 
linear chromosome – 2045217 
Pvbp2p2 5'---attggatcctgctttgacacctcg---3'  (Amplify 
vbp2 gene) 
linear chromosome – 2046170 
Pvbp3p1 5'---cat-gga-tcc-cag-cct-tga-aca-ttt-g---3' 
(Amplify vbp3 gene.) 
linear chromosome – 2040238 
Pvbp3p2 5'---tgcggatccgtgaagctcaatcg---3' (Amplify 
vbp3 gene) 
linear chromosome – 2041180 
Oligo G-
402 
5'---catacggcgtgacatcg---3' (Amplify T-DNA 




5'---acatggatccctacagg---3'  (Amplify T-DNA 
from “pull-down” T-complex.) 
plasmid pIG121Hm 
nptIIIF 5'---gaagatctctcgagttggcagcatcacc---3' 
(Amplify nptIII from plasmid pCB301) 
pCB301 
nptIIIR 5'---gaagatcttactaaaacaattcatccag---3' 
(Amplify nptIII from plasmid pCB301) 
pCB301 
Pex18F 5'---gaagatctgttgaatactcatactcttc---3' (Amplify 
backbone of pEX18Tc) 
pEX18Tc 
Pex18R 5'---gaagatcttgtcagaccaagtttactcat---3' 
(Amplify backbone of pEX18Tc) 
pEX18Tc 
Pvbp1C1 5'---gaggaagcttaaaggatcctcggc---3'  (Amplify 
vbp1 with its flanking sequence) 
Plasmid AT–123445 
Pvbp1C2 5'---gcggaagcttgatgcttggtacg---3'  (Amplify 
vbp1 with its flanking sequence) 
Plasmid AT–125499 
Pvbp2C1 5'---gatcaagcttccaataattgcggcc---3'  (Amplify 
vbp2 with its flanking sequence) 
linear chromosome – 2044606 
Pvbp2C2 5'---gtctcaagcttgcgccgatagtg---3'  (Amplify 
vbp2 with its flanking sequence) 
linear chromosome – 2046637 
Pvbp3C1 5'---ccaaaagcttaaacgcgctgcaag---3'  (Amplify 
vbp3 with its flanking sequence) 
linear chromosome – 2039641 
Pvbp3C2 5'---cgagaagcttgcaaccggttcatg---3'  (Amplify 
vbp3 with its flanking sequence) 
linear chromosome – 2041668 
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PvbpCS1 5'---gggctgcaggaattcgatatc---3'  (Verify that 
plasmids pCBvbp1C, pCBvbp2C and 
pCBvbp3C were introduced into 
GMI9017∆vbp2∆vbp3) 
.pCB301 near Hind III site 
PvbpCS2 5'---gaggtcgacggtatcgataag---3'  (Verify that 
plasmids pCBvbp1C, pCBvbp2C and 
pCBvbp3C were introduced into 
GMI9017∆vbp2∆vbp3) 
pCB301 near Hind III site 
Ptdna1 5'---gcggcggcgataactctcag----3' (Verify that 
T-DNA was co-immunoprecipitated by anti-
VBP1 antibody) 
Corresponding to the “ipt” gene 
of T-region in the Ti plasmid 
Ptdna2 5'---ggaattgactatgagcagcttg---3' (Verify that 
T-DNA was co-immunoprecipitated by anti-
VBP1 antibody) 
Corresponding to the “ipt” gene 
of T-region in the Ti plasmid 
Ptibac1 5'---gtggctgtgttggttatgagc---3' (Verify whether 
the co-immunoprecipitated DNA is T-DNA or 
Ti plasmid) 
Corresponding to the “virB1” 
gene of Ti plasmid 
Ptibac2 5'---gtcttcggatttgcggttgtc---3' (Verify whether 
the co-immunoprecipitated DNA is T-DNA or 
Ti plasmid) 
Corresponding to the “virB1” 
gene of Ti plasmid 
Prsf1 5'---ctgcgctaggctacacaccg---3' (Verify that 
plasmid pML122 was co-immunoprecipitated 
by anti-VBP1 antibody) 
Region of RSF1010 in plasmid 
pML122 
Prsf2 5'---cgacgaactccggcatgtgc---3' (Verify that 
plasmid pML122 was co-immunoprecipitated 
by anti-VBP1 antibody) 





Table 2.5. Antibiotics and other stock solutions used in this study 











Con. in A. 
tumefaciens 
(µg/ml) 
Ampicillin (Amp) Dissolved in dH2O, 
filter sterilized 
100 100 100 
Carbenicillin (Cb) Same as above 100 100 100 
Chloramphenical 
(Chl) 
Dissolved in absolute 
ethanol 
34 17 --- 
Gentamycin (Gm) Dissolved in dH2O, 
filter sterilized 
50 10 50 
Kanamycin (Km) Dissolved in dH2O, 
filter sterilized 
100 50 100 
Tetracycline (Tc) Dissolved in absolute 
ethanol 
5 10 5 
Acetosyringone  Dissolved in dimethyl 
sulfoxide. 
19.62 ---- 19.62 
IPTG Dissolved in dH2O, 
filter sterilized 
24 24 ---- 
RNase Dissolved in 10 mM 
Tris-HCl (pH7.5) and 
15 mM NaCl 
10 20 20 
Proteinase K Dissolved in dH2O, 
filter sterilized 
20 50 50 
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mM Tris-HCl, 10 mM EDTA, pH 8.0) supplemented with 100 mg/l RNase. The cell 
pellet must be vortexed to completely suspend the cells so that no clumps were visible in 
the suspension.  Then, 200 µl of freshly prepared alkaline lysis solution II (0.2 N NaOH, 
1% SDS) was added to the suspension. The contents were gently mixed by inverting the 
tube 3~5 times until the suspension became viscous and slightly clear solution. Adding 
150 µl of alkaline lysis solution III (3 M potassium, 5 M acetate) to the viscous bacterial 
lysate, the mixture was inverted for 4~6 times to disperse alkaline lysis solution III 
through the viscous bacterial lysate.  The bacterial lysate was extracted with equal 
volume of chloroform once. The aqueous upper layer in the emulsion was collected by 
centrifugation at 14, 000 rpm (Eppendorf 5417C) for 5 min and then was transferred to a 
clean eppendorf tube.  Two volumes of ethanol were added to the supernatant to 
precipitate the plasmid DNA. The solution was mixed by vortexing and was stood for 2 
minutes at room temperature so that the plasmid DNA is able to completely precipitate. 
The precipitated plasmid DNA was collected by centrifugation at 14, 000 rpm 
(Eppendorf 5417C) for 5 min.  The DNA pellet was washed once with 70% ethanol and 
dried in a vacuum concentrator (Eppendorf 5301).  The isolated plasmid DNA was 
dissolved in 20 ml (for low copy plasmid) or 50 ml (for high copy plasmid) of sterile 
water and stored at -20 °C, ready for subsequent use. 
2.2.2. Preparation of A. tumefaciens genomic DNA 
Total DNA of A. tumefaciens was prepared according to Charles and Nester (1993).  
Cells from 100 ml of overnight culture were collected by centrifugation at 4, 000 rpm for 
5 min.  The cell pellet was washed once with 4 ml of TES (10 mM Tris-HCl, 25 mM 
EDTA, 150 mM NaCl, pH 8.0), and then resuspended in 4 ml of TE buffer (10 mM Tris-
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HCl, 25 mM EDTA, pH 8.0) by vortexing.  Adding 500 µl of 5 M NaCl, 500 µl of 
proteinase K (5 mg/ml), and 500 µl of 10% SDS to the suspension, the mixture was 
incubated at 68 °C for 30 min to lyse the cells.  The cell lysate was extracted once with 
1:1 phenol-chloroform and pure chloroform respectively. The aqueous upper supernatant 
was transferred to a clean tube. Ammonium acetate solution (7.5 M) was added to the 
supernatant to a final concentration of 2 M and then 2 volumes of ethanol were added to 
the mixture to precipitate genomic DNA.  The precipitated DNA was collected by 
centrifugation and washed once with 70% ethanol.  The isolated genomic DNA was dried 
in a vacuum concentrator and then stored at -20 °C. When used, the genomic DNA can be 
dissolved in 500 µl of sterile water or TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 
2.2.3. Preparation of E. coli competent cells 
Highly efficient competent cells of E. coli DH5α and BL21 (DE3) strains were 
prepared according to the Inoue protocol (Sambrook and Russell, 2001). Freshly growing 
E. coli colonies from LB agar plates were inoculated into 100 ml of SOB medium in a 1-
liter conical flask and then allowed to grow at room temperature (about 19°C) with 
vigorous shaking (250 rpm). After the cells grow to an OD600 of 0.5~0.7, the culture was 
chilled on ice for 10 min and the cells were collected by centrifugation at 3, 600 rpm 
(Eppendorf 5810R) for 5 min at 4 °C.  The cell pellet was resuspended in 30 ml of ice-
cold TB buffer (10 mM PIPS, 55 mM MnCl2, 15 mM CaCl2, 250mM KCl, pH 6.7; all 
components except MnCl2 were dissolved and autoclaved; 1M MnCl2 solution was filter-
sterilized and added to make TB buffer; store at 4 °C) and incubated on ice for 10 min.  
The cells were washed once by TB buffer and resuspended in 5 ml of ice-cold TB buffer.  
Thereafter DMSO was added to the cell suspension to a final concentration of 7%. The 
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competent cell suspension was aliquoted to pre-cooled sterile eppendorf tubes at 100 µl 
each and then frozen in liquid nitrogen immediately. The competent cells were stored at –
80 °C freezer ready for using. 
2.2.4. Amplification of DNA by polymerase chain reaction (PCR) 
DNA fragments and related genes were amplified by the basic polymerase chain 
reaction (PCR). The composition of the PCR reaction mixture was shown as following.  
10 × PCR buffer (without MgCl2) 5 µl 
MgCl2 (25 mM) 3 µl 
Primer 1 (10 µM) 2 µl 
Primer 2 (10 µM) 2 µl 
dNTPs (10 mM each)  1 µl 
Template DNA (20-100 ng/µl) 1 µl 
Taq DNA polymerase (1 unit/µl) 1 µl  
Add distilled water to a final volume of 50 µl 
The basic PCR was normally run using the following program. 
1 cycle  95 °C for 0.5 ~ 1 min 
28 cycles 95 °C for 30 seconds 
 Annealing at (Tm-5) °C for 30 seconds 
 Extension at 72 °C for 1 min per kb 
1 cycle 72 °C for 10 min 
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2.2.5. DNA digestion and ligation 
DNA digestion and ligation were conducted according to the instruction manual 
provided by the enzyme supplier. Usually, the DNA digestion mixture comprised of 
buffer, DNA, restriction endonuclease and sterile water. The mixture was incubated at 37 
°C for 2 hours to overnight as required. For single-digestion vectors, dephosphorylation 
is required for the subsequent ligation. In this case, one unit of shrimp alkaline 
phophatase (SAP) was added to the digestion mixture to conduct the dephosphorylation. 
The digested vectors and DNA fragments used for ligation were further purified using 
agarose gel electrophoresis and QIAGEN gel extraction kit. Bacteriophage T4 DNA 
ligase was used to ligate the digested DNA fragments to the digested vectors. The 
ligation was performed at 16 °C (or room temperature) for 3~4 hours (or overnight). 
2.2.6. Agarose gel electrophoresis and DNA purification 
DNA fragments were separated by agarose gel electrophoresis in TAE buffer (0.04M 
Tris-acetate, 0.001 M EDTA, pH 8.0) along with a standard DNA ladder (Fermentas). 
Normally, the concentration of agarose gel is 1% and ethidium bromide (EB) was directly 
added to the agarose gel to a final concentration of 0.5 µg/ml. The separated DNA 
fragments were recovered from the agarose gel by using QIAquick Gel Extraction Kit 
(QIAGEN). The recovery procedure provided by the manufacturer was briefly described 
as following. The agarose gel containing the band of the interesting DNA was cut out and 
transferred to a pre-weighted eppendorf tube.  Three gel volumes (300 µl buffer to 100 
mg gel) of QG buffer were added to the gel. The gel was allowed to incubate with the QG 
buffer in a 55 °C waterbath for 5~10 min to dissolve completely.  For DNA fragments 
larger than 4 kb or smaller than 500 bp, one gel volume of isopropanol was added to the 
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mixture to increase the recovery efficiency of DNA.  To bind DNA, the mixture was 
transferred to a QIAquick spin column in a 2-ml collection tube and centrifuged for 1 min 
at 14, 000 rpm (Eppendorf 5417C).  The DNA bound column was washed once with 750 
µl of PE buffer by centrifugation. After the flow-through was discarded, the column 
required one additional centrifugation to remove any residual ethanol.  To elute DNA, the 
column was placed into a clean 1.5-ml tube and 50 µl of sterile water was applied to the 
center of the column membrane. The eluted DNA was collected by centrifugation at 14, 
000 rpm (Eppendorf 5417C) for 1 min.  
2.2.7. Transformation of bacterial cells 
In most operations, DNA was transferred into E. coli cells by heat-shock following 
the standard protocol (Sambrook and Russell, 2001). Frozen competent cells (100 µl) 
were thawed on ice. The transforming DNA (up to 25 ng per 50 µl of competent cells), 
including plasmid and ligation product, was added to the competent cell suspension in a 
volume not exceeding 5% of that of the competent cells. The competent cells were mixed 
with the transforming DNA by swirling gently and were then incubated on ice for 30 
minutes.  The mixture of cells and DNA were heat-shocked at 42 °C for 90 seconds and 
immediately chilled on ice for 2 min. 900 µl of fresh LB medium were added to the 
transformed cells.  The transformed cells were incubated at 37 °C for 45 min with 
shaking to allow the bacteria to recover and to express the antibiotic resistance marker 
encoded by the transforming DNA. The cells were collected by centrifugation and spread 
onto LB agar plates containing the appropriate antibiotic(s). Colonies usually appeared 
after overnight incubation at 37 °C. 
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Plasmids were introduced into A. tumefaciens by electroporation (Cangelosi et al., 
1991). Occasionally, electroporation was also used to introduce plasmid DNA into E. coli 
cells (Sambrook and Russell, 2001). Plasmid DNA used for electroporation was prepared 
using alkaline lysis with SDS (Sambrook and Russell, 2001) and further purified by 
GeneClean Kit (QIAGEN). Electrocompetent bacterial cells were prepared by growing 
cells on agar plates, washing the bacteria cells extensively at low temperature, and then 
resuspending the cells in ice-cold 10% glycerol solution. The detail operation procedure 
was as follows. Bacterial cells were inoculated onto agar plates (A. tumefaciens onto 
MG/L plates, E.coli onto LB plates) and grew overnight (A. tumefaciens at 28 °C, E.coli 
at 37 °C) or until the bacterial cells reached a specific amount. The bacterial cells were 
scraped from the agar plates with a sterile wooden stick and then transferred to an 
eppendorf tube.  The cells were washed twice with ice-cold sterile water and then washed 
once with ice-cold 10% glycerol.  The cell pellet was resuspended in 50µl of ice-cold 
10% glycerol. The transforming plasmid DNA (0.5~1 µg in 10 µl or less of water) was 
added to the electrocompetent bacterial cell suspension.  The mixture of cells and DNA 
was incubated on ice for 2 min and then transferred into a pre-chilled 0.2-cm BioRad 
electroporation cuvette.  Gene Pulser II Electroporation System (BioRad) was set at 25 
µF capacitance, voltage of 2.5 kV and the pulse controller to 400 Ω (for E. coli set to 200 
Ω).  The condensation and moisture on the outside of the cuvette should be wiped away 
with tissue paper before the cuvette was slide into the shocking chamber base. After 
delivering a pulse of electricity to the cells at the settings indicated above, 1 ml of liquid 
medium (MG/L to A.tumefaciens, LB to E. coli) was immediately added to the 
electroporated cells. Then, the mixture was transferred to a 15-ml culture tube and 
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cultured for 1 hour (A. tumefaciens at 28 °C, E.coli at 37 °C) with shaking to allow the 
electroporated bacterial cells to recover and to express the antibiotic resistance marker 
encoded by the transforming plasmid. The cells were collected by centrifugation and 
spread onto agar plates (A. tumefaciens onto MG/L plates, E. coli onto LB plates) 
containing selectable antibiotics. Colonies usually appeared on the third day for A. 
tumefaciens and on the second day for E. coli. In successful transformations, the time 
constant was typically about 9 milli-seconds for A. tumefaciens and 4.5 milli-seconds for 
E. coli. 
2.2.8. DNA sequencing 
Sequencing templates (plasmids or PCR products) were purified by using GeneClean 
Kit (QIAGEN). The sequencing PCR run mixture contains 2 µl of BigDyeTM Ready Mix 
(v 3.0), 0.5 µl of primer (10 µmol l-1), 2 µl of template (purified plasmids or PCR 
products, 100~200 ng µl-1) and 5.5 µl of deionized water. The total volume of the run 
mixture is 10 µl. The cycle sequencing was normally performed using the following 
program. 
1 cycle  96 °C for 0.5 ~ 1 min 
25 cycles 96 °C for 15 seconds 
 Annealing at 50 °C for 15 seconds 
 Extension at 60 °C for 4 min  
 Hold at 4 °C until ready to purify 
After the cycle sequencing is finished, the contents in the PCR tube were spun down 
and then were transferred into a clear 1.5-ml tube. 25 µl of absolute ethanol and 1 µl of 3 
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M sodium acetate were added to the tube. The contents in the tube were mixed by 
vortexing and the tube was allowed to stand at room temperature for 15 min to precipitate 
the extension products. The pellet was collected by centrifugation at 14,000 rpm 
(Eppendorf 5417C) for 20 min. The pellet was washed with 70% ethanol twice and then 
centrifuged at 14,000 rpm (Eppendorf 5417C) for 10 min. After the supernatants were 
carefully aspirated from the tube, the pellet was dried in a vacuum centrifuge for 10~15 
minutes and stored at –20 °C. This pellet was ready to be submitted for running 
electrophoresis. 
2.3. Protein Analytical Techniques 
2.3.1. SDS-PAGE gel electrophoresis 
Proteins were separated by SDS-PAGE gel electrophoresis according to their 
molecular weight. The buffers and solutions used in SDS-PAGE gel electrophoresis are 
listed in Table 2.6. The electrophoresis apparatus used in SDS-PAGE gel electrophoresis 
was the Mini-Protean III Electrophoresis Cell (BioRad). The apparatus was assembled 
according to the instruction manual provided by the manufacturer. Acrylamide/bis-
acrylamide solution was prepared as described in Molecular Cloning (Sambrook et al, 
1989) and stored in the dark at 4 °C.  Ammonium persulfate (APS) solution was freshly 
prepared before each use.  Separating gel buffer and stacking gel buffer were stored at 
room temperature.  Electrophoresis buffer was prepared as 10 × stock solution and stored 
at room temperature.  Sample-loading buffer was prepared without DTT and stored at 
room temperature; when used, DTT was added to the sample-loading buffer from 1 M 
DTT stock solution. DTT stock solution was stored at –20 °C.  SDS stock solution was 
stored at room temperature.  
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Table 2.6. Buffers and solutions used in SDS-PAGE gel electrophoresis  
Buffer or Solution Concentration Preparation 
Acrylamide/bis-
acrylamide solution 
30% acrylamide, 0.8% bis-
acrylamide. 
150 g acrylamide, 4 g bis-acrylamide, 
dissolved in 500 ml H2O and filtered 
with Whatman paper 
Separating gel 
buffer 
3 M Tris-HCl, pH 8.8 181.5 g Tris dissolved in 500 ml H2O 
and adjusted pH to 8.8 with HCl 
Stacking gel buffer 0.5 M Tris-HCl, pH 6.8 30 g Tris, 10 ml concentrated HCl 
dissolved in 500 ml H2O and adjusted 




10%  (W/V) ammonium 
persulfate 
1 g ammonium persulfate dissolved in 
10 ml H2O 
SDS stock solution 10% (W/V) SDS 50 g SDS dissolved in 500 ml H2O 
Sample-loading 
buffer 
2 × buffer 
100 mM Tris-HCl, 4% SDS, 
20% glycerol, 0.002% 
bromophenol blue 
16 ml Stacking gel buffer, 3.2 g SDS, 
16 ml glycerol, 1.6 mg bromophenol 
blue bring to 80 ml. 
DTT stock solution 1 M DTT 1.543 g DTT dissolved in 10 ml H2O 
Electrophoresis 
buffer 
10 × buffer 
0.25 M Tris, 2.5 M Glycine, 1% 
SDS, pH 8.3 
30.2 g Tris, 188.0 g Glycine, 10 g 
SDS dissolved in 1000 ml H2O and 
adjusted pH to 8.3 
Staining solution 0.5 g Coomassie Brilliant Blue 
R250 in 180 ml methanol: H2O 
(1:1, V/V) and 20 ml glacial 
acetic acid 
Coomassie Brilliant Blue R250 
should be dissolved in methanol, and 
then add H2O. 
Destaining solution Methanol: H2O: glacial acetic acid (V/V) = 9:9:1 
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For the routine analysis of proteins, 10% PAGE gel was used. For proteins whose 
molecular weight is below 10 kDa, 15% or 17.5% PAGE gel was used. The 
polyacrylamide gels (PAGE) were prepared as follows. 
Separating polyacrylamide gels 
Gel concentration 7% 10% 12% 15% 17.5% 
Separating gel buffer 1.9 ml 1.9 ml 1.9 ml 1.9ml 1.9ml 
Acrylamide/bis-acrylamide 
solution 3.5 ml 5 ml 6ml 7.5 ml 8.75ml 
10% (W/V) SDS 150 µl 150 µl 150 µl 150 µl 150 µl 
10% (W/V) APS 150 µl 150 µl 150 µl 120 µl 100 µl 
TEMED 9 µl 9 µl 9 µl 8 µl 6 µl 
H2O 9.21 ml 7.71 ml 6.71 ml 5.24 ml 4.01 ml 
Total volume (ml) 15 15 15 15 15 
Stacking gel was 2.5% and prepared by mixing 2 ml stacking gel buffer, 1.3 ml 
acrylamide/bis-acrylamide solution, 80 µl 10% SDS, 80 µl 10% APS, 8 µl TEMED and 
4.5 ml H2O. Before loading, 40 µl of protein sample was mixed with 50 µl sample-
loading buffer and 10 µl of 1 M DTT solution. The sample mixture was heated at 95 °C 
for 5 minutes to reduce the disulfide bonds. Usually the gel was run at a constant voltage 
of 100 V until the bromophenol blue reached the bottom of the gel.  After the gel was 
stained in staining solution for 2~4 hours, the gel was destained with destaining solution 
for 3~4 times and the protein bands would appear. 
2.3.2. Western blot analysis 
For Western blot analysis, proteins separated by SDS-PAGE gel electrophoresis 
were transferred electrophoretically to an Immun-BlotTM PVDF membrane (Bio-Rad) 
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with Hoefer TE 22 Mighty Small Transfer Tank Transfer Unit (Amersham Pharmacia 
Biotech). The transfer buffer used in this study was Towbin buffer [48 mM Tris, 38 mM 
Glycine, 0.37% (W/V) SDS, pH 8.3, 20% (V/V) Methanol]. Transfer was performed 
either at 100 mA for 2~3 hours or at 60 mA overnight. After transfer was completed, the 
PVDF membrane was removed from the sandwich and then incubated with 10% non-fat 
milk in TBST buffer [20 mM Tris, 150 mM NaCl, 0.1% (V/V) Tween-20, pH 7.5] to 
block the remaining protein-binding sites in the PVDF membrane. The blocking reaction 
required 2 hours at room temperature on an orbital shaker. After blocking reaction 
finished, the PVDF membrane was washed at least three times with TBST buffer for ten 
minutes each on a rocking platform. Then, the PVDF membrane was incubated with the 
TBST-diluted primary antibody (usually in a 1:5000 dilution) for 1 hour at room 
temperature while continuously rocking the sample. To remove the unbound primary 
antibody, the PVDF membrane were washed at least three times as the aforementioned. 
After washing finished, the PVDF membrane was incubated with the TBST-diluted 
second antibody (usually in a 1:10000 dilution). The unbound second antibodies were 
washed away by three extensive TBST washes. The fluorescence produced by the HRP-
conjugated second antibody was detected with the ECL Western blotting analysis system 
(Amersham Life Science). 
2.4. Pull-down Assay 
2.4.1. Preparation of recombinant proteins  
The plasmids encoding maltose-binding protein (MBP), MBP-VirD2 fusion protein, 
MBP-VirJ fusion protein, and MBP-VirD2 C-termini (MBP-C-VirD2) fusion protein 
were introduced into E. Coli respectively. The bacterial cells were grown to a 
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concentration of approximately OD600 = 0.5; isopropyl β–D-thiogalactoside (IPTG) was 
added to the cultures in a final concentration of 0.3 mM to induce the expression of 
fusion proteins. The bacterial cultures were allowed to grow for additional 2~3 hours.  
All the subsequent operations were performed at 4°C. The cells of 500 ml culture were 
harvested by centrifugation and resuspended in 25 ml lysis buffer [150 mM NaCl; 10 mM 
EDTA; 10 mM EGTA; 20 mM Tris; 2 mM DTT; 2 mM phenylmethylsulfonyl fluoride 
(PMSF); 0.25% Tween-20; 10 mg l-1 leupeptins; 5 mg l-1 antipain; pH = 7.4]. The cell 
suspension was sonicated to near clarity and centrifuged at 17,000 × g for 20 min. 
Aliquots of the supernatant were stored at -20°C. Fusion protein purification was 
conducted as described by Pan et al. (1995) with minor modifications. Briefly, 2 ml 
amylose resin (New England Biolabs) was washed five times with column buffer (30 mM 
NaCl; 2 mM EDTA; 2 mM EGTA, 20 mM Tris; 1 mM DTT; 2.5 mM MgCl2; 1 mM 
PMSF; 2 mg l-1 leupeptins, 1 mg l-1 antipain, pH = 7.4). Then, 15 ml E. coli lysate, which 
was diluted five times from 3 ml supernatant with 12 ml column buffer, was added to the 
amylose resin and incubated for 45 min with rocking. The protein-bound amylose resin 
was loaded to a column. After the column was washed with 15 ml column buffer, the 
bound proteins were eluted with column buffer containing 10 mM maltose. The purity of 
the purified fusion proteins were examined by 10% SDS-PAGE. All the purified fusion 
proteins were concentrated by Centra-prep and freeze-dried. 
2.4.2. Isolation of VirD2-binding proteins 
To prepare A. tumefaciens protein extracts, A. tumefaciens strain A348 was grown 
at 28°C in MG/L medium for 16~18 h. The bacterial cells were collected by 
centrifugation, washed once with water, and then resuspended to OD600 of 0.4 in the IB 
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medium containing 200 µM acetosyringone (AS). The IB cell cultures were incubated at 
28°C for another 16~18 h with shaking. The cells harvested from 5 L of IB cell culture 
were washed once with water, and resuspended in 15 ml of Agrobacterium lysis buffer A 
(30 mM NaCl; 10 mM MgCl2; 5 mM EDTA; 5 mM EGTA; 20 mM Tris; 2 mM DTT; 2 
mM PMSF; 0.5% Triton-100; 10 mg l-1 leupeptins; 5 mg l-1 antipain; pH = 7.4). The cells 
were disrupted by French Press (cell pressure: 35K psi). The protein extract was collected 
by centrifugation at 12,000 × g for 15 min at 4°C and diluted with equal volume of lysis 
buffer A (but without Triton-100). The aliquots of the extract were stored at –20°C until 
the pull-down assay. 
To conduct the pull-down assay, E. coli protein extracts containing MBP, MBP-
VirJ, MBP-C-VirD2, or MBP-VirD2 were prepared as described above and allowed to 
incubate with pre-equilibrated amylose resins (50% v/v) for 45 min at 4°C with rocking. 
Care was taken to ensure that an equal amount of each of the proteins remained bound to 
the resin. The protein-bound amylose resins were washed with column buffer. Then, an 
equal amount of Agrobacterium protein extract was added to each of the protein-bound 
amylose resins and incubated for 60 min at 4°C with rocking. The resulting amylose 
resins were loaded to columns and washed with 6~10 column volumes of column buffer. 
The bound protein complexes were eluted with column buffer containing 10 mM maltose 
and concentrated by Centra-prep. The concentrated pull-down protein samples were 
freeze-dried and stored at -20°C. 
2.5. In-gel Digestion, MALDI-TOF Analysis and Tandem MS Sequencing 
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All the pulled down protein samples were adjusted to the same protein 
concentration and separated by 10% or 12% SDS-PAGE gel. Protein bands were 
carefully excised from Coomassie Blue-stained gels, cut into small pieces, and then 
destained with several washes of 50 mM ammonium bicarbonate in 50% aqueous 
acetonitrile. The gel pieces were dehydrated with 100% acetonitrile, dried in Savant 
Speed-vac, rehydrated with a solution containing 10 mM DTT and 100 mM ammonium 
bicarbonate, and incubated at 57°C for 60 min to reduce the disulfide bonds. The reduced 
sulfhydryl group was alkylated by 55 mM iodoacetamide in 100 mM ammonium 
bicarbonate at room temperature for 60 min. After alkylation, the gel pieces were washed 
with 100 mM ammonium bicarbonate solution, dehydrated with 100% acetonitrile at least 
6 times, and then dried in Savant Speed-vac again. Sequencing grade modified trypsin 
(12.5 mg l-1 in 50 mM ammonium bicarbonate, pH 8.0) was added to the dried gel pieces 
and incubated overnight at 37°C. The resulting trypsinized peptides were extracted with 
20 mM ammonium bicarbonate solution, 5% formic acid in 50% aqueous acetonitrile, 
and 100% acetonitrile, respectively. The extracted peptides were combined, lyophilized, 
and then resuspended in 0.1% trifluoroacetic acid (TFA). An aliquot of the resuspended 
peptides was spotted onto the stainless steel MALDI sample plate and overlaid with equal 
volume of matrix solution (20 g l-1 α-cyano-4-hydroxycinnamic acid in 0.1% TFA; 50% 
aqueous acetonitrile). The sample/matrix mixture was air dried. An Applied Biosystems 
Voyager-DE STR MALDI mass spectrometer was used to acquire the MALDI-time of 
flight (TOF) spectra. The instrument was operated in the positive reflector delayed 
extraction mode. Peptide mass spectra were searched against theoretically derived spectra 
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from proteins in the nonredundant databases of National Center for Biotechnology 
Information (NCBI) to match peptide mass fingerprints. 
Partial amino acid sequence of a single peptide was obtained by quadrupole-time of 
flight (Q-TOF) hybrid tandem mass (MS/MS) spectrometer. For Q-TOF MS/MS 
analysis, the trypsinized peptide samples were concentrated and desalted by the Zip-Tip 
method. Based on the mass spectra acquired by MALDI-TOF, dominant peptides were 
selected for MS/MS analysis. After peptides were selected, the Q-TOF mass spectrometer 
was automatically switched from MS to MS/MS mode and the Q-TOF MS/MS spectra 
were collected. The amino acid sequences were determined by searching the Q-TOF 
MS/MS spectra against the NCBI non-redundant protein databases. 
2.6. Expression of VBP Proteins and Generation of Anti-VBP Protein 
Antibodies 
2.6.1. Expression and purification of VBP proteins 
To over-express VBP1, VBP2 and VBP3 proteins, the full-length vbp1, vbp2, vbp3 
genes were amplified from A. tumefaciens C58 genomic DNA by PCR and were 
subcloned into vector pRSET-A or pRSET-B (InvitrogenTM) to make in-frame fusions to 
the histidine (His) tag. The resulting plasmids pRvbp1, pRvbp2, and pRvbp3 were 
introduced to E. coli strain BL21 (DE3) to over-express the His-VBP1, His-VBP2, and 
His-VBP3 proteins, respectively. The IPTG-induced E. coli BL21 cells harboring these 
plasmids were collected and resuspended in lysis buffer 2 (300 mM NaCl; 2 mM PMSF; 
50 mM sodium phosphate, pH 7.4). Bacterial cells were disrupted by French Press (cell 
pressure: 35K psi). The pellet was collected by centrifugation at 17,000 × g for 15 min at 
4°C, resuspended in denaturing column buffer (8 M urea; 300 mM NaCl; 2 mM PMSF; 
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50 mM sodium phosphate; pH 7.4), and then incubated at room temperature for 1 hour 
with shaking. The supernatant was collected by centrifugation and incubated with the 
pre-equilibrated TALON metal affinity resin (Clontech) at room temperature for 1 hour. 
After His-VBP protein was bound to TALON metal affinity resin, the resin was loaded to 
a column and washed with 10~15 resin volumes of denaturing column buffer. His-VBP 
protein was eluted with denaturing column buffer plus 150 mM imidazol. In each 
purification operation, eight fractions of the eluate were collected with 1.5 ml per 
fraction. The purity and concentration of His-VBP in each collected fraction were 
assessed by SDS-PAGE with standard BSA as a reference protein. The collected 
fractions with the highest concentration of His-VBP were combined and further purified 
by preparative SDS-PAGE electrophoresis. After the His-VBP protein was separated by 
the preparative SDS-PAGE gels, the gels were shortly stained with 1 M KCl and the 
lightly white protein band was then cut out with a scalpel. The gel slices were placed in a 
dialysis tube (Gibco) containing 1× electrophoresis buffer (Table 2.6). The protein in the 
gel slices was eluted by electrodialysis in a transfer apparatus with the electrophoresis 
buffer. The electrodialysis was performed in a cold room (4~8 °C) at a constant current of 
100 mA for overnight. The protein eluted from the gel slices was transferred to a clear 
dialysis tube and dialyzed against five liters of water in a cold room (4~8 °C) for 
overnight. After the dialysis is finished, a large amount of protein precipitate should 
appear in the dialysis tube. The protein precipitate was collected by centrifugation and 
dissolved in small amount of Tris-HCl buffer (50 mM Tris, pH 8.2). The concentration of 
the His-VBP protein was adjusted to 0.2 g l-1. The purified His-VBP protein was ready to 
inject into rabbit to generate anti-His-VBP antibody. 
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2.6.2. Generation of anti-His-VBP antibodies 
To obtain the polyclonal antibody against VBP proteins, the purified His-VBP1, 
His-VBP2 and His-VBP3 were intramuscularly injected into New Zealand wild type 
female rabbits respectively. A small amount (about 5 ml) of preimmune blood was drawn 
from each rabbit prior to any injections so that we can examine them for background 
activity. Zero point five ml of purified His-VBP protein (0.1 mg) was mixed and 
emulsified with an equal volume of Incomplete Freund’s Adjuvant (IFA). The freshly 
prepared emulsion was immediately injected into one limb of the rabbit. The first boost 
was done four weeks later. The dosage for each booster is 50 µg, which was emulsified in 
0.5 ml of IFA emulsion and injected into another limb. After the first booster, the rabbit 
would boost every week and the limbs were used in rotation during the subsequent boost 
injections. A small amount (about 5 ml) of blood was drawn before each boost injection. 
The serum was used to test the antibody titers by Western blotting. Usually, large bleed 
would be done after the sixth boost. The blood collected from rabbit was allowed to clot 
at room temperature for overnight. The antiserum was collected from the clot by 
centrifugation at 1,500 × g for 10 minutes at room temperature and was stored at –20 °C. 
2.7. Pulling down of A. tumefaciens Proteins by VBP Proteins 
2.7.1. Binding of VBP proteins to T-complex (or VirD2) 
To detect the binding of VBP protein to T-complex (or VirD2), the denaturant urea 
and salt were removed from the protein-bound resin. His-VBP bound resin was washed 
with buffers having NaCl gradient from 300 to 0 mM and urea gradient from 8 to 0 mM. 
Eventually, the His-VBP bound resin was washed with incubating buffer (2.5 mM 
MgCl2; 50 mM NaCl; 2 mM PMSF; 20 mg l-1 leupeptines; 30 mM Tris-HCl; pH 7.4). To 
 73
refold the denatured His-VBP protein, the His-VBP bound resin was incubated with 
incubating buffer at 4°C for 60 min with rocking, and then washed three times with 
incubating buffer. T-complex-containing A. tumefaciens extract was prepared as 
described for the pull-down assay, but Agrobacterium lysis buffer A was replaced by 
incubating buffer. His-KatA (Xu et al., 2001) was used as a negative control. The resin-
bound T-complex was eluted with incubating buffer containing 150 mM imidazol. The 
eluted proteins (or T-complex) were concentrated and freeze-dried. VirD2 and VirE2 in 
the pulled-down T-complex were analyzed by Western blot and further identified by 
MALDI-TOF. To get the T-strand from the pulled-down T-complex, the T-complex-
containing fraction collected from eluate was extracted with phenol:chloroform 
immediately. Detection of T-strand in the pulled-down T-complex was done by PCR. To 
test the strength of the VirD2-VBP1 interaction, MgCl2 and NaCl in the incubating buffer 
were adjusted to different concentrations (MgCl2: 0mmolL-1 or 2.5mmolL-1; NaCl: 
0mmolL-1, 50mmolL-1, 100mmolL-1, 200mmolL-1 or 300mmolL-1). 
2.7.2. Binding of VBP proteins to T4SS components 
The procedure for the binding of VBP proteins to T4SS components was similar to 
that for the binding of VBP protein to VirD2 (or T-complex). However, because most of 
the T4SS components are membrane proteins and the extraction of T4SS components 
may require detergent, T4SS components-containing A. tumefaciens extract was prepared 
using different buffers. Two different kinds of buffer were used to prepare the T4SS 
components-containing A. tumefaciens extract and to conduct the binding assay. One 
kind of the buffer was the same buffer as in the binding of VBP protein to T-complex 
(2.5 mM MgCl2; 50 mM NaCl; 2 mM PMSF; 20 mg l-1 leupeptines; 30 mM Tris-HCl; pH 
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7.4). The other kind of buffer contained 0.5% Triton-100. The composition of the second 
buffer is 2.5 mM MgCl2, 50 mM NaCl, 2 mM PMSF, 20 mg l-1 leupeptines, 30 mM Tris-
HCl, pH 7.4, and 0.5% Triton-100. Other operations were the same as described in the 
binding of VBP protein to T-complex. The pulled-down T4SS components were analyzed 
by Western blot. 
2.8. Co-immunoprecipitation 
2.8.1. Co-immunoprecipitation of T4SS components by anti-VBP1 antiserum 
A. tumefaciens A348 cells harvested from 1 liter of IB culture were resuspended in 
4 ml lysis buffer B (2.5mmolL-1 MgCl2, 50mmolL-1 NaCl, 2mmolL-1 PMSF, 20µg/ml 
leupeptines, 10µg/ml antipain, 50mmolL-1 Tris-HCl, pH 7.4). The cells were disrupted by 
French Press (cell pressure: 35K psi). To dissolve membrane VirB/D4 proteins, Triton X-
100 was added to a 0.5% final concentration and the mixture was incubated for 1 h at 4°C 
with rocking. The supernatant fraction was collected by centrifugation at 12,000 × g for 
20 min at 4°C and was diluted 1 time with lysis buffer B. To reduce the background of 
nonspecific proteins, the diluted protein extract was pre-cleared with protein A-Sepharose 
and preimmune serum (Sambrook and Russell, 2001). Preimmune serum was added to 
the Agrobacterium protein extract at a dilution of 1:150 and 50% (w/v) slurry of protein 
A-Sepharose (in lysis buffer B) was added at a ratio of 1:6 (protein A-Sepharose:extract). 
The mixture was incubated at 4°C for 1 h with rocking. Protein A-Sepharose and non-
specifically-coprecipitated proteins were removed by centrifugation at 5,000 g. The 
supernatant was the pre-cleared protein extract and was used to perform the co-
immunoprecipitation. To co-immunoprecipitate the VBP1 binding proteins, anti-VBP1 
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antiserum was added to the pre-cleared protein extract at a dilution of 1:200 and 50% 
(w/v) slurry of protein A-Sepharose (in lysis buffer B) was added at a ratio of 1:8 (protein 
A-Sepharose:extract). The mixture was incubated at 4°C for 4 h with rocking. Protein A-
Sepharose and co-immunoprecipitates were collected by centrifugation. The protein A-
Sepharose and co-immunoprecipitates were washed twice with lysis buffer B 
supplemented with 0.1% Triton X-100 and three times with lysis buffer B. Nonreducing 
SDS loading buffer was added to the protein A-Sepharose and co-immunoprecipitates 
directly. The co-immunoprecipitated proteins were separated by SDS-PAGE and 
analyzed by Western blot. To demonstrate that the non-specifically-coprecipitated 
proteins were removed from the pre-cleared protein extract, two controls (protein A-
Sepharose incubated with pre-cleared protein extract as well as protein A-Sepharose 
incubated with both pre-cleared protein extract and preimmune serum) were conducted. 
2.8.2. Co-immunoprecipitation of T-complex by anti-VBP1 antiserum 
The procedure for the co-immunoprecipitation of T-complex is similar to the co-
immunoprecipitation of T4SS components. For the preparation of AS-induced 
Agrobacterium cell extract, the disrupted cells were not treated by 0.5% Triton X-100. 
The protein extract did not contain any detergent. Sepharose beads and co-
immunoprecipitates were washed five times with lysis buffer B. The co-
immunoprecipitates were eluted by incubation for 20 min at 96 ºC with the buffer of 
10mmolL-1 Tris-HCl, pH 6.8.  The eluted co-immunoprecipitates were used as the 
template to amplify the T-DNA. Proteins in the eluted co-immunoprecipitates were 
separated by SDS-PAGE and detected by Western blot. 
2.8.3. Co-immunoprecipitation of plasmid pML122 by anti-VBP1 antiserum 
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For the co-immunoprecipitation of plasmid pML122, A. tumefaciens strains 
harboring pML122 were grown in MG/L liquid medium and did not undergo AS-
induction. Other procedures were the same as for the co-immunoprecipitation of T-
complex. 
2.9. Mutation at vbp Genes 
2.9.1. Mutation at vbp2 
To generate vbp2 mutation, the sacB-based gene replacement strategy (Hoang et al., 
1998) was employed. The sacB gene encodes levansucrase, which synthesizes lavens 
(high molecular-weight fructose polymers) in the presence of sucrose. The accumulation 
of lavens in the periplasm of Gram- bacteria is toxic and thus causes the bacterial cells to 
die. To obtain a sacB-based suicide vector suitable for A. tumefaciens gene replacement, 
we replaced the TcR gene in plasmid pEX18Tc (Hoang et al., 1998) with KmR gene. 
Primers Pex18F and Pex18R were used to amplify a 5-kb non-TcR-resistance fragment 
from plasmid pEX18Tc. A 1.04-kb KmR-encoding cassette fragment was amplified by 
primers nptIIIF and nptIIIR from plasmid pCB301 (Xiang et al., 1999). These two 
fragments were ligated to generate the KmR-plasmid pQM118. The vbp2 gene 
replacement vector was constructed as follows. First, a 2.183-kb vbp2 downstream 
fragment was amplified by primers Pdow3 and Pdow4 and inserted to the Hind III site of 
pQM118 to generate plasmid pEXKmVD. Then, primers Pup10 and Pup11 were used to 
amplify a 1.395-kb vbp2 upstream fragment. Finally, the upstream fragment was inserted 
to the BamH I site of pEXKmVD to produce plasmid pEXKmVUD. The purified plasmid 
pEXKmVUD was introduced to A. tumefaciens cells by electroporation. The 
electroporated A. tumefaciens cells were plated on kanamycin-containing MG/L agar 
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plate to select for single cross-over transformants. The KmR-colonies were purified once 
by streaking on fresh kanamycin-containing MG/L plate, and then were plated on MG/L 
agar plate containing 5% sucrose to select the double cross-over colonies. The vbp2 
mutant was identified from the Km-sensitive and sucrose-resistant colonies by PCR. 
2.9.2. Mutation at vbp3 
To generate vbp3 mutation, single cross-over strategy was adopted to disrupt vbp3 
gene (Miller and Mekalanos, 1988). When the plasmid pUCvbp3 carrying a vbp3 internal 
fragment was introduced to A. tumefaciens, the whole plasmid could insert into the vbp3 
gene of A. tumefaciens by homologous recombination and thus disrupt the vbp3 gene. 
The plasmid pUCvbp3 was constructed by amplifying a 591-bp vbp3 fragment, which is 
from the 4~595 nuleotides of the vbp3 ORF (The full length of the vbp3 ORF is 936 bp), 
with primers Pvbp3-1 and Pvbp3-3 and ligating it to the BamH I site of pUC19 to form 
the ApR-resistant plasmid pUCvbp3. The plasmid pUCvbp3 was electroporated to A. 
tumefaciens cells. After electroporation, the vbp3 insertion mutant was selected by 
plating the electroporated cells on MG/L agar plate containing ampicillin and further 
confirmed by PCR. 
2.10. Virulence Assays 
 A. tumefaciens strains were grown in MG/L liquid medium overnight at 28°C 
supplemented with appropriate antibiotics. The bacterial cells were collected by 
centrifugation and resuspended in fresh MG/L medium. Cell concentrations were 
adjusted to OD600 = 0.05, 0.1 and 1. The leaves of Kalanchoe plants were wounded with 
a hypodermic needle. Two µl of bacterial cell suspension was inoculated onto each 
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wound area. Each strain was inoculated in three different cell concentrations. Each 
inoculation was repeated at least two times on different leaves. The tumors were 
photographed 30~40 days after inoculation.  
2.11. Conjugation Assay 
Donor Agrobacterium strains were cultured in MG/L overnight at 28 ºC with 
appropriate antibiotics. Recipient E. coli MT607 (or helper MT616) were cultured in LB 
overnight at 37 ºC. Cells were washed with water twice and resuspended in cell 
concentration of OD600nm = 1.0. Equal volume of donor and recipient cell suspension (or 
with helper) were mixed. Small amount of the cell mixture was diluted and plated on AB 
agar plate with appropriate antibiotics to count the number of input donor. For 
conjugation assay, cell mixture was spotted on LB agar plate and incubated overnight at 
28 ºC. The agar plug was excised, suspended in water, and vigorously shaken to dislodge 
mating cells. Cells were collected by centrifugation and resuspended in water. Serial 
dilutions were then plated onto LB agar plate with gentamycin antibiotic and grown at 37 
ºC to select and count transconjugant E. coli. cells. 
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Chapter 3  Identification and Characterization of a VirD2-
binding Protein 
3.1. Identification of a Novel VirD2-binding Protein 
 As we discussed before, VirD2 is a major player of the T-DNA transfer. Any 
protein that is involved in the T-DNA transfer may directly or indirectly interact with 
VirD2. Traditionally, two hybrid system was used to screen protein-interacting partners. 
However, this genetic approache often gave false results and the derived results required 
further verification by in vitro binding assay. In this study, we adopted a biochemical 
approach, which is a pull-down assay, to screen for protein-interacting partners. This 
biochemical approach would enable us to identify protein-interacting partners 
expeditiously and unequivocally. 
To identify additional bacterial proteins that may be involved in T-DNA processing 
and T-complex movement, we fused VirD2 protein to maltose binding protein (MBP). 
MBP is a periplasmic protein encoded by malE gene of E. coli. It can specifically bind 
maltose, which allows a one-step purification for the MBP fusion proteins. So, the 
recombinant MBP-VirD2 protein should be able to bind to amylose resin specifically and 
can be used as an affinity ligand to pull down VirD2-binding proteins from AS-induced 
A. tumefaciens protein extracts. When we initially conducted the pull-down assay, we 
found that MBP-VirD2 fusion protein was easy to be degraded to smaller protein 
molecules (lane 3 in Fig. 3.1). The degradation of MBP-VirD2 made it difficult to 
identify any possible VirD2-binding proteins because the degraded MBP-VirD2 fusion 
































Fig. 3.1.  Coomassie blue-stained SDS-PAGE analysis of proteins pulled down
by MBP-VirD2 fusion protein. E. coli cells expressing MBP, MBP-VirJ and
MBP-VirD2 were sonicated. The supernatants were loaded onto amylose resin
columns; the unbound proteins were washed away. As negative controls, MBP
(lane 1), MBP-VirJ (lane 2) and MBP-VirD2 (lane 3) were eluted with maltose
directly. For the pull down assay, amylose resins bound with MBP-VirD2 (lane 4),
MBP-VirJ (lane 5) and MBP (lane 6) were further incubated with AS-induced A.
tumefaciens protein extract respectively. After washing, the bound proteins were
eluted with maltose. Proteins were resolved by 12% SDS-PAGE gel. The unique
band is indicated by an arrow (lane 4). 
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separation and may also disturb the subsequent MALDI-TOF MS identification of the 
potential VirD2-binding proteins. Consequently, we included proteinase inhibitors and 
two controls: MBP and MBP-VirJ fusion protein. Another problem we encountered is the 
cellular concentration of the potential VirD2-binding proteins. If the concentration of the 
potential VirD2-binding protein is very low in A. tumefaciens cells, we have to culture a 
large number of bacterial cells so that the amount of the potential VirD2-binding proteins 
pulled down by MBP-VirD2 is enough to support the SDS-PAGE analysis and MALDI-
TOF MS identification. In this study, we cultured five liters of agrobacterial culture for 
each pull-down assay. The eluted fusion proteins and their pulled-down proteins were 
analyzed on SDS-PAGE gel (Fig. 3.1). We found one unique band in the MBP-VirD2 
pulled-down proteins (indicated by an arrow in lane 4, Fig. 3.1). We excised all the 
protein bands in the MBP-VirD2 pulled-down proteins and other corresponding protein 
bands (around the same molecular weight as the prominent MBP-VirD2 binding protein) 
in the controls and identified all these proteins using MALDI-TOF MS. However, only 
the unique protein band in lane 4 gave an apparent match with an A. tumefaciens protein, 
whereas all other identified protein bands were matched with MBP, VirD2 or VirJ.  
          The peptide mass map of the prominent MBP-VirD2-binding protein is shown in 
Fig. 3.2. The top six protein candidates offered by MS-Fit search results of this peptide 
mass map are listed in Table 3.1, indicating that the top two protein candidates had 
significantly higher molecular weight search (MOWSE) scores than other candidates. 
The MOWSE score of the first protein candidate is 9.79e+007, whereas, the MOWSE 
score of the third protein candidate is 5.02e+004. Both of the top two protein candidates
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Fig. 3.2.  MALDI-TOF peptide mass map of the prominent VirD2-binding
protein. The unique protein band from lane 4 in Fig. 1 was excised and in-gel digested
by trypsin. The resulting peptides were analyzed using a MALDI-TOF mass
spectrometer to obtain the mass map. Peptide peaks that correspond to the calculated
tryptic peptide masses of an A. tumrfaciens protein are indicated by triangles. 
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Table 3.1.  MS-Fit search results of MALDI-TOF peptide mass map of 
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had molecular weight and species consistent with the unique protein band. The amino 
acid sequences of these two protein candidates are shown in Fig. 3.3. Both protein 
candidates are encoded by an identical A. tumefaciens gene; one (Atu5117; accession: 
NC_003306.1) was predicted by the University of Washington genome project (Wood et 
al., 2001), another (AGR_pAT_170p; accession: NC_003064.1) by the Cereon genome 
project (Goodner et al., 2001). Twelve main peptide masses in the peptide mass 
spectrium (Fig. 3.2) matched with the calculated tryptic peptide masses from the first 
candidate. The matched peptide fragments are shown in shaded letters in Fig. 3.3 and 
cover 53% amino acids of the first protein candidate. Although the MS-Fit results have 
given us an unambiguous identification of an A. tumefaciens protein that may bind with 
VirD2 protein, we think that further confirmation is still required for this identification 
because only twelve (30%) of the forty submitted peptide masses were matched to the 
first protein candidate (Table 3.1). So many submitted peptides (70%) were not matched 
to the same protein candidate, demonstrating that this protein band may be a mixture of 
several proteins. Consequently, we sequenced the five dominant peptides of tryptic 
digestion production by using Q-TOF MS/MS analysis to further confirm the 
identification. The sequencing results were shown in Table 3.2. The sequences of these 
five peptides matched 100% with the Agrobacterium protein. The positions of these five 
sequenced peptides in the top two protein candidates were shown in Fig. 3.4. A peptide 
fragment matched exactly with the N-terminus of the first candidate (Fig. 3.3), indicating 
that the open reading frame predicted by the University of Washington genome project is 
correct. We designated this protein as VBP1. 
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1                              11                     21        31                            41                  51
MKTSLDH   IPPQIQTELQ   RALEIIHEEF   EDALEGGTAK FKKRGRILKI ILFGSYARGT
MPTMKTSLDH  IPPQIQTELQ   RALEIIHEEF   EDALEGGTAK FKKRGRILKI ILFGSYARGT
61                          71                        81        91                          101                111
QVDEPFTSKG  YRSDFDLLVI VNNRKLTDFA EYWYKAADRL IRDKMIKRPV QIIVHSLREV
QVDEPFTSKG YRSDFDLLVI VNNRKLTDFA EYWYKAADRL IRDKMIKRPV QIIVHSLREV
121                      131                   141              151                    161                       171
NTSLQESQHF  FSDIRKEGIA  LYELDDKPLA  EPKTLTPEEQ LRVAKEHFEK RFGAGRNFAA
NTSLQESQHF  FSDIRKEGIA  LYELDDKPLA  EPKTLTPEEQ LRVAKEHFEK RFGAGRNFAA
181                         191                      201       211                       221                   231
LSDAALQKGM  ISEAAFLLHQ  AIEQAYASVL  LTLTNYTPAS  HNLKVLRSFA EERDRRLIEA
LSDAALQKGM  ISEAAFLLHQ  AIEQAYASVL  LTLTNYTPAS  HNLKVLRSFA EERDRRLIEA
241                        251                       261       271                      281                    291
FPRDHHRERA WFNTINEAYV KARYSSQYKI SQEALDWIGE  RATLLLSLVG EVCRDHISAL
FPRDHHRERA WFNTINEAYV KARYSSQYKI SQEALDWIGE  RATLLLSLVG EVCRDHISAL





Fig. 3.3.  Coverage map of the matched peptides from the top two
candidates of VirD2-binding proteins. The matched peptide fragments are
shown in shaded letters and cover 53% (166/313) or 52% (164/316) amino
acids of the protein. The trypsin cleavage sites were underlined. Numeric
indicates the position of amino acid in the proteins. U Wash represents the
ORF predicted by University of Washington genome project. Cereon
represents the ORF predicted by Cereon genome project. One mass peak
matched exactly with the N-terminal peptide fragment of this protein,
confirming that the ORF predicted by U Wash is correct. 
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Table 3.2.  Details of the five peptides sequenced by Q-TOF-MS/MS analysis







1                           11                  21                     31                      41                     51
MKTSLDH  IPPQIQTELQ   RALEIIHEEF   EDALEGGTAK FKKRGRILKI   ILFGSYARGT
MPTMKTSLDH  IPPQIQTELQ   RALEIIHEEF   EDALEGGTAK FKKRGRILKI   ILFGSYARGT
61                          71                        81        91                         101                     111
QVDEPFTSKG   YRSDFDLLVI VNNRKLTDFA EYWYKAADRL IRDKMIKRPV QIIVHSLREV
QVDEPFTSKG YRSDFDLLVI VNNRKLTDFA EYWYKAADRL IRDKMIKRPV QIIVHSLREV
121                      131                   141              151                   161                       171
NTSLQESQHF FSDIRKEGIA LYELDDKPLA  EPKTLTPEEQ LRVAKEHFEK RFGAGRNFAA
NTSLQESQHF FSDIRKEGIA LYELDDKPLA  EPKTLTPEEQ LRVAKEHFEK RFGAGRNFAA
181                          191                    201                      211                       221         231
LSDAALQKGM  ISEAAFLLHQ  AIEQAYASVL  LTLTNYTPAS  HNLKVLRSFA  EERDRRLIEA
LSDAALQKGM  ISEAAFLLHQ  AIEQAYASVL  LTLTNYTPAS  HNLKVLRSFA  EERDRRLIEA
241                        251                     261                       271                      281         291
FPRDHHRERA  WFNTINEAYV KARYSSQYKI SQEALDWIGE RATLLLSLVG   EVCRDHISAL
FPRDHHRERA  WFNTINEAYV KARYSSQYKI SQEALDWIGE RATLLLSLVG   EVCRDHISAL





Fig. 3.4. Positions of five peptide fragments sequenced by Q-TOF. The
sequenced peptide fragments are shown in shaded letters. The trypsin cleavage
sites were underlined. Numbers indicate the positions of amino acid in the
proteins. U Wash represents the ORF predicted by University of Washington
genome project. Cereon represents the ORF predicted by Cereon genome
project. 
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        We determined the genomic locus of VBP1-encoding gene based on the genome 
data; vbp1 gene is located on the AT plasmid. But, it was reported that AT plasmid is a 
cryptic plasmid and not essential for tumor induction (Rosenberg and Huguet, 1984). 
However, when we conducted the BLAST search, we surprisingly found that A. 
tumefaciens also has two other genes highly homologous to vbp1. These two homologous 
genes are Atu4860 (accession: NC_003305.1) and nucleotidyltranferase (accession: 
NC_003305.1) in the U. Wash. version of A. tumefaciens genome; AGR_L_53p 
(accession: NC_003063.1) and AGR_L_62p (accession: NC_003063.1) in the Cereon 
version of A. tumefaciens genome. Atu4860 gene and AGR_L_53p gene is the same 
gene; we designated them as vbp2. Nucleotidyltransferase gene and AGR_L_62p gene is 
the same gene; we designated them as vbp3. The sequence alignment of VBP1 and VBP2 
was shown in Fig. 3.5. The amino acid sequence of VBP2 exhibits 72% identity and 80% 
similarity to VBP1. VBP3 also shows high homologous to VBP1 (Fig. 3.6). VBP3 shares 
56% identity and 71% similarity with VBP1. Both of vbp2 and vbp3 are located on the 
linear chromosome and very close to each other. The distance between vbp2 and vbp3 
genes is only 3.884 kb. Only three putative open read frames (ORF) lie between vbp2 and 
vbp3 genes. Each of these three VBP proteins contains a putative nucleotidyltransferase 
motif in their N-termini and a putative higher eukaryotes and prokaryotes nucleotide-
binding (HEPN) domain in their C-termini based on a motif finding computer program 
(www.ncbi.nlm.nih.gov/BLAST) (Fig. 3.7). In the U. Wash. version of A. tumefaciens 
genome, the predicted VBP1, VBP2 and VBP3 proteins contain 313, 311 and 308 amino 
acids respectively. 
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VBP1 : 1   MKTSLDHIPPQIQTELQRALEIIHEEFEDALEGGTAKFKKRGRILKIILFGSYARGTQVD 60
MK+SLDHIP + Q EL RALEI+HEEFEDAL  GTA FKKRGRILKIILFGSYARGT VD
VBP2 : 2   MKSSLDHIPHRKQRELARALEILHEEFEDALGEGTADFKKRGRILKIILFGSYARGTFVD 61
VBP1 : 61  EPFTSKGYRSDFDLLVIVNNRKLTDFAEYWYKAADRLIRDKMIKRPVQIIVHSLREVNTS 120
EP T KGYRSDFDLLVIVNNRKLTD A YWYKAADR+IRD  I+ P Q IVHSLREVNT
VBP2 : 62  EPHTMKGYRSDFDLLVIVNNRKLTDHATYWYKAADRIIRDSFIETPTQFIVHSLREVNTE 121
VBP1 : 121 LQESQHFFSDIRKEGIALYELDDKPLAEPKTLTPEEQLRVAKEHFEKRFGAGRNFAALSD 180  
L++  +FFSDIRKEGI LYELDD+PLAEPK LT EE+L VA+EH  +RF AG  F  LS
VBP2 : 122 LKKGHYFFSDIRKEGIVLYELDDEPLAEPKLLTAEERLNVAREHCRERFEAGTEFFVLSC 181
VBP1 : 181 AALQKGMISEAAFLLHQAIEQAYASVLLTLTNYTPASHNLKVLRSFAEERDRRLIEAFPR 240
A   G    AAFLLHQAIEQAY+ VLLTLTNY PASHN+K LRS AEE+D RL++AFPR
VBP2 : 182 HARNSGFTKRAAFLLHQAIEQAYSCVLLTLTNYGPASHNIKFLRSLAEEQDLRLVDAFPR 241
VBP1 : 241 DHHRERAWFNTINEAYVKARYSSQYKISQEALDWIGERATLLLSLVGEVCRDHISALE 298
DHHR+RAWFNTINEAYVKARYS  ++IS+EAL W+GER   LL LV  VC +HI  ++
VBP2 : 242 DHHRQRAWFNTINEAYVKARYSKHFEISEEALGWLGERTAHLLELVKVVCDEHIEKVD 299
Fig. 3.5. Sequence comparison of VBP1 and VBP2 from Agrobacterium
tumefaciens. The amino acid sequence of VBP2 shows 72% identity and 80%
similarity to VBP1. The bolded letters show the identical amino acids. The “+”
symbol represents similar amino acid. Numeric indicates the position of amino
acid in the proteins. 
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VBP1: 1   MKTSLDHIPPQIQTELQRALEIIHEEFEDALEGGTAKFKKRGRILKIILFGSYARGTQVD 60
MKTSL+H+P + Q EL R + II EEF D +E   +  KK GRI KIILFGSYARGT VD
VBP3: 1   MKTSLEHLPERKQRELARVVGIIQEEFADLVERSKSDAKKDGRIFKIILFGSYARGTWVD 60
VBP1: 61  EPFTSKGYRSDFDLLVIVNNRKLTDFAEYWYKAADRLIRDKMIKRPVQIIVHSLREVNTS 120
EP TSKGYRSDFD+LVIV+N++L D  +YW K  DRL+ DK I+ PV +IVH  RE++
VBP3: 61  EPHTSKGYRSDFDILVIVSNKELAD-PKYWDKTTDRLMWDKEIETPVGLIVHGAREISNF 119
VBP1: 121 LQESQHFFSDIRKEGIALYELDDKPLAEPKTLTPEEQLRVAKEHFEKRFGAGRNFAALSD 180
L + Q FF D+ +EGI LYE DD+PLAEPK L+P + LRVA++HF +     R+FA ++
VBP3: 120 LNDGQPFFVDLAREGIVLYEFDDRPLAEPKPLSPADALRVAEDHFLRHLPDARDFADVAK 179
VBP1: 181 AALQKGMISEAAFLLHQAIEQAYASVLLTLTNYTPASHNLKVLRSFAEERDRRLIEAFPR 240
+ KG +  AAF LHQA+E AY   LLTLTNY+PASHNLK LR  +E RDRRLI+ +PR
VBP3: 180 YLVAKGNLHLAAFNLHQAVETAYNCYLLTLTNYSPASHNLKFLRGLSEGRDRRLIDIWPR 239
VBP1: 241 DHHRERAWFNTINEAYVKARYSSQYKISQEALDWIGERATLLLSLVGEVCRDHISALERD 300
D  R   W+N +NEAYVKARYS ++++S+EAL W+ ER   L  LV  +CR+HI  LE
VBP3: 240 DRQRFTTWYNILNEAYVKARYSKRFEVSEEALTWLQERTAELHKLVETLCREHIEKLEHA 299
VBP1: 301 AGR 303
AG+
VBP3: 300 AGQ 302
Fig. 3.6. Sequence comparison of VBP1 and VBP3 from Agrobacterium
tumefaciens. The amino acid sequence of VBP3 shows 56% identity and 71%
similarity to VBP1. The bolded letters show the identical amino acids. The “+”
symbol represents similar amino acid. Numeric indicates the position of amino





Fig. 3.7. Motif search results of three VBP proteins. All three VBP proteins
contain a putative nucleotidyltransferase motif in their N-termini and a putative
higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domain in their C-
termini. COG1708: Predicted nucleotidyltransferases (General function prediction
only); HEPN: Higher Eukaryotes and Prokaryotes Nucleotide-binding domain.
Numeric indicates the position of amino acid in the proteins. 
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         3.2. Expression and Purification of Three VBP Proteins 
After these three vbp genes, vbp1, vbp2 and vbp3, were identified, we subsequently 
cloned and expressed these three vbp genes. In order to obtain enough VBP proteins for 
the generation of VBP antibodies, we used pRSET plasmids (InvitrogemTM), pRSET-A 
and pRSET-B, as vectors to clone and express these three vbp genes. The pRSET plasmid 
has a multiple cloning site located in the downstream of a six-histidine encoding 
sequence, which allows us to insert the vbp gene and make the VBP protein in-frame 
fusion onto the C-terminus of the six-histidine (His) tag conveniently. The histidine tag 
functions as a metal binding domain and allows simple one-step purification of the 
recombinant proteins by immobilized metal affinity chromatography. In compared with 
other fusion proteins that allow simple one-step purification, such as MBP and GST 
fusion proteins (Nilsson et al., 1997), His-tagged fusion proteins possess several 
advantages in term of the expression and purification of protein: 1) His-tag has less 
adverse effects on protein function than other fusion proteins because His-tag has a 
smaller size. 2) His-tagged fusion proteins can be purified under extreme conditions, such 
as denaturing condition that is often required for dissolving the fusion proteins expressed 
as inclusion body. 3) This method is simple and the generation of fusion genes can be 
done through PCR (reviewed by Porath, 1992). In addition, an enterokinase cleavage site 
was designed between the His-tag and the N-terminus of fused protein. After the 
recombinant protein is purified, the His-tag can be cleaved to obtain the protein with the 
desired sequence. 
3.2.1. Construction of plasmids for expressing VBP proteins 
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To construct the plasmid pRvbp1, which was used to express VBP1, a 947 bp DNA 
fragment containing the full length of vbp1 gene was amplified from A. tumefaciens C58 
genomic DNA by primers Pvbp1-1 and Pvbp1-2 and was inserted into the XhoI site of 
pRSET-A. The full-length sequence of vbp2 is 952 bp. This DNA fragment was 
amplified by primers Pvbp2p1 and Pvbp2p2. The vbp2 gene was inserted into the BamHI 
site of pRSET-B to generate the plasmid pRvbp2, which was used to express VBP2. The 
primers Pvbp3p1 and Pvbp3p2 were used to amplify the vbp3 gene fragment. This 936 bp 
vbp3 gene fragment was also inserted into the BamHI site of pRSET-B. The resulting 
plasmid pRvbp3 was used to express VBP3. All the inserted vbp genes in these three 
plasmids (pRvbp1, pRvbp2 and pRvbp3) were sequenced to confirm that the ligation is 
correct and the corresponding vbp gene was fused into the open read frame of His-tag 
(sequence data not shown). The construction procedure for these three plasmids was 
shown in Fig. 3.8. 
3.2.2. Purification of three His-VBP fusion proteins 
The pRSET vectors are T7 promoter-driven vectors. In order to over-express three 
His-VBP proteins, these three pRSET-derived plasmids (pRvbp1, pRvbp2 and pRvbp3) 
were introduced into E. coli strain BL21 (DE3) respectively. BL21 (DE3) strain carries 
lambda-DE3, which contains the T7 bacteriophage gene 1, encoding T7 RNA polymerase 
under the control of the lacUV5 promoter. The lacUV5 promoter can be induced by 
isopropyl-β-D-thiogalactopyranoside (IPTG). The time course of His-VBP1 expression 
was shown in the panel A of Fig. 3.9 (lanes 1~4). His-VBP1 protein could be induced by 
IPTG and the expression level of His-VBP1 protein was very high. His-VBP2 and His-























































Fig. 3.8. Construction of three plasmids used for expressing three VBP
proteins. The 947 bp vbp1 gene was inserted into the XhoI site of pRSET-A.
The 952 bp vbp2 gene was inserted into the BamHI site of pRSET-B. The 936 bp
vbp3 gene was also inserted into the BamHI site of pRSET-B. pUC represents
pUC origin. All three vbp genes were made in-frame fusions to the histidine
(His) tag. 
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Fig. 3.9. Expression and purification of three His-VBP fusion proteins. (A).
Inducing time course of His-VBP1 expression. (B). Purification of His-VBP1
under denaturing and non-denaturing conditions. (C). Estimation of the purity
and concentration of purified His-VBP1 and His-VBP2 by compared with
standard bovine serum albumin (BSA). (D). Purification of His-VBP3. 
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of these three proteins, bacterial cells were usually cultured for 3~4 hours after IPTG was 
added to the culture. 
Since proteins over-expressed in bacteria are typically insoluble, we used different 
buffers to extract these three His-VBP fusion proteins. His-VBP1 showed a low solubility 
in native buffer and only small amount of His-VBP1 proteins was extracted by non-
denaturing buffer (lane 5, panel A, Fig. 3.9). Most of His-VBP1 proteins required 
denaturing buffer to extract (lane 6, panel A, Fig. 3.9). Even if only small amount of His-
VBP1 proteins could be extracted in non-denaturing buffer we still try to conduct the 
purification under native conditions. However, the soluble His-VBP1 cannot bind to the 
TALON metal affinity resin (lanes 1~3, panel B, Fig. 3.9), demonstrating that the His-tag 
in His-VBP1 may fold into the inside of the fusion protein under native conditions. When 
His-VBP1 was denatured, it can specifically bind to the TALON metal affinity resin 
(lanes 4~6, panel B, Fig. 3.9). So, we purified His-VBP1 under denaturing conditions. 
Similar results were obtained in His-VBP2 (data not shown). In contrast to His-VBP1 and 
His-VBP2, most of His-VBP3 proteins were soluble in native buffer (lanes 1~3, panel D, 
Fig. 3.9) and the native His-VBP3 protein could bind to the TALON metal affinity resin. 
However, many nonspecific bindings were observed under native conditions (data not 
shown). Considering the purification efficiency of His-VBP3 and the comparability of 
His-VBP3 to other two His-VBP proteins, His-VBP3 was also purified under denaturing 
conditions. The purity of the purified His-VBP1, His-VBP2 and His-VBP3 was checked 
by SDS-PAGE (lane 6 of panel B, panel C, and lanes 5, 6 of panel D in Fig. 3.9). 
3.2.3. Antibody production 
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Each of the purified His-VBP proteins was injected to two rabbits for raising the 
antibody. The antiserum was subjected to Western blot analysis using the AS-induced A. 
tumefaciens A348 extract, the cell lysate of E. coli strain BL21 (DE3) harboring the 
corresponding plasmid and the purified His-VBP proteins. After third boost, the antibody 
titer has reached a plateau. Large bleeding was done after fourth boost. Because three 
VBP proteins possess high homology to each other, the ant-His-VBP antibodies also 
showed cross-reaction to each other (data not shown). Besides their high homology, their 
immigrating distances in SDS-PAGE were almost the same because their molecular 
weights showed little difference. Therefore, it is difficult to differentiate these three VBP 
proteins by using Western blotting analysis. 
3.3. Verification of the Interactions between VirD2 and VBP Proteins 
3.3.1. Specificity of binding between VirD2 and VBP1 
During the initial experiments, the pulled-down proteins were analyzed by using 
Coomassie Blue-stained SDS-PAGE gel and then identified by MALDI-TOF MS. It is 
possible that trace VBP1 pulled down by the negative controls, such as MBP and MBP-
VirJ fusion protein (Fig. 3.1), may not be detected by Coomassie blue staining because of 
the relative low sensitivity of Coomassie blue staining. To confirm that the binding 
between VirD2 and VBP1 is specific, we conducted the pull-down assay with MBP, 
MBP-VirJ fusion protein, MBP-VirD2 fusion protein and MBP-VirD2-C-terminus 
(MBP-C-VirD2) fusion protein. The pulled-down proteins were then analyzed by 
Western blot using anti-His-VBP1 antibody, as it is well known that the sensitivity of 
Western blot is much higher than that of Coomassie blue staining. Western blot analysis 




























Fig. 3.10. Western blot analysis of proteins pulled down by MBP fusion
proteins. An equal amount of AS-induced A. tumefaciens protein extract was
incubated with amylose resin alone (lane 2), MBP bound amylose resin (lane 3),
MBP-VirJ bound amylose (lane 4), MBP-C-VirD2 bound amylose resin (lane 5) or
MBP-VirD2 bound amylose resin (lane 6) for 60 min at 4°C. The resins were
washed and the bound proteins were eluted with maltose. The pulled down proteins
were separated by SDS-PAGE. VBP1 protein was detected by Western blot with
rabbit anti-His-VBP1 antibody. As a positive control of Western blot, A. tumefaciens
protein extract was loaded onto lane 1. 
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 (lane 6 in Fig. 3.10), but not to amylose resin alone (lane 2 in Fig. 3.10), MBP (lane 3 in 
Fig. 3.10), MBP-VirJ fusion protein (lane 4 in Fig. 3.10), or MBP-C-VirD2 fusion 
protein (lane 5 in Fig. 3.10). This result also demonstrated that the hypothetical protein 
(VBP1) indeed is present in Agrobacterium cell because the AS-induced A. tumefaciens 
A348 extract showed a single strong band (lane 1 in Fig. 3.10). 
Because the bait protein that was used to “fish out” the native VBP1 protein is a 
recombinant MBP-VirD2 fusion protein, it is unknown whether the recombinant VirD2 
protein can maintain its native conformation and function. It is necessary to verify that 
native VirD2 can bind to VBP1 protein. To confirm the specific binding between native 
VirD2 and VBP1, we used His-VBP1 fusion protein as an affinity ligand to pull down the 
native VirD2 protein from AS-induced A. tumefaciens cell extract. His-KatA fusion 
protein was used as a negative control as KatA is a catalase (Xu et al., 2001) and thus 
was not expected to bind VirD2. Because most of the His-VBP1 fusion protein over-
expressed in E. coli was insoluble (panel A of Fig. 3.9), we used a denaturing buffer to 
dissolve both His-VBP1 and His-KatA. After the denatured His-VBP1 and His-KatA 
were bound to TALON metal affinity resin, the denaturant urea and salt were removed 
from the protein-bound resin by washing the columns with non-denaturing and low salt 
buffer. Before the His-tagged fusion protein-bound resins were used to bind VirD2, the 
fusion protein-bound resins were incubated at 4°C for 60 min to allow the denatured His-
VBP1 and His-KatA to refold. The bound proteins were eluted with imidazole and 
resolved by SDS-PAGE. VirD2 protein was detected by Western blot using anti-His-
VirD2 antibody (Fig. 3.11). Both AS-induced A. tumefaciens cell extract and His-VBP1 































Fig. 3.11. Specific binding of VirD2 to His-VBP1. Equal amount of His-VBP1
bound resin (lane 2) or His-KatA bound resin (lane 4) was incubated with an
equal volume of AS-induced A. tumefaciens protein extract. After incubation for
60 min at 4°C, the resins were washed and then eluted with imidazol. The eluted
proteins were separated by SDS-PAGE. VirD2 was detected by Western blot
with rabbit anti-His-VirD2 antibody. Purified His-VBP1 (lane 1) and His-KatA
(lane 3) were used as negative controls. A. tumefaciens protein extract (lane 5)
was used as a positive control.  
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 band appeared on the lane of His-KatA pulled-down protein sample (lane 4 in Fig. 3.11). 
The result demonstrated that only His-VBP1 could pull down VirD2. Therefore, the 
binding between VBP1 and VirD2 is specific.  
As we used the crude A. tumefaciens cell extract to perform the pull-down assay, 
the possibility may exist that a mutual partner protein(s) mediates this interaction. To 
further demonstrate if the interaction between VirD2 and VBP1 is direct or indirect, we 
used purified MBP-VirD2 fusion protein to bind purified His-VBP1 protein. Cell lysates 
from E. coli expressing MBP or MBP-VirD2 fusion proteins were used to bind the 
amylose resin. The unbound proteins were washed out. The MBP-bound amylose resin or 
MBP-VirD2 fusion protein-bound amylose resin were incubated with purified His-VBP1 
or purified His-KatA respectively. The amylose resins were washed and the bound 
proteins were eluted with maltose. Coomassie blue staining result of the bound proteins 
showed that purified MBP-VirD2 fusion protein could specifically bind with purified 
His-VBP1 (lane 1 in Fig. 3.12), indicating that VirD2 interacts directly with VBP1. 
3.3.2. Pulling down of VirD2 by VBP2 and VBP3 
Since the amino acid sequences of VBP2 and VBP3 are highly homologous to 
VBP1 and all three VBP proteins contain a putative nucleotidyltransferase motif and a 
putative HEPN domain, we wanted to determine if VBP2 and VBP3 have the same 
function as VBP1. We tested whether VBP2 and VBP3 could also pull down VirD2. His-
VBP2 and His-VBP3 were used to conduct the pull-down assay with the same operating 
procedure as His-VBP1. As shown in Fig. 3.13, both VBP2 (lane 4 in Fig. 3.13) and 
VBP3 (lane 5 in Fig. 3.13) could pull down VirD2 from AS-induced A. tumefaciens 
A348 protein extract. This indicates that both VBP2 and VBP3 can also bind VirD2. 
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Fig. 3.12. Specific binding of purified His-VBP1 to purified MBP-VirD2.
Equal amount of MBP-bound amylose resin (lanes 3, 4) or MBP-VirD2-bound
amylose resin (lanes 1, 2) was incubated with equal amounts of purified His-
VBP1 (lanes 1, 3) or purified His-KatA (lanes 2, 4) respectively. After
incubation for 60 min at 4°C, the resins were washed and then eluted with
maltose. The eluted proteins were separated by SDS-PAGE and analyzed by
Coomassie blue stain. 
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Fig. 3.13. Pulling down of VirD2 by VBP2 and VBP3. Equal amount of
His-KatA bound resin (lane 2), His-VBP1 bound resin (lane 3), His-VBP2
bound resin (lane 4) or His-VBP3 bound resin (lane 5) was incubated with
an equal volume of AS-induced A. tumefaciens protein extract. After
incubation for 60 min at 4°C, the resins were washed and then eluted with
imidazol. The eluted proteins were separated by SDS-PAGE. VirD2 was
detected by Western blot with rabbit anti-His-VirD2 antibody. A.
tumefaciens protein extract (lane 1) was used as a positive control.  
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         3.3.3. Strength of VBP1-VirD2 interaction 
After we confirmed the specific interaction between VBP1 and VirD2 as well as 
testified that both VBP2 and VBP3 could also bind VirD2, we next attempted to analyze 
the strength of VBP1-VirD2 interaction. To test the strength of the interaction between 
VBP1 and VirD2, we examined the effect of increasing salt concentration on the recovery 
of the VirD2 by His-VBP1. The effect of salt concentration on the protein-protein 
interaction was usually used as a criterion to judge the strength of the protein-protein 
interaction (Bachand et al., 1999; Luban et al., 1993). The His-VBP1 bound TALON 
metal affinity resin was incubated with AS-induced A. tumefaciens A348 protein extract 
containing different concentrations of salt and Mg2+. Then, the resin was washed with the 
incubation buffer containing the same concentrations of salt and Mg2+ as in the A348 
protein extract. At the same time, His-VBP1 bound resin was also incubated with the 
incubating buffer containing the tested concentrations of salt and Mg2+ to ensure that the 
tested concentrations of salt and Mg2+ would not affect the binding of His-VBP1 to the 
resin (data not shown). In another word, the bound His-VBP1 would not be washed away 
by the buffers containing different concentrations of salt and Mg2+. The effect of 
increasing salt concentration on the recovery of the VirD2 was aroused by the VBP1-
VirD2 interaction not by the binding between His-VBP1 and resin. The bound proteins 
were eluted with imidazol. The pulled down proteins were separated by SDS-PAGE and 
analyzed by both Coomassie blue staining and Western blotting. Coomassie blue staining 
results further confirmed that equal amounts of His-VBP1 were still present after 
incubating and washing with these different salt concentrations (data not shown). 
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Fig. 3.14. Effect of the concentration of NaCl and Mg2+ on the
VBP1-VirD2 interaction. His-VBP1 bound resin was incubated with
AS-induced A. tumefaciens A348 extract under different
concentrations of NaCl and Mg2+ at 4°C for 60 min, and subsequently
washed with the incubating buffer containing specific concentration
of NaCl and Mg2+ (indicated at the top of the lanes). The proteins
were eluted with imidazol and analyzed by Western blotting. 
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between VBP1 and VirD2. The VBP1-VirD2 interaction could sustain 200 mM NaCl, 
indicating that The VBP1-VirD2 interaction was strong. 
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Chapter 4  The Role of VirD2-binding Protein in T-DNA 
Transfer 
4.1. Generation of vbp Mutants in A. tumefaciens 
VBP proteins could specifically bind with VirD2 and the VBP1-VirD2 interaction 
was strong. However, it is still unknown whether the VBP1-VirD2 interaction plays 
important roles in T-DNA transfer. Determining the biological function of the identified 
VirD2-binding protein(s) is one of the important goals of this study. To study the 
biological functions of these three VBP proteins, we adopted the mutagenesis strategy. If 
these three VBP proteins were important in the T-DNA complex trafficking, the mutation 
of the vbp genes would affect the T-DNA transfer. Because all three VBP proteins could 
bind with VirD2, they may functionally complement each other. Thus, we must “knock 
out” all three vbp genes to determine the biological functions. Since vbp1 is harbored on 
the cryptic plasmid AT, the effect of vbp1 may be removed by using A. tumefaciens strain 
GMI9017, which lacks the vbp1-containing AT plasmid (Rosenberg and Huguet, 1984). 
Therefore, we focused on generating mutations at vbp2 and vbp3.  
4.1.1. Generation of vbp2 mutants in A. tumefaciens 
To generate vbp2 mutants, we electroporated sacB-based suicide plasmid 
pEXKmVUD, which carries both upstream and downstream sequences of vbp2, to A348 
and GMI9017 (Fig. 4.1). KmR-transformants could only result from the integration of the 
plasmid into the agrobacterial genome because this plasmid cannot replicate inside 
agrobacterial cells. Therefore, kanamycin-containing MG/L agar plates were used to 































Fig. 4.1. Schematic diagram of vbp2 mutation strategy. The plasmid
pEXKmVUD carries two DNA fragments amplified from A. tumeficiens C58
genomic DNA that correspond to the upstream (shadowy arrows) and
downstream (black arrows) sequences of vbp2 gene. The nptIII (open rectangles)
represents kanamycin-resistant gene. The sacB (open arrows) is a
counterselectable marker gene that confers sucrose sensitivity. A fragment of
vbp2 gene was shown in stippled rectangles. Colonies having undergone single
cross-over homologous recombination (×) were screened as kanamycin
resistance and sucrose sensitivity. Double cross-over homologous recombination
event was selected by plating the single cross-over colonies on media containing
5% sucrose. The vbp2-deletion mutants were screened from the kanamycin-
sensitive and sucrose-resistant colonies. (A). The plasmid pEXKmVUD was
integrated into the A. tumefacien genome by homologous recombination at the
downstream of vbp2. (B). The plasmid pEXKmVUD was integrated into the A.
tumefacien genome by homologous recombination at the upstream of vbp2.
Double cross-over homologous recombination may occur in the two fragments
homologous to the upstream of vbp2 (A1 and B2, two shadowy arrows) or in the
two fragments homologous to the downstream of vbp2 (A2 and B1, two black
arrows). 
the agrobacterial genome. The suicide plasmid pEXKmVUD could be integrated into the 
agrobacterial genome on either the upstream (Fig. 4.1B) or the downstream (Fig. 4.1A) of 
the vbp2 gene in the single cross-over event. Previous observations showed that the 
frequency of the first recombination event, i.e. the frequency of the plasmid into the 
host’s genome DNA, appears to be dependent upon the length of homologous DNA 
(Edwards et al., 1998; Watt et al., 1985). The plasmid pEXKmVUD carries a 2.183-kb 
vbp2 downstream fragment and a 1.395-kb vbp2 upstream fragment. The length of the 
downstream homologous DNA is significantly longer than that of the upstream. To 
demonstrate the effect of the length of homologous DNA on the frequency of the single 
cross-over event, the KmR-transformants from the integration of plasmid pEXKmVUD 
into the downstream of vbp2 gene (Fig. 4.1A) were differentiated from those from the 
integration of plasmid pEXKmVUD into the upstream of vbp2 gene (Fig. 4.1B) by using 
PCR. Our results showed that most of the single cross-over mutants, the KmR-
transformants, resulted from the single cross-over event occurring on the downstream of 
the vbp2 gene (data not shown). 
The purified and PCR-confirmed KmR-transformants were used to screen for the 
double cross-over mutants. To select the double cross-over mutants, the KmR-
transformants were plated on sucrose-containing MG/L plate to select for the sucroseR-
transformants. The sucroseR-transformants were generated due to the double cross-over 
homologous recombination, which resulted in the loss of the integrated suicide plasmid. 
The double cross-over homologous recombination could also occur in two ways, either 
on the upstream homologous region (A1 and B2 in Fig. 4.1) or on the downstream 
homologous region (A2 and B1 in Fig. 4.1). So, two classes of sucroseR-transformants 
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were identified: the vbp2 wild type colonies (A2 and B2 in Fig. 4.1) and the vbp2-
deletion mutants (A1 and B1 in Fig. 4.1). The vbp2-deletion mutants were screened from 
the sucroseR-transformants by PCR using Pscreen1 and Pscreen2 as the primers. As 
shown in Fig. 4.2, vbp2-deletion mutant was obtained based on PCR analysis, which was 
followed by restriction digestion. 
In contrast to the first homologous recombination event, the frequency of the 
second homologous recombination event appears to be independent of the length of 
homologous DNA. Previous studies on homologous recombination in E. coli (Bi and Liu, 
1995) have showed that for plasmid- or chromosomal-located regions of homology 
greater than 100 bp the length of the intervening sequence has a greater influence over 
the deletion frequency than the length of the homologous regions on either side. When 
we used two different kinds of single cross-over mutants to screen the double cross-over 
mutants, we found that the percentage of vbp2-deletion mutant colonies appeared in the 
first kind of single cross-over mutant (Fig. 4.1A) was different from that appeared in the 
second kind of single cross-over mutant (Fig. 4.1B). The frequency of vbp2-deletion 
mutant colonies appeared in Fig. 4.1B was significantly higher than that in Fig. 4.1A 
(data not shown). This result was consistent with the previous studies in E. coli (Bi and 
Liu, 1995), indicating that the double cross-over homologous recombination mechanism 
in A. tumefaciens may be similar to that in E.coli.  
To confirm that the vbp2 fragment was indeed deleted as expected, the PCR 
fragments amplified by the primers Pscreen1 and Pscreen2 from both the wild type and 
the vbp2-deletion mutant were sequenced. Sequencing results showed that vbp2 gene 




























Fig. 4.2. Screening of vbp2-deletion mutants. The vbp2-deletion mutants were
screened by PCR. Two oligonucleotides Pscreen1 (annealed to upstream of
vbp2) and Pscreen2 (annealed to downstream of vbp2) were used as the primers.
The PCR products from a vbp2-deletion mutant (lanes 1 and 4) and from a wild
type (lanes 2 and 3) were treated by BamHI (lanes 1and 2) or without restriction
digestion (lanes 3 and 4). The PCR product from vbp2-deletion mutant was
digested to two fragments (lane 1) because a small fragment from vector’s
multiple-cloning sites (MCS) was inserted. The PCR product from the wild type
could not be digested to two fragments (lane 2) because the DNA fragment does
not have the BamHI site. These two PCR fragments were sequenced to confirm
that the vbp2 fragment was deleted as expected (sequence data was show in Fig.
4.3). vbp2- represents vbp2-deletion mutant. vbp2+ represents vbp2 wild type. 
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VBP2 wild type:    -----agcacttt-tggcatttga-tcaacgtgtc-gaagcgtata-aagttcatgg- 








Fig. 4.3. Sequence of the deleted vbp2 fragment. The bold letters indicate
the deleted vbp2 fragment. The shadowy letters represent the small
fragment replaced by vector’s multiple-cloning sites (MCS). The
underlined letters highlight the start code. 
deletion mutants derived from A348 and GMI9017 were designated A348∆vbp2 and 
GMI9017∆vbp2, respectively. 
4.1.2. Generation of vbp3 mutants in A. tumefaciens 
For the mutation of vbp3, we initially also wanted to construct a sacB-based suicide 
plasmid that carried both upstream and downstream sequences of vbp3 and to use the 
same methodology as in the vbp2 mutation, because the counterselectable marker sacB 
gene allows these rare double cross-over events to be identified in the general bacterial 
population. In addition, this sacB-based method allows the creation of deletions in 
specific genes on the chromosome eventually devoid of any unwanted selection marker 
and thus the gene inactivation created by this in-frame deletion often has a reduced polar 
effect on downstream genes in the same operon. However, when we tried to construct the 
sacB-based suicide plasmid that carried both upstream and downstream sequences of 
vbp3, we found that the vbp3 upstream fragments could not be inserted into this suicide 
vector. We could not get the sacB-based suicide plasmid carrying both upstream and 
downstream sequences of vbp3. Therefore, a different strategy was used to generate the 
vbp3 mutants.  
Mutation at vbp3 was generated by insertion of a plasmid containing part of the 
vbp3 gene into the chromosomal copy of vbp3 by homologous recombination (Fig. 4.4). 
We inserted a short fragment of vbp3 into plasmid pUC19 to generate pUCvbp3. Plasmid 
pUCvbp3 was electroporated to A348∆vbp2 and GMI9017∆vbp2 strains. The 
transformants were selected by carbenicillin-containing MG/L plate. The vbp3-insertion 
mutants were screened from the CbR-transformants by PCR. Screening results were 










Fig. 4.4. Schematic diagram of vbp3 mutation strategy. The plasmid
pUCvbp3, which carried a short fragment of vbp3 gene, was integrated into the
A. tumefacien genome by homologous recombination at the locus of vbp3. The
vbp3 gene was disrupted by the plasmid pUCvbp3. bla (open rectangles)
represents the carbenicillin resistant gene. The filled rectangles stand for the
vbp3 gene fragment near to the start code. The filled arrows indicate the





Amplified by Pvbps1 and Pvbps3
Amplified by Pvbps1 and Ppuc1







Fig. 4.5. Screening of vbp3-insertion mutants. The vbp3-insertion mutants
were screened from CbR-transformants by PCR. Three primers, Pvbps1
(annealed to the 5´ region of vbp3), Pvbps3 (annealed to the 3´ region of vbp3),
and Ppuc1 (annealed to the sequence of plasmid) were used to amplify the PCR
product. If a CbR-transformant was generated because of the integration of
plasmid pUCvbp3 into the vbp3 locus, a PCR fragment can be generated by
primers Pvbps1 and Ppuc1 and not by primers Pvbps1 and Pvbps3. Otherwise,
the CbR-transformant was generated by illegal integration. The colonies in lanes
3 and 5 are the desirable vbp3-insertion mutants.  
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Pvbps1 and Pvbps3 from different CbR-colonies. The lower panel showed that the PCR 
products from the same CbR-colonies as the upper panel except amplified by primers 
Pvbps1 and Ppuc1. As shown in Fig. 4.5, if vbp3 gene was disrupted by the plasmid 
pUC19, a PCR fragment can be generated by primers Pvbps1 and Ppuc1 and not by 
primers Pvbps1 and Pvbps3. The colonies in lanes 3 and 5 (Fig. 4.5) were shown to be 
the vbp3-insertion mutants. The PCR fragment amplified by primers Pvbps1 and Ppuc1 
from vbp3-insertion mutants was sequenced to confirm that vbp3 was disrupted by the 
insertion of plasmid pUC19 into the 595th nucleotide of vbp3 gene, whereas, the full 
length of the vbp3 gene is 936 nucleotides (data not shown). The confirmed vbp3-
insertion mutants derived from A348∆vbp2 and GMI9017∆vbp2 were designated 
A348∆vbp2∆vbp3 and GMI9017∆vbp2∆vbp3, respectively. 
4.2. Effect of vbp Mutation on Tumorigenesis 
         To test the effect of vbp mutation on A. tumefaciens ability to cause tumors, we 
inoculated different vbp mutation strains, A348∆vbp2, GMI9017∆vbp2, 
A348∆vbp2∆vbp3, GMI9017∆vbp2∆vbp3, as well as their parent strains A348 and 
GMI9017, onto the leaves of Kalanchoe plants. As shown in Fig. 4.6A, 
GMI9017∆vbp2∆vbp3 strain, in which no fully functional vbp gene remained, was highly 
attenuated in the ability to cause tumors on plants, whereas other three vbp mutation 
strains, A348∆vbp2, GMI9017∆vbp2 and A348∆vbp2∆vbp3, did not show apparent 
difference in tumor formation when compared with their parent strains. This 
demonstrated that all three vbp genes, vbp1, vbp2 and vbp3, could functionally 
complement each other. This result also demonstrated that the mutations of both vbp2 and 
































Fig. 4.6. Effect of vbp mutation on tumorigenesis. (A) Tumorigenesis
comparison of different Agrobacterium tumefaciens strains. A. tumefaciens strains
A348, GMI9017, A348∆vbp2, GMI9017∆vbp2, A348∆vbp2∆vbp3, and
GMI9017∆vbp2∆vbp3 were grown in MG/L medium at 28°C for 1 day. The cell
concentration was adjusted to 1×108 cells/ml. Then 2 µl of cell suspension was
inoculated onto each wounded line on the leaves of Kalanchoe plants. (B) The
tumorigenicity of the stain GMI9017∆vbp2∆vbp3 lacking all three VBP activities
was restored by the reintroduction of any vbp gene on the pCB301 replicon. DNA
fragments containing full length of three vbp genes and their flanking sequences
were inserted to the Hind III site of plasmid pCB301 respectively to generate three
plasmids pCBvbp1C, pCBvbp2C and pCBvbp3C. These three plasmids were
introduced into GMI9017∆vbp2∆vbp3 respectively. Cell concentrations of all
strains were adjusted to 1×108 cells/ml. Then 2 µl of cell suspension was
inoculated onto each wounded line.  (C, D, E) Effect of inoculation concentrations
on the tumorigenesis of GMI9017∆vbp2∆vbp3.  The cell concentrations of
GMI9017∆vbp2∆vbp3 were adjusted to 1×109 cells/ml (C), 1×108 cells/ml (D) and
5×107 cells/ml (E). Then 2 µl of cell suspension was inoculated onto each
wounded line. The tumors were photographed 35-42 ds after inoculation. 
translation because the vbp2 and vbp3 double mutation strain A348∆vbp2∆vbp3 did not 
show apparent difference in tumor formation. If the mutations of vbp2 and vbp3 exert 
polar effects on the upstream or downstream genes, the polar effects would be manifested 
in the A348∆vbp2∆vbp3 strain. Even so, we still used pCB301 replicon to construct three 
plasmids pCBvbp1C, pCBvbp2C and pCBvbp3C, which carry full length of vbp1 gene, 
vbp2 gene and vbp3 gene as well as their flanking sequences. We introduced these three 
plasmids to GMI9017∆vbp2∆vbp3 strain one by one to test whether the reintroduction of 
any one single vbp gene could restore the tumorigenicity of GMI9017∆vbp2∆vbp3 strain. 
Fig. 4.6B showed that the reintroduction of any one single vbp gene could fully restore 
the ability of the no fully functional vbp gene mutant to cause tumors. To further compare 
the virulence of GMI9017∆vbp2∆vbp3 and its parent strain GMI9017, we infected 
Kalanchoe plants with different cell concentrations. At a high concentration of 1 × 109 
cells/ml (Fig. 4.6C), GMI9017∆vbp2∆vbp3 strain could induce much less and smaller 
tumors on plants than GMI9017. At all other tested concentrations less than 1 × 108 
cells/ml (Fig. 4.6D, E), GMI9017∆vbp2∆vbp3 strain could not induce tumors on plants. 
Similar results were obtained when we inoculated these strains onto the stems of tobacco 
plants (data not shown). We wondered whether the vbp mutation would affect the growth 
rate of A. tumefaciens cells. Therefore, we compared the growth curves of 
GMI9017∆vbp2∆vbp3 and its parent strain GMI9017. No significant difference in 
growth rate between GMI9017∆vbp2∆vbp3 and its parent strain GMI9017 was observed 
(Fig. 4.7). These suggested that vbp is important for the bacterial virulence to cause 







Fig. 4.7. The growth curves of Agrobacterium tumefaciens strains
GMI9017 and GMI9017∆vbp2∆vbp3. The A. tumefaciens cells were
grown in MG/L liquid media. The OD600 of culture was measured at
different time intervals. 
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        4.3. Evidence for the Existence of VirD2-T-strand-VirE2 Complex in the 
Induced Agrobacterium Crude Extract 
4.3.1. Pulling down of VirD2-T-strand-VirE2 complex by VBP1 
As discussed in chapter 1, VirD2 covalently associated with the 5΄-end of the T-
strand. VirE2, as a single-stranded (ss) DNA-binding protein, possibly coated the ssT-
strand along its length to form a VirD2-T-strand-VirE2 complex structure. However, 
some recent studies argued against the existence of such a T-complex structure inside A. 
tumefaciens cells. VBP1 can specifically and strongly bind to VirD2. Consequently, we 
attempted to pull down the VirD2-T-strand-VirE2 complex from AS-induced A. 
tumefaciens cell extract by using VBP1 as the affinity ligand. If the VirD2-T-strand-
VirE2 complex exists inside A. tumefaciens cells, it should be pulled down by VBP1.  
When we used anti-VirE2 antibody to analyze the VBP pulling-down proteins by 
Western blotting, we found that VirE2 can also be pulled down. As shown in Fig. 4.8, all 
three VBP proteins can specifically pull down VirE2 protein. Based on the Western 
blotting results, we estimated a large amount of VirE2 protein was pulled down as 
compared with VirD2. So, we want to determine if VirE2 was pulled down in the form of 
VirD2-T-strand-VirE2 complex. To ensure that VirE2 and T-strand can be pulled down 
in the form of T-complex, we chose four A. tumefaciens strains, A348 (wild type), 
WR1715 (VirD2 deletion), LBA4404 (T-DNA deletion), and LBA4404 harboring 
pIG121Hm (known T-DNA), to perform the binding between VBP1 and VirD2-T-strand-
VirE2 complex. His-tagged VBP1-bound resin was incubated with the AS-induced cell 
extracts of these four strains respectively. The complexes pulled down from these four 
strains were analyzed by Western blot (Fig. 4.9). From the total bacterial lysate of 
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Fig. 4.8. Detection of VirE2 in the VBP-pulling down protein samples.
Equal amount of His-KatA bound resin (lane 2), His-VBP1 bound resin (lane
3), His-VBP2 bound resin (lane 4) or His-VBP3 bound resin (lane 5) was
incubated with an equal volume of AS-induced A. tumefaciens crude extract.
After incubation for 60 min at 4°C, the resins were washed and then eluted
with imidazol. The eluted proteins were separated by SDS-PAGE. VirE2 was
detected by Western blot with rabbit anti-His-VirE2 antibody. A. tumefaciens
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Fig. 4.9. VirE2 was pulled down by VBP1 in the form of VirD2-T-strand-
VirE2 complex. Equal quantities of His-tagged VBP1 bound resin were
incubated with equal volume of AS-induced A348 extract (lane 2), WR1715
extract (lane 4), extract of LBA4404 harboring pIG121Hm (lane 6), and
LBA4404 extract (lane 8) respectively. Following a 60min-incubation at 4°C,
the resins were washed and then eluted with imidazol. The eluted complexes
were separated by SDS-PAGE. VirD2 (upper panel) and VirE2 (lower panel)
were detected by Western blot with rabbit anti-His-tagged VirD2 antibody and
anti-His-tagged VirE2 antibody respectively. As positive controls of Western
blot, small amounts of A348 extract (lane 1), WR1715 extract (lane 3), extract
of LBA4404 harboring pIG121Hm (lane 5), or LBA4404 extract (lane 7) were
loaded onto the same SDS-PAGE gel. 
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induced wild type strain A348 cells, both VirD2 and VirE2 can be pulled down by VBP1 
(lane 2 in Fig. 4.9). WR1715 is a VirD2 mutant. In this strain, 70% of virD2 sequence 
was deleted (Shurvinton et al., 1992). No VirD2 protein was detected in the WR1715 
extract, but VirE2 can still be detected in the cell extract (lane 3 in Fig. 4.9). When we 
used the AS-induced WR1715 cell extract to conduct the pull down assay, VirE2 cannot 
be pulled down (lane 4 in Fig. 4.9), indicating that the pulling down of VirE2 by VBP1 is 
dependent on VirD2. LBA4404 is a vir helper strain. This strain harbors the disarmed Ti 
plasmid pAL4404. In this strain, T-DNA was deleted, but all other virulence proteins 
work (Ooms et al., 1982). When His-tagged VBP1-bound resin was incubated with the 
AS-induced LBA4404 cell extract, VirE2 cannot be pulled down either (lane 8 in Fig. 
4.9), although both VirD2 and VirE2 can be detected in the cell extract (lane 7 in Fig. 
4.9). This demonstrated that the pulling down of VirE2 by VBP1 is also dependent on T-
strand. When plasmid pIG121Hm was introduced to LBA4404, the pIG121Hm-harboring 
LBA4404 strain can generate the VirD2-T-strand-VirE2 complex because the pIG121Hm 
plasmid carries a known T-region (Ohata et al., 1990). So, VirE2 can be pulled down 
(lane 6 in Fig. 4.9). All these results demonstrated that VirE2 was pulled down due to the 
existence of VirD2-T-strand-VirE2 complex. 
To determine whether the T-strand can be pulled down by VBP1. Plasmid 
pIG121Hm was introduced into WR1715 strain. The pIG121Hm-harboring WR1715 
strain was used as a negative control because this strain cannot generate the VirD2-T-
strand-VirE2 complex due to the virD2 deletion. As shown in Fig. 4.10, T-DNA fragment 
can be amplified in the pulled-down complexes from the pIG121Hm-harboring LBA4404 
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Amplified T-DNA
Fig. 4.10. Amplification of T-DNA from the VBP1-pulling down protein
samples. To obtain the T-strand from the VBP1-pulling down protein samples,
The protein samples pulled down from the extract of LBA4404 harboring
pIG121Hm (lane 2) and the extract of WR1715 harboring pIG121Hm (lane 4)
were extracted by phenol:chloroform immediately and then centrifuged. The
T-strand was precipitated by 70% ethanol from the aqueous supernatant. The
precipitate was used as the template to amplify the T-DNA fragment by PCR.
As positive controls of PCR, the extract of LBA4404 harboring pIG121Hm
(lane 2) and the extract of WR1715 harboring pIG121Hm (lane 5) were also
used as templates to amplify the T-DNA. DNA ladder was loaded onto lane 1. 
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down complexes from the pIG121Hm-harboring WR1715 (known T-DNA, but VirD2 
deletion) (lane 4 in Fig. 4.10) by PCR. This demonstrated that the template in the pulled-
down complexes from the pIG121Hm-harboring LBA4404 is the T-strand, not plasmid 
pIG121Hm itself, i.e. the T-strand was pulled down.  
In order to show how much proteins of VirD2 and VirE2 were pulled down by 
VBP1, the pulled down complexes from different strains were also analyzed by 
Coomassie blue staining (Fig. 4.11). The corresponding protein bands (around the same 
molecular weight as VirD2 and VirE2) in SDS-PAGE gel were excised and then 
identified by MALDI-TOF. In Fig. 4.11, VirE2 was identified in the position of band 1 
and VirD2 was identified in the position of band 2. Both VirD2 and VirE2 protein bands 
were identified in samples from A348 (lane 1 in Fig. 4.11) and the pIG121Hm-harboring 
LBA4404 (lane 2 in Fig. 4.11). Only VirD2 protein band was identified in the sample 
from LBA4404 (lane 4 in Fig. 4.11). Neither VirD2 nor VirE2 was identified in the 
sample from WR1715 (lane 3 in Fig. 4.11). The VirE2 protein bands (lane 1 and 2 in Fig. 
4.11) were very dark. Their concentrations were estimated to be the same as VBP1 
protein band. Whereas the VirD2 protein band, whose position was beneath the VirE2, 
was very faint in all identified lanes. The peptide mass spectrum of band 1 from lane 1 of 
Fig. 4.11 was shown in Fig. 4.12. Fourteen main peptide masses matched with the 
calculated tryptic peptide masses from VirE2 (the peaks indicated by black triangle in 
Fig. 4.12). The matched peptides cover 46% (249/533) amino acids of the VirE2 protein. 
The MS-Fit search results of peptide masses of band 1 were summarized in Table 4.1. 
VirE2 got significant higher MOWSE score than other candidates. Fig. 4.13 is the peptide 


















































Fig. 4.11. Coomassie blue-staining analysis of VBP1-pulling down protein
samples. For Coomassie blue-staining detection of VirD2 and VirE2, larger
amounts of His-tagged VBP1 bound resin and A. tumefaciens extracts were
used to carry out the pull down assay. The eluted protein samples were further
concentrated and then freeze-dried. The protein samples from A348 (lane 1),
LBA4404 harboring pIG121Hm (lane 2), WR1715 (lane 3), and LBA4404
(lane 4) were separated by 10% SDS-PAGE gel. Proteins were detected by
Coomassie blue stain. The related protein bands were excised, in-gel digested
by trypsin, and eventually identified by MALDI-TOF. The top dark bands
(positions in band 1) in lane 1 and 2 were identified as VirE2. The faint bands
beneath the top dark band (positions in band 2) were identified as VirD2.
Three lanes (1, 2, 4) have VirD2 band, but only two lanes (1, 2) have VirE2
band. Neither VirD2 nor VirE2 was identified in lane 3. The bottom dark
bands (positions in band 3) were identified as VBP1. 
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Fig. 4.12.  MALDI-TOF peptide mass map of the band 1 from lane 1 of Fig.
4.11. The band 1 from lane 1 of Fig. 4.11 was excised and in-gel digested by
trypsin. The resulting peptides were analyzed using a MALDI-TOF mass
spectrometer to obtain the mass map. Peptide mass peaks that correspond to the
calculated tryptic peptide masses of A. tumefaciens VirE2 protein are indicated
by triangles. 
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VirE2 protein10955163Agrobacterium tumefaciens60587.7 / 6.5614/17 (82%)7.29e+010
hypothetical protein29376549ENTEROCOCCUS FAECALIS V58312269.2 / 8.675/17 (29%)1.6e+004
An1 protein21950765PARACENTROTUS LIVIDUS31151.1 / 4.395/17 (29%)4.76e+004
hypothetical protein23051505METHANOSARCINA BARKERI6605.7 / 4.484/17 (23%)6.05e+004




plasmid pTiA6  60603.8 / 6.5713/17 (76%)8.77e+009
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2148.26811368.8182 1857.99611512.9076 2514.1716 2772.66171750.9753 2204.2228 2569.2492
1068.6074 1557.78461723.0888 2520.36012214.64491997.11691324.7206982.5438
Fig. 4.13.  MALDI-TOF peptide mass map of the band 2 from lane 1 of Fig.
4.11. The band 2 from lane 1 of Fig. 4.11 was excised and in-gel digested by
trypsin. The resulting peptides were analyzed using a MALDI-TOF mass
spectrometer to obtain the mass map. Peptide mass peaks that correspond to the
calculated tryptic peptide masses of A. tumefaciens VirD2 protein are indicated by
triangles. 
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 main peptide masses matched with the calculated tryptic peptide masses from VirD2. 
The matched peptides covered 49% (209/424) amino acids of the VirD2 protein. The 
MS-Fit search results of peptide masse map of band 2 showed that this protein band got 
an unambiguous match with VirD2 (Table 4.2). The corresponding protein bands in other 
lanes of Fig. 4.11 obtained similar peptide mass spectra and MS-Fit search results (data 
not shown). All these data support the contention that VBP1 can pull down the T-
complex and the VirD2-T-strand-VirE2 complex exists in A. tumefaciens crude extract. 
Our result that the VirD2-T-strand-VirE2 complex can be pulled down by VBP1 
strongly supported the existence of the VirD2-T-strand-VirE2 complex in A. tumefacins 
crude extract, which is coincident with an early study (Christie et al., 1988). This early 
study showed that T-strand-VirE2 complex can be immunoprecipitated by VirE2-specific 
antiserum from crude cell extract and VirE2 protein was detected primarily in the 
cytoplasm. In vitro, VirE2-single stranded DNA complex can be formed favorably 
(Citovsky et al., 1997). Other research facts showed that VirE2 accumulates in A. 
tumefaciens at the same time as the T-strand and in stoichiometric amounts sufficient to 
bind the T-strand completely (Citovsky et al., 1988; Zambryski, 1992). We cannot 
imagine why the VirD2-T-strand-VirE2 complex cannot be formed in A. tumefaciens 
cytoplasm if both of free VirD2-T-strand complex and VirE2 molecules co-exist in the 
cytoplasm. Although recent studies (Simone et al., 2001; Schrammeijer et al., 2003; 
Cascales and Christie, 2004; Vergunst et al., 2000; Chen et al., 2000) strongly support 
that VirD2-T-strand complex and VirE2 are transported separately, separate transport of 
VirD2-T-strand complex and VirE2 cannot exclude the existence of the VirD2-T-strand-
VirE2 complex. 
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8777587SPHINGOMONAS PAUCIMOBILIS34629.5 / 5.557/31 (22%)8.58e+003





95914.4 / 6.429/31 (29%)1.37e+004
organic solvent tolerance 
protein, putative28867782 
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COELICOLOR A3(2)130905.2 / 4.777/31 (22%)2.43e+004
VirD2 protein10955158Agrobacterium tumefaciens47546.7 / 7.9716/31 (51%)1.92e+010
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       4.3.2. Co-immunoprecipitation of the VirD2-T-strand-VirE2 complex by anti-
VBP1 antiserum 
We have demonstrated that recombinant His-VBP1 protein could pull down the 
VirD2-T-strand-VirE2 complex. To further confirm that native VBP1 protein can bind 
the VirD2-T-strand-VirE2 complex and provide more solid evidence for the existence of 
VirD2-T-strand-VirE2 complex, we used anti-VBP1 antiserum to co-immunoprecipitate 
the VBP1-VirD2-T-strand-VirE2 complex from the AS-induced Agrobacterium crude 
extract. We used three Agrobacterium strains, C58, GMI9017∆vbp2∆vbp3, and 
GMI9017∆vbp2∆vbp3 harboring plasmid pCBvbp1C, to perform the co-
immunoprecipitation. C58 is a wild type strain whose genome was completely 
sequenced. GMI9017∆vbp2∆vbp3 strain is derivative of C58. In this strain plasmid AT 
was cured and both vbp2 and vbp3 were deleted. Plasmid pCBvbp1C can express VBP1 
protein and restore the tumorigenicity of GMI9017∆vbp2∆vbp3 strain (Fig. 4.6B). Two 
pairs of primers were designed to amplify the DNA from co-immunoprecipitates. One 
pair of primers that correspond to the “ipt” gene can amplify the T-strand from the 
VBP1-VirD2-T-strand-VirE2 complex and the T-region from Ti-plasmid. The other pair 
of primers that correspond to the “virB1” gene can amplify the backbone of Ti-plasmid. 
If the DNA template from co-immunoprecipitate is T-strand, only the T-strand gene “ipt” 
can be amplified. If the DNA template from co-immunoprecipitate is Ti-plasmid, both the 
T-region gene “ipt” and Ti-plasmid backbone gene “virB1” can be amplified. As we 
expected, the VBP1-VirD2-T-strand-VirE2 complex can be co-immunoprecipitated by 
anti-VBP1 antiserum because all three proteins, VBP1, VirD2 and VirE2 can be detected 
in the co-immunoprecipitate and only the T-DNA fragment corresponding to the “ipt” 
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gene can be amplified from the co-immunoprecipitate (lane 2 of Fig. 4.14), whereas both 
T-DNA fragment and Ti-plasmid backbone fragment can be amplified from supernatant 
(lane 1 in Fig. 4.14). When the cell extract from GMI9017∆vbp2∆vbp3 strain was used to 
perform the co-immunoprecipitation, no component of VBP1-VirD2-T-strand-VirE2 
complex was detected in the co-immunoprecipitate (lane 4 in Fig. 4.14). However, when 
the plasmid pCBvbp1C, which can express VBP1 protein, was introduced into 
GMI9017∆vbp2∆vbp3 strain, all components of VBP1-VirD2-T-strand-VirE2 complex 
can be co-immunoprecipitated (lane 6 in Fig. 4.14). This result confirmed that native 
VBP1 could bind VirD2 and the existence of VirD2-T-strand-VirE2 complex in 
Agrobacterium crude extract. 
4.4. Interactions between VBP Protein and T4SS Components 
4.4.1. Pulling down of T4SS components by VBP1 
VBP1 can strongly bind VirD2. We asked whether VBP1 accompanies VirD2 to the 
membrane transport site. Next, we wanted to know if T4SS components could be pulled 
down by VBP1. As we know, most of the T4SS components are membrane proteins. The 
extraction of T4SS components may require detergent. However, detergent may affect 
the binding between VBP1 and T4SS components. So, we used 0.5% Triton-buffer and 
non-Triton-buffer to extract T4SS components. To ensure the reliability of the pull down 
assay, we conducted two negative controls, one is the blank resin, and the other is the 
His-tagged KatA bound resin. As mentioned before, KatA is a catalase (Xu et al., 2001) 
and thus was not expected to bind T4SS components. We used equal amounts of blank 
resin, His-tagged KatA bound resin, and His-tagged VBP1 bound resin to incubate with
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Fig. 4.14. Co-immunoprecipitation of T-complex by anti-VBP1 antiserum. AS-
induced cell crude extracts from three A. tumefaciens strains were pre-cleared by
protein A-Sepharose and preimmune serum to reduce the background of nonspecific
proteins. The pre-cleared crude extracts were incubated with protein A-Sepharose
and anti-VBP1 antiserum at 4°C for 4 h with rocking. The co-immunoprecipitates
bound to Sepharose beads were washed five times and then eluted from the beads by
incubation at 96°C for 20 min with small amount of buffer. Proteins in the co-
immunoprecipitates were separated by SDS-PAGE and analyzed by Western blot.
DNA in the co-immunoprecipitates was detected by PCR amplification and gel
electrophoresis (top panel). Strains: C58 is a wild type strain; GMI9017∆vbp2∆vbp3
is a vbp mutant in which all three vbp genes were mutated; GMI9017∆vbp2∆vbp3
(+VBP1) is the GMI9017∆vbp2∆vbp3 mutant producing VBP1 from plasmid
pCBvbp1C. T-complex was co-immunoprecipitated from C58 (lane 2) and
GMI9017∆vbp2∆vbp3 (+VBP1) (lane 6). 
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equal volumes of AS-induced Agrobacterium extract. The pulled down proteins were 
separated by SDS-PAGE and analyzed by Western blot with the related antibodies. In all 
detected 6 VirB proteins (Fig. 4.15), VirB4, VrB8, and VirB11 can be specifically pulled-
down by VBP1 (lanes 4 and 5 in Fig. 4.15) because these three proteins cannot be 
detected in two negative controls (lanes 2 and 3 in Fig. 4.15). VirB9 and VirB10 showed 
non-specifically binding to resin as we can see that both of them can be pulled down by 
blank resin and His-tagged KatA bound resin (lanes 2 and 3 in Fig. 4.15). This result also 
showed that VirB9 and VirB10 couldn’t be detected in the pulled down proteins from the 
non-Triton extract, demonstrating that VirB9 and VirB10 may not be extracted by non-
Triton buffer (lane 5 in Fig. 4.15). VirB7 cannot be detected in all the pulled down 
protein samples.  
As we know T4SS components interact with each other (Ward et al., 2002) and 
VBP1 can bind VirD2, it is possible that some T4SS components may be pulled down via 
interacting with other components not directly by VBP1. Based on the specific 
interactions between the T4SS components and VirD2-T-strand substrate, the T4SS 
components can be divided into three classes (Cascales and Christie, 2004). Class I 
includes VirB11, VirB9, VirB8, VirB6, and VirB2. These proteins show close contacts 
with the T-strand during translocation and were proposed to correspond to channel 
subunits of the secretory apparatus. Class II comprises VirB10, VirB7, VirB5, and VirB4. 
These proteins show indirect contacts with the T-strand. They possibly interact with the 
transfer intermediate in some way. VirB1, VirB3, and another presumptive secretory 
component, VirJ are defined as class III. This protein class does not show contacts with 














































Fig. 4.15. Detection of T4SS components in the VBP1-pulling down proteins.
Pre-equilibrated blank TALON metal affinity resin, His-tagged KatA bound
TALON metal affinity resin, or His-tagged VBP1 bound TALON metal affinity
resin were incubated with AS-induced A. tumefaciens A348 0.5% Triton extract or
non-Triton extract at 4°C for 1 hour. The resins were washed 5 times with
incubating buffer. The pulled down proteins were dissolved in the SDS-PAGE
loading buffer directly. A348 0.5% Triton extract was loaded onto lane 1 as a
positive control. Protein pulled down by blank resin was loaded onto lane 2. Protein
pulled down by His-tagged KatA was loaded onto lane 3.  Lane 4 and 5 were loaded
proteins pulled down by His-tagged VBP1, but proteins in lane 5 were pulled down
from A348 non-Triton extract. The separated proteins were analyzed by using
Western blot. 
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       VirB8 and VirB11 that were shown to bind to VBP1 specifically in this study belong 
to the proteins of the class I that show close contacts with the VirD2-T-strand substrate 
during translocation. To determine if these proteins were pulled down by VBP1 directly 
or indirectly, we used three mutated A. tumefaciens strains, WR1715 (virD2 deletion), 
A348∆B8 (virB8 deletion), and A348∆B11 (virB11 deletion) to carry out the pull down 
assay. Results were shown in Fig. 4.16. In the protein sample pulled down from the AS-
induced WR1715 cell extract, both VirB8 and VirB11 could be detected (lane 4 in Fig. 
4.16), indicating that VirD2 did not affect the pulling down of VirB8 and VirB11. In the 
AS-induced A348∆B11 crude extract, VirB8 could be detected (lane 5 in Fig. 4.16). 
When the AS-induced A348∆B11 crude extract was used to conduct the pull down assay, 
VirB8 could not be pulled down by VBP1 (lane 6 in Fig. 4.16), demonstrating that the 
pulling down of VirB8 by VBP1 was dependent on VirB11. However, when we used the 
AS-induced A348∆B8 crude extract to conduct the pull down assay, VirB11 could be 
pulled down by VBP1 (lane 8 in Fig. 4.16), suggesting that the pulling down of VirB11 
by VBP1 did not require VirB8. Results in Fig. 4.16 gave us such a conclusion that 
VirB11 was pulled down by VBP1 directly and VirB8 was pulled down by VBP1 via 
VirB11. 
4.4.2. Pulling down of VirB11 by VBP2 and VBP3 
We have confirmed that all three VBP proteins could specifically interact with 
VirD2 (Fig. 3.13). We also have shown that VBP1 could specifically pull down VirB11. 
To further determine if VBP2 and VBP3 have the same function as VBP1. We tested 
whether VBP2 and VBP3 could also pull down VirB11. His-VBP2 and His-VBP3 were 




























































A348 WR1715 A348∆B11 A348∆B8
1 2 3 4 5 6 7 8
Fig. 4.16. VirB11 interacts with VBP1 directly and VirB8 is pulled
down via VirB11. His-tagged VBP1-bound TALON metal affinity resin
was incubated with related A. tumefaciens mutant strain 0.5% Triton
extract. The pulled down proteins were separated by SDS-PAGE and
analyzed by Western blot. Lane 1: A348 crude extract; Lane 2: proteins
pulled down from A348; Lane 3: WR1715 (VirD2 deletion) crude
extract; Lane 4: proteins pulled down from WR1715; Lane 5: A348∆B11
(virB11 deletion) extract; Lane 6: proteins pulled down from A348∆B11;
Lane 7: A348∆B8 (virB8 deletion) extract; Lane 8: proteins pulled down
from A348∆B8 
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shown in Fig. 4.17, both VBP2 (lane 4 in Fig. 4.17) and VBP3 (lane 5 in Fig. 4.17) could 
pull down VirB11 from AS-induced A. tumefaciens A348 protein extract. This indicates 
that both VBP2 and VBP3 can also bind VirB11 and further confirms that all three VBP 
proteins could functionally complement each other.  
4.4.3. Co-immunoprecipitation of T4SS components by anti-VBP1 antiserum 
The pull-down results showed that VirD4 (data not shown), VirB4 and VirB11 can 
be pulled down by His-VBP1, but VirD4 showed non-specifically binding to the blank 
TALON metal affinity resin (data not shown) and VirB4 showed non-specifically binding 
to the His-KatA (lane 3 in Fig. 4.15). To clear the ambiguous pull-down results, we 
further used co-immunoprecipitation approach to verify the interaction between VBP1 
and T4SS components. Co-immunoprecipitation results showed that VirD2, VirD4, 
VirB4 and VirB11 were co-immunoprecipitated by anti-VBP1 antiserum (lane 4 in Fig. 
4.18), but not by preimmune serum (lane 3 in Fig. 4.18). Other T4SS components cannot 
be co-immunoprecipitated by anti-VBP1 antiserum. Results also showed that protein A-
Sepharose beads do not bind T4SS components. As we know VBP1 can bind VirD2, we 
want to know whether the co-immunoprecipitation of T4SS components by ant-VBP1 
antiserum is dependent on VirD2 and we also need to know whether the co-
immunoprecipitation is VBP1-specific. We used four A. tumefaciens strains to perform 
the co-immunoprecipitation. As shown in Fig. 4.19, in a vbp mutant 
GMI9017∆vbp2∆vbp3, in which all three vbp genes were mutated, VirD2, VirD4, VirB4 
and VirB11 cannot be co-immunoprecipitated by anti-VBP1 antiserum (lane 4 in Fig. 
4.19). When plasmid pCBvbp1C was introduced into this vbp mutant to produce VBP1 
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1 2 3 4 5
Fig. 4.17. Pulling down of VirB11 by VBP2 and VBP3. Equal amount of
His-KatA bound resin (lane 2), His-VBP1 bound resin (lane 3), His-VBP2
bound resin (lane 4) or His-VBP3 bound resin (lane 5) was incubated with
an equal volume of AS-induced A. tumefaciens A348 protein extract. After
incubation for 60 min at 4°C, the resins were washed 5 times with
incubating buffer. The pulled down proteins were dissolved in the SDS-
PAGE loading buffer directly and separated by SDS-PAGE. VirB11 was
detected by Western blot with rabbit anti-VirB11 antibody. A. tumefaciens






































Protein A + 0.5% Triton extract
Fig. 4.18. Co-immunoprecipitation of T4SS components by anti-VBP1
antiserum. Agrobacterium A348 0.25% Triton extract was pre-cleared by protein
A-Sepharose and preimmune serum to reduce the background of nonspecific
proteins. Equal amounts of pre-cleared A348 0.25% Triton extract were co-
immunoprecipitated with equal volume of preimmune serum (lane 3) or anti-VBP1
antiserum (lane 4) at 4°C for 4 h with rocking. As a negative co-immunopreciptation
control, blank protein A-Sepharose bead (lane 2) was also used to incubate with pre-
cleared A348 0.25% Triton extract. After incubation, the protein A-Sepharose beads
were washed twice with lysis buffer B supplemented with 0.1% Triton X-100 and
three times with lysis buffer B. The co-immunoprecipitated complexes were
dissolved in the SDS-PAGE loading buffer directly and analyzed by Western blot.










































































Fig. 4.19. Verification of specific co-immunoprecipitation of T4SS
components by anti-VBP1 antiserum. To test if the co-immunoprecipitation is
specific, pre-cleared 0.25% Triton extracts from four A. tumefaciens strains were
co-immunoprecipited with anti-VBP1 antiserum respectively. Strains: A348 is a
wild type strain; GMI9017∆vbp2∆vbp3 is a vbp mutant in which all three vbp
genes were mutated; WR1715 is a virD2-deletion mutant;
GMI9017∆vbp2∆vbp3 (+VBP1) is the GMI9017∆vbp2∆vbp3 mutant producing
VBP1 from plasmid pCBvbp1C. Co-immunoprecipitated complexes from these
four strains were analyzed by Western blot (lanes 2, 4, 6, 8). Crude pre-cleared
0.25% Triton extracts from these four strains were used as positive blotting
controls and were loaded on to lanes 1, 3, 5, and 7 respectively. 
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immunoprecipitated (lane 8 in Fig. 4.19), indicating that co-immunoprecipitation of 
VirD2, VirD4, VirB4 and VirB11 by anti-VBP1 antiserum is VBP1-specific. In a virD2-
deletion mutant WR1715, VirD4, VirB4 and VirB11 can also be co-immunoprecipitated 
(lane 6 in Fig. 4.19), implying that the co-immunoprecipitation of VirD4, VirB4 and 
VirB11 by anti-VBP1 antiserum is independent on VirD2. These results suggested that 
VBP1 interacts with VirD2 and T4SS components possibly by two different domains and 
thus supported a hypothesis that VBP1 help the T-complex (VirD2) to recognize the 
T4SS transport site. 
VirD4, VirB11 and VirB4 are three energetic components of T4SS. Recent study 
showed that VirD4 strongly interacts with both VirB11 and VirB4 (Atmakuri et al., 
2004). We thus assayed whether the co-immunoprecipitation of VirB11 and VirB4 is 
dependent on each other. We used virB11 and virB4 mutants, A348∆B11 and A348∆B4, 
to carry out the co-immunoprecipitation. As shown in Fig. 4.20 (lanes 3 and 4), the co-
immunoprecipitation of VirB11 and VirB4 by anti-VBP1 antiserum is independent on 
each other. 
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Fig. 4.20. Co-immunoprecipitation of VirB4 and VirB11 is independent of
each other. Pre-cleared 0.25% Triton extracts from four A. tumefaciens strains
were co-immunoprecipited with anti-VBP1 antiserum respectively. Strains: A348
is a wild type strain; GMI9017∆vbp2∆vbp3 is a vbp mutant in which all three vbp
genes were mutated; A348∆B4 is a virB4-deletion mutant; A348∆B11 is a virB11-
deletion mutant. Co-immunoprecipitates from these four strains were analyzed by
Western blot. VirB4 can be co-immunoprecipitated from A348∆B11 mutant (lane
4) and VirB11 can be co-immunoprecipitated from A348∆B4 mutant (lane 3). 
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Chapter 5  The Role of VirD2-binding Protein in Conjugal 
DNA Transfer 
Previous studies (Beijersbergen et al., 1992; Buchanan-Wollaston et al., 1987; 
Cook and Farrand, 1992; Chen et al., 2002) demonstrated that A. tumefaciens is capable 
of transferring the IncQ plasmid RSF1010 into eukaryotic and bacterial cells. Plasmid 
RSF1010 was also shown to reduce T-DNA transfer (Binns et al., 1995), presumably 
because it competes with transferred substrates at the transport pore (Stahl et al., 1998). 
In this study, we have demonstrated that vbp triple mutant highly attenuates the 
tumorigenicity of A. tumefaciens and VBP proteins interact with both VirD2 and VirD4. 
It is conceivable that the influence of vbp mutants on the mobilization frequency of 
RSF1010 by VirB/D4 T4SS would be sophisticated.  
5.1. VBP Proteins Affect the Conjugal Transfer of pML122 Mediated by A. 
tumefaciens Conjugal System 
We next want to know whether vbp mutants would affect other DNA transfer 
system in A. tumefaciens. RSF1010 has been shown to be mobilized by A. tumefaciens 
strains without VirB/D4 T4SS transport pore (Cook and Farrand, 1992; Chen et al., 2002), 
indicating that RSF1010 can be mobilized by other A. tumefaciens DNA transfer system. 
So, we introduced a derivate of RSF1010, pML122, into different A. tumefaciens strains 
(Table 5.1; for the characteristics of strains, please see Table 2.1; for the plasmid 
characteristics, please see Table 2.2) by electroporation. Since RSF1010 has been shown 
to compete the same VirB/D4 T4SS transport pore with T-complex (Stahl et al., 1998), 
we assayed the conjugal transfer of pML122 in A. tumefaciens under non-inducing 
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Table 5.1. Effect of vbp mutation on the mobilization of a RSF1010 derivative 
pML122 from Agrobacterium to E. coli (MT607) under non-inducing conditions 
3.4 ± 3.1 29 1.0 GMI9017∆vbp2∆vbp3 (pCBvbp3C) 
5.2 ± 5.1 31 0.9 GMI9017∆vbp2∆vbp3 (pCBvbp2C) 
6.0 ± 6.0 79 0.9 GMI9017∆vbp2∆vbp3 (pCBvbp1C) 
8.5 ± 9.8 49 1.1 A348∆B11 
7.8 ± 4.4 87 1.0 A348∆B4 
<10-90 1.0 GMI9017∆vbp2∆vbp3 
5.5 ± 5.2 46 0.9 GMI9017∆vbp2 
5.7 ± 2.1 64 0.9 GMI9017 
9.2 ± 1.3 96 1.0 A348∆vbp2∆vbp3 
7.8 ± 5.0 86 1.1 A348∆vbp2 
9.6 ± 4.9 97 1.1 A348 
Frequency /per 









Numbers of input donors and transconjugants are the data from a representative experiment.
Frequency data represent the means of triplicates (±SD) from a single experiment. Two
independent experiments were performed. Although absolute numbers varied between two
individual experiments, the relative frequencies among the mutant strains showed the same
tendencies in two experiments. 
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conditions, in order to reduce the interference of T-DNA transfer to pML122 transfer. We 
used E. coli. as recipient. The mobilization frequencies of pML122 in different A. 
tumefaciens strains were shown in Table 5.1. The transfer frequencies in two virB 
mutants, A348∆B4 and A348∆B11, are similar to wild type strain A348, indicating that 
the mobilization of pML122 in A. tumefaciens under non-inducing conditions was 
mediated by other A. tumefaciens DNA transfer system not by VirB/D4 T4SS. Without 
VirB/D4 T4SS, the mobilization frequency of RSF1010 in A. tumefaciens is very low, 
which is consistent with previous observations (Cook and Farrand, 1992; Chen et al., 
2002). However, the results in Table 5.1 showed that the vbp triple mutant 
GMI9017∆vbp2∆vbp3 reduced the mobilization frequency of pML122 at least several 
decade-fold. When any of these three vbp genes was reintroduced into the vbp triple 
mutant GMI9017∆vbp2∆vbp3 by another replicon (pCBvbp1C, pCBvbp2C, and 
pCBvbp3C), the mobilization frequency of pML122 was restored to the level of vbp wild 
type. These results indicated that VBP proteins affect the RSF1010 mobilization by other 
A. tumefaciens conjugal system.  
We also assayed the mobilization frequencies of pML122 in these A. tumefaciens 
strains with a helper, E. coli. MT616 strain. MT616 harbors plasmid pRK600, which was 
used to mobilize the megaplasmids via oriT. Plasmid pRK600 does not replicate in A. 
tumefaciens, but it evidently persists for a sufficient period of time to express the RK2 
transfer genes (Finan et al., 1988). So, MT616 can help A. tumefaciens to mobilize 
pML122. Under the help of MT616, the mobilization frequency of pML122 in A. 
tumefaciens was increased to 4.4 ~ 8.2 × 10-4 transconjugants per input donor, but vbp 
mutants did not affect the mobilization frequency of pML122 mediated by the RK2 
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transfer genes (data not shown), indicating that VBP proteins were not involved in the 
RK2 DNA transfer system. 
5.2. VBP Proteins Interact with pML122  
VBP proteins affected the pML122 mobilization mediated by A. tumefaciens 
conjugal system, implying that VBP protein might interact with plasmid pML122 in a 
way or another. Thus, we used anti-VBP1 antiserum to incubate with the non-induced 
cell extract of A. tumefaciens strains that harbor plasmid pML122 to determine whether 
plasmid pML122 could be co-immunoprecipitated by anti-VBP1 antiserum. We 
introduced plasmid pML122 to three A. tumefaciens strains, A348, 
GMI9017∆vbp2∆vbp3, and GMI9017∆vbp2∆vbp3 harboring pCBvbp1C. These three 
pML122-harboring strains were grown in MG/L liquid medium under non-inducing 
conditions. The non-induced cell extracts from these three strains were used to perform 
the co-immunoprecipitation. The co-immunoprecipitates were used as the template to 
amplify the pML122 fragment and the pCBvbp1C fragment.  The PCR amplification 
result was shown in Fig. 5.1. Plasmid pML122 could be co-immunoprecipitated by anti-
VBP1 antiserum from A348 extract (lane 2 in Fig. 5.1), but not from 
GMI9017∆vbp2∆vbp3 extract (lane 4 in Fig. 5.1), in which no VBP protein was 
expressed. However, when the plasmid pCBvbp1C was introduced to 
GMI9017∆vbp2∆vbp3, plasmid pML122 could be co-immunoprecipitated (lane 6 in Fig. 
5.1). To test whether the plasmid pCBvbp1C could also be co-immunoprecipitated by 
anti-VBP1 antiserum from strain GMI9017∆vbp2∆vbp3 harboring pCBvbp1C, two 
primers, PvbpCS1 and PvbpCS2, were used to amplify the pCBvbp1C fragment. The 
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Fig. 5.1. Co-immunoprecipitation of plasmid pML122 by anti-VBP1 antiserum.
Plasmid pML122 was introduced into A348, GMI9017∆vbp2∆vbp3 and
GMI9017∆vbp2∆vbp3 (+VBP1) respectively. Non-induced cell crude extracts from
these three pML122-harboring strains were pre-cleared by protein A-Sepharose and
preimmune serum to reduce the background of nonspecific proteins. The pre-cleared
crude extracts were incubated with protein A-Sepharose and anti-VBP1 antiserum at
4°C for 4 h with rocking. The co-immunoprecipitates bound to Sepharose beads were
washed five times and then eluted from the beads by incubation at 96°C for 20 min
with small amount of buffer. Proteins in the co-immunoprecipitates were detected by
SDS-PAGE and Western blot (lower panel). DNA in the co-immunoprecipitates was
detected by PCR amplification and gel electrophoresis (upper panel). Strains: A348 is
a wild type strain; GMI9017∆vbp2∆vbp3 is a vbp mutant in which all three vbp genes
were mutated; GMI9017∆vbp2∆vbp3 (+VBP1) is the GMI9017∆vbp2∆vbp3 mutant
producing VBP1 from plasmid pCBvbp1C. Plasmid pML122 was immunoprecipitated
from A58 (lane 2) and GMI9017∆vbp2∆vbp3 (+VBP1) (lane 6), whereas, plasmid
pCBvbp1C was not co-immunoprecipitated from GMI9017∆vbp2∆vbp3 (+VBP1)
(lane 6). 
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immunoprecipitate of strain GMI9017∆vbp2∆vbp3 harboring pCBvbp1C (lane 6), 
although the pCBvbp1C fragment could be amplified from the crude extract (lane 5). 
This demonstrated that VBP proteins specifically interact with plasmid pML122 in some 
way and thus confirmed that VBP proteins affect the conjugal transfer of pML122 
mediated by A. tumefaciens conjugal system. 
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Chapter 6  Definition of Recruiting Proteins in Nucleoprotein 
Complex Transfer 
Using MBP-VirD2 fusion protein as an affinity ligand to perform the pull-down 
assay, we isolated a VirD2-binding protein, designated VBP1. No proteins with known 
function are homologous to VBP1. Thus, VBP1 is a novel protein and the function of 
VBP1 remains unclear. Recombinant protein His-VBP1 was shown to be able to pull 
down VirD2. Further analysis suggested that the binding between VirD2 and VBP1 is 
highly specific. Homology analysis showed that Agrobacterium tumefaciens has two 
additional homologous genes, vbp2 and vbp3. VBP2 and VBP3 can also bind VirD2 just 
like VBP1. To determine the biological function of vbp genes, we conducted the mutation 
of vbp genes in A. tumefaciens. The vbp triple mutant GMI9017∆vbp2∆vbp3, in which no 
fully functional vbp gene exists, exhibited highly attenuated virulence. This strongly 
supports that VBP1 is involved in the T-DNA transfer. Our results also showed that VBP 
proteins could pull down the VirD2-T-strand-VirE2 complex from AS-induced A. 
tumefaciens extract and specifically bind with some T4SS components. These pull-down 
results were further confirmed by co-immunoprecipitation. Anti-VBP1 antiserum can co-
immunoprecipitate VirD2-T-strand-VirE2 complex as well as T4SS components: VirD4, 
VirB11 and VirB4. In addition, VBP proteins were shown to affect the conjugal transfer 
of plasmid pML122 mediated by A. tumefaciens non-T4SS DNA transfer system and to 
interact with this plasmid in some ways. However, the biochemical function of VBP1 is 
still not clear. 
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6.1. VBP is Possibly an Auxiliary Protein of Relaxosome, the T-DNA 
Processing Complex 
BLAST searches revealed that all three VBP proteins have a putative 
nucleotidyltrasferase motif and a putative HEPN domain. Nucleotidyltrasferases are 
classified into more than 10 distinct superfamilies. The member proteins catalyze the 
same chemical reaction: the coupling of nucleoside triphosphates to a free hydroxyl 
group via elimination of pyrophosphate. Nucleotidyltransferases are involved in diverse 
biological functions that range from DNA repair, telomere maintenance, immunoglobulin 
gene rearrangement to regulation of biosynthetic pathways and signal transduction. It is 
known that protein nucleotidyltransferases, such as protein uridylyl transferases (GlnD) 
and protein adenylyl transferases (GlnE), could catalyze the nucleotidylation of specific 
proteins to regulate the functions of the modified proteins (Aravind and Koonin, 1999). 
Therefore, it is possible that the identified VBP1 might be involved in the T-DNA 
transfer because VBP1 could possess putative nucleotidyltransferase activity that may be 
involved in diverse biological functions. 
To know more about the biochemical function of VBP, we analyzed the functions 
of genes adjacent to vbp. All three predicted proteins encoded by the ORFs in the 
upstream of vbp1 are hypothetical proteins of unknown function. The first predicted 
protein encoded by the ORF in the downstream of vbp1 is an aminotransferase and the 
second predicted protein is a two-component response regulator. We did not find any 
informative relationship among these proteins. However, we found some interesting 
genes adjacent to the two homologous genes, vbp2 and vbp3. The predicted proteins 















































































Dtr system of Plasmid pTiC58 of 
Agrobacterium tumefaciens C58 
(NC_003308)
Dtr system of plasmid pAtC58 of 
Agrobacterium tumefaciens C58 
(NC_003306)
Region of vbp2 and vbp3
on linear chromosome of 




























































Region of vbp homolog 
on plasmid pAgK84 of Agrobacterium 
radiobacter K84 (NC_006277)
Fig. 6.1. Comparison of gene organization in the regions of vbp homologs with
Dtr systems in Agrobacterium. Gene organization of the region between vbp2 and
vbp3 on the linear chromosome of Agrobacterium tumefaciens C58 is shown at the
bottom. A vbp homologous gene (nucleotidyltransferase gene) is also found on the
plasmid pAgK84 from Agrobacterium radiobacter K84. Genes with predicted amino
acid sequence similarity are shaded similarly. Genes whose predicted amino acid
sequences are not similar are filled with blank. The numeric indicates the position of
nucleotides in linear chromosome or plasmids. Sequence of Agrobacterium
tumefaciens C58 was cited from the genome version of University of Washington. 
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organization of vbp3 region is very similar for the RP4 tra regions (Leloup et al., 2002). 
A similar gene organization in the region of a vbp homolog was also found to exist in the 
plasmid pAgK84 of Agrobacterium radiobacter K84. Comparison of the gene 
organization of these identified or putative tra regions (Farrand et al., 1996; Chen et al., 
2002) in Agrobacterium revealed that VBP or its homologous protein is most likely to be 
a subunit of DNA transfer and replication (Dtr) system (Fig. 6.1).  
6.2. VBP may also be Involved in the Recruitment of T-complex to T4SS 
Transport Site  
The processing of T-DNA and its transfer from Agrobacterium to plants is similar 
to the interbacterial conjugal transport of a variety of plasmids (Lessl and Lanka, 1994). 
In both processes, transferred DNA was cleaved at specific cis-acting sits (conjugation at 
oriT and T-DNA transfer at T-border) and transferred in a single-stranded form. 
Moreover, the protein that catalyzes the T-DNA scission remains bound to the 5´-end of 
the T-strand molecule. Plasmid conjugation conceptually can be divided into two 
function systems: the DNA transfer and replication (Dtr) system and the mating pair 
formation (Mpf) system. In the Dtr system, relaxase and auxiliary proteins, which can be 
host- or plasmid- encoded, assemble at oriT to form a nucleoprotein complex called the 
relaxosome. In many cases, a protein (normally called coupling protein) is needed to 
couple the Dtr to the Mpf. The most direct evidence that the mechanisms of T-DNA 
transfer and conjugation are functionally related is the extensive sequence similarities 
between Agrobacterium virB-encoded type IV secretion system (T4SS) proteins and IncN 
plasmid pKM101-encoded Mpf system proteins (Lessl et al., 1992). The observation that 
the conjugal intermediate of plasmid RSF1010 inhibits Agrobacterium virulence by 
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competing with the VirD2-T strand and/or VirE2 for a common export site (Stahl et al., 
1998) demonstrates that Agrobacterium virB-encoded type IV secretion system (T4SS) 
has the capacity to mobilize other relaxosome. VirD4 sequence is highly similar to TraG 
of RP4 and behaves as a coupling protein, linking the T-DNA processing system and the 
mating channel. Coupling proteins determine the recognition between relaxosome and 
Mpf (Hamilton et al., 2000; Liosa et al., 2003). In plasmid conjugal system, several 
coupling protein (CP)-relaxase interactions have been demonstrated by in vitro studies. 
The TraGRP4 CP interacts with TraIRP4 relaxase/helicase (Schroder et al., 2002) and with 
Mob relaxase of the mobilizable plasmid pBHR1 (Szpirer et al., 2000). The TrwBR388 CP 
interacts with TrwCR388 relaxase/helicase, and the TraDF CP interacts with TraMF, a Dtr 
protein that participates in processing by binding at sites near the F plasmid oriT 
sequence (Disque-Kochem and Dreiseikelmann, 1997).  
In Agrobacterium T-DNA transfer system, VirE2 was demonstrated to be a 
substrate of T4SS and to interact with VirD4 coupling protein, but it was estimated only 
5% of VirE2 was recruited to cell poles and less than 1% of VirE2 formed the VirE2-
VirD4 complex. Most of VirE2 was believed to serve as a reservoir of this recruitment 
substrate (Atmakuri et al., 2003). If T-strand moves in the form of VirD2-T-strand-VirE2 
complx, VirE2 may help the VirD2-T-strand-VirE2 complex to be recruited to the T4SS 
transport sites. However, in order to guarantee that the VirD2-T-strand-VirE2 complex to 
be recruited to the T4SS transporter sites in a 5´ to 3´ direction, the leading 5´-end of the 
VirD2-T-strand-VirE2 complex requires a protein that possesses high affinity to VirD4 or 
related T4SS components, otherwise, the VirD2-T-strand-VirE2 complex would be 
recruited to the transport sites in disorder. If T-strand moves in the form of VirD2-T-
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strand complex and VirE2 is transported separately, we do not know how the VirD2-T-
strand complex moves to the transport site and whether the movement of VirD2-T-strand 
complex is active or passive. It is conceivable that the recruitment of VirD2-T-strand 
complex to the T4SS transporter site is more difficult than the recruitment of single 
VirE2 molecule to the T4SS transporter site because A. tumefaciens cell does not have a 
reservoir of VirD2-T-strand complex to serve for the recruitment of this complex to T4SS 
and the VirD2-T-strand complex molecule is much bigger than VirE2 molecule. In this 
case, a protein that possesses high affinity to VirD4 is also required to help the 
recruitment of VirD2-T-strand complex to the transport sites.  However, so far, only 
week interaction between VirD2 (T-strand) and VirD4 was observed in an in vivo study 
(Cascales and Christie, 2004). No evidence showed that VirD2 strongly interacts with 
VirD4 CP and could be recruited to the T4SS transport sites. Therefore, an additional 
protein that can strongly interact with both VirD2 and VirD4 (or other inner membrane 
T4SS components) will efficiently enhance the recruitment of T-complex to T4SS.  
VBP1 can specifically and strongly bind VirD2, coupling protein VirD4 and two 
T4SS component proteins VirB4, VirB11. VirD4 plays an important role in recognizing 
T4SS translocating substrate (Atmakuri et al., 2003; Kumer and Das, 2002; Cascales and 
Christie, 2003). VirB11 is the first VirB protein that contacts with the VirD2-T-strand 
complex, just following the coupling protein VirD4 (Cascales and Christie, 2004). 
Structural studies on VirB11 have shown that VirB11 ATPases assemble as structurally 
dynamic, homohexameric rings with central channels large enough to accommodate 
DNA or unfolded polypeptides (Savvides et al., 2003). VirB11 is proposed to function as 
a gating molecular of T4SS at the inner membrane and to drive substrate export (Cascales 
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and Christie, 2003; Savvides et al., 2003). Like VirB11, VirB4 contains a conserved 
Walker A nucleotide-binding motif and the purified VirB4 also shows week ATPase 
activity (Dang et al., 1999). VirB4 is an inner membrane protein and possesses two 
domains that embed into, or protrude across, the cytoplasmic membrane, possibly 
forming contacts with machine subunits across the inner membrane (Cascales and 
Christie, 2003; Dang et al., 1999). VirB4 also shows interaction with VirB11 (Ward et 
al., 2002). Recent study (Atmakuri et al., 2004) showed VirD4 could form complex with 
VirB11 and VirB4. Nucleoside triphosphate binding site (Walker A motif) mutations of 
VirD4, VirB11 and VirB4 do not disrupt VirD4 substrate binding or transfer to VirB11, 
suggesting that these early reactions proceed independently of ATP binding or hydrolysis 
served by T4SS components. This observation may support a hypothesis that additional 
proteins may serve for these early reactions. VBP1 contains a putative 
nucleotidyltransferase motif and a putative higher eukaryotes and prokaryotes nucleotide-
binding (HEPN) domain. So, it may serve for the early binding of T-complex to VirD4 or 
transfer to VirB11. Study on the cell fraction of Agrobacterium showed that no VBP1 
protein was detected by Western blot in the membrane fraction, indicating that VBP1 
protein is a cytoplasmic protein (data not shown). In detailed analyzing the amino acid 
sequences of three VBP proteins, we found three VBP proteins contain clusters of 
positively charged residues at their C-termini (Fig. 6.2), which share an important 
common feature with type IV secretion substrates (Christie, 2004; Vergunst et al., 2005). 
The positive charge clusters were believed to be the transport signals of type IV secretion 
substrates and to mediate the interactions between the secretion substrate and the VirD4 
CP (Christie, 2004; Vergunst et al., 2005). Therefore, we speculate that the cytoplasmic
 160
Verified VirB/D4 T4SS substrates
VirE2 ----KLPSDAAQLLAEPSDRYSRAFVRPEPALPPISDSRRTYESRPRSQSVNSF
VirE3 ----NSEQQALLNELLSVPLPGPLPKADHERPRVLESSRSRERSMSGGLSL
VirF        ----GGPNAVGLLTTNESFEKNINEVYNRTRAELDASSRDRSRSGLSR
VirD2     ----ATDSLSATAHLQQRRGVLSKRPREDDDGEPSERKRERDERSKDGRGGNRR
MobA-RSF1010 ----ALARPDATDNRGRLDLAALGGPMKNDRTLQAIGRQLKAMGCER
Relaxases verified to bind with coupling proteins






Fig. 6.2. Three VBP proteins contain clusters of positively charged amino acid
residues at their C termini. Positively charged residues, Arg (R), Lys (K), and
His (H) were bolded and underlined. This positive charge bias of VBP proteins
shares an important common feature with type IV secretion substrates. The charge
bias in the C-termini of type IV secretion substrates was postulated to be the type
IV secretion signal recognized by the coupling protein (CP) component of the type
IV secretion system and to mediate the interactions between CP and substrates
(Christie, 2004; Vergunst et al., 2005). Vir and VBP proteins were encoded by A.
tumefaciens C58. 
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VirD2 binding protein, VBP1, may mediate the recruitment of VirD2 to type IV secretion 
system. As vbp triple mutant also affected the conjugal transfer of plasmid pML122 in A. 
tumefaciens and pML122 can be co-immunoprecipitated by anti-VBP1 antiserum, 
implying that VBP proteins may involved in the recruitment of some plasmid conjugation 
intermediates to the membrane transport sites, we defined the VBP proteins as a new 
class of protein; recruiting protein that can recruit the DNA transfer intermediate to the 
membrane transport sites. 
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Chapter 7  Conclusions and Future Prospects 
7.1. Conclusions 
A VirD2-binding protein (VBP1) was identified in this study by using a pull-down 
assay and peptide-mass-fingerpriting. VBP1 protein is encoded by an agrobacterial AT 
plasmid gene. This gene was designed vbp1 gene. Homology analysis showed that two 
vbp1 homologous genes were located on the agrobacterial linear chromosome DNA and 
their positions were close to each other. These two vbp1 homologous genes were 
designed vbp2 and vbp3. All three VBP proteins do not show homology to any protein of 
known function, but possess a putative nucleotidyltransferase motif in their N-termini and 
a putative higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domain in their 
C-termini. All these indicated that a novel VirD2-binding protein was identified. 
Three vbp genes were cloned to pRSET vectors and expressed as His-tagged fusion 
proteins. All three VBP proteins showed high expression level in E. coli. By using these 
three His-VBP fusion proteins as the affinity ligands, all three VBP proteins were 
demonstrated to be able to bind VirD2 specifically. To determine the biological functions 
of three vbp genes, we conducted the mutations of vbp2 and vbp3 in two A. tumefaciens 
strains A348 and GMI9017. A348 is a wild type strain and contains all three vbp genes. 
In GMI9017 strain, AT plasmid was cured, so, GMI9017 strain only contains vbp2 and 
vbp3 genes. Four vbp mutants were obtained in this study. These four vbp mutants were 
designed as A348∆vbp2, A348∆vbp2∆vbp3, GMI9017∆vbp2 and 
GMI9017∆vbp2∆vbp3 and were used to determine the effects of vbp mutations on the 
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tumorigenesis of A. tumefaciens. The results showed that vbp genes were involved in the 
tumorigenesis and these three vbp genes could complement each other functionally. 
We used His-VBP1 as an affinity ligand to conduct the pull down assay and found 
that a large amount of VirE2 was pulled down compared with VirD2. The pull down 
results from four different A. tumefaciens strains demonstrated that VirE2 was pulled 
down in the form of VirD2-T-strand-VirE2 complex and the T-strand could also be 
amplified from the pulled down samples. Data in this study strongly supported that the T-
complex existed in the A. tumefaciens extract in the form of VirD2-T-strand-VirE2 
complex. This conclusion agreed with an early observation (Christie et al., 1988). Co-
immunoprecipitation with anti-VBP1 antiserum verified that native VBP1 could bind 
VirD2-T-strand-VirE2 complex and further confirmed that VirD2-T-strand-VirE2 
complex exists in A. tumefaciens extract. 
Both pull-down and co-immunoprecipitation results showed that VBP1 specifically 
and strongly interacts with VirD4 as well as two T4SS components, VirB4 and VirB11. 
Like VBP1, both VBP2 and VBP3 could pull down VirB11. This further confirmed that 
all three VBP proteins have similar functions. 
By analyzing the functions of genes adjacent to the two vbp1 homologous genes 
vbp2 and vbp3 as well as comparing the T-DNA processing complex with the 
relaxosomes in conjugal plasmids, VBP1 was supposed to be an auxiliary protein of T-
DNA processing nucleoprotein complex.  
Based on the observations that VBP1 specifically and strongly interacts with VirD2 
and VirB/D4 T4SS components: VirD4, VirB4 and VirB11, as well as vbp triple mutant 
highly attenuates the tumorigenesis of A. tumefaciens, VBP proteins were suggested to be 
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involved in the recruitment of T-complex to the T4SS transporter site. Vbp triple mutant 
was also shown to affect the conjugal transfer of a RSF1010 derivate in A. tumefaciens 
and the RSF1010 derivate can be co-immunoprecipitated by anti-VBP1 antiserum from A. 
tumefaciens extract, suggesting that VBP proteins may be involved in some plasmid 
conjugation systems. So, we defined VBP proteins as a new class of proteins: recruiting 
proteins that could recruit the DNA transfer intermediate to the membrane transport sites. 
7.2. Future Prospects 
In this study, VBP proteins were demonstrated to be involved in the tumorigenesis 
of A. tumefaciens and some plasmid conjugation systems. The redundancy of three 
homologs for one VirD2-binding function indicated that VBP might play an important 
role in the T-DNA transfer. However, the precise biochemical function of VBP proteins 
remained unclear although VBP proteins were defined as a new class of proteins: 
recruiting proteins. To fully understand the biochemical function of VBP proteins, further 
studies are required and should be focused on the following three aspects. 
The first is the effect of VBP proteins on the T-strand production. If VBP proteins 
serve as an auxiliary protein of T-DNA processing nucleoprotein complex, the deletion of 
three vbp genes would affect the T-strand production. So, the establishment of 
quantitative assay of T-strand level in A. tumefaciens is very important for the further 
study of the VBP functions. In this study, four different vbp mutation strains were 
obtained. After the quantitative assay of T-strand level in A. tumefaciens is established, 
the T-strand level in different vbp mutation strains can be easily assayed.  
The second is the subcellular location of VBP proteins. Although we have testified 
that VBP1 protein was a cytoplasmic protein we do not know whether VBP proteins were 
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co-localized with T-strand movement. If VBP proteins help T-complex to move and to 
recognize the T4SS transporter site, VBP would be co-localized with T-complex and 
localized at the T4SS transporter site. 
The third is the identification of any enzymatic activity of VBP proteins. All three 
VBP proteins possess the conserved domain of nucleotidyltransferase. Undoubtedly, 
identification of any enzymatic activity of VBP protein would be very useful to the 
understanding of the precise biochemical functions of VBP proteins. However, 
nucleotidyltransferase is a superfamily that includes more than 10 distinct sub-
superfamilies. So, the identification of any enzymatic activity of VBP protein is still a 
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